Cerebral endothelial cells in vitro:influence of glia derived extracellular matrix and matrix metalloproteinases on BBB properties by Weidenfeller, A. (Alla)
  
 
Biochemie 
 
 
 
 
 
 
 
 
CEREBRAL ENDOTHELIAL CELLS IN VITRO: 
INFLUENCE OF GLIA-DERIVED EXTRACELLULAR MATRIX AND MATRIX 
METALLOPROTEINASES ON BBB PROPERTIES 



Inaugural-Dissertation 
zur Erlangung des Doktorgrades 
in der Graduate School of Chemistry 
im Fachbereich Chemie und Pharmazie 
der Mathematisch-Naturwissenschaftlichen Fakultät 
der Westfälischen Wilhelms-Universität Münster 
 
 
vorgelegt von 
Alla Weidenfeller (geb. Zozulya) 
aus Pervomaysk (Ukraine) 
 
 
-2004- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dekan:     Prof. Dr. L. Leker 
Erster Gutachter:    Prof. Dr. H.-J. Galla 
Zweiter Gutachter:   Prof. Dr. K.-H. Klempnauer 
 
 
Tag der mündlichen Prüfung:  02.07.2004 
 
Tag der Promotion:   02.07.2004 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        Meinen Eltern  
           
 Ich möchte mich bedanken bei… 
 
 Prof. Dr. H.-J. Galla für die interessante Themenstellung, die freundliche Unterstützung und 
stetige Dikussionsbereitschaft während meiner Arbeit 
 Dr. H. Koller und Prof. Dr. H. Eckert für die Unterstützung dieser Arbeit durch das 
Promotions-Stipendium im Rahmen der International Graduate School of Chemistry der 
Westfälischen Wilhelms-Universität Münster 
 Dr. Joachim Wegener, der mir geduldig und freundlich Hilfestellungen bei der 
Durchführung von ECIS-Experimenten leistete und mit kompetenten Ratschlägen zur Seite 
stand  
 Dr. J. Eble (Institut für Biochemie und Pathobiochemie, Klinikum Münster) für das 
freundliche Überlassen von Integrin Antikörpern, die Möglichkeit der Durchführung von 
FACS Analysen und die interessanten wissenschaftlichen Diskussionen  
 Dr. Lothar Heinrich (AG Degussa, Marl) für sein Freundschaft und seine Hilfe während 
meiner Zeit in Münster  
 Prof. Dr. H. Robeneck für die Hilfsbereitschaft bei der Anfertigung von 
transmissionselektronenmikroskopischen Proben 
 Prof. Dr. Olga Matyshevska für die Unterstützung bei persönlichen und wissenschaftlichen 
Belangen 
 Joe, Christian, Anja, Andreas und Patrick für die Durchsicht dieses Manuskriptes 
 Sabine für die Hilfe in der Zellkultur, Joe und Björn Reiss für die Unterstützung bei den 
ECIS-Messungen und Christian für die Hilfe bei molekularbiologischen Experimenten 
 allen Mitgliedern der BHS-Gruppe – auch den inzwischen Ehemaligen – für ihre 
Freundschaft und die schöne Promotionszeit. Ganz besonderen Dank den Laborkollegen 
Anja, Beate, Christian, Dagmar, Evelyn, Frank, Jens, Joe, Mairin, Herrn Seidl, Susanne, 
Patrick, Tanja und Ulf. Herrn Dr. Greving und Christian ganz besonders für die Deutsch-
Einführung für Ausländer und die wirklich wichtigen Worte des alltäglichen Lebens. Ohne 
eure Hilfe hätte ich nie so gut Deutsch gelernt. Dem „lieben T.“ für die optimistische 
Einstellung und Hilfsbereitschaft in Computerfragen und darüber hinaus 
 dem ganzen Insitut für das einmalig gute Arbeitsklima, besonders bei Wolfgang und Freddy, 
Lydia, Antje, Steffi und Walter 
 mein besonderer Dank gilt Anja und Susanne für ihre Lust und Energie neben dem Labor 
auch etwas anderes zu unternehmen 
 meinen neuen und alten Freunden aus Münster und Kiev, besonders bei: Ira und Sasha, 
Luda, Lida, Lilia, Oleg, Nata (USA), Anja und Andreas, Susanne und Hendrick, Sabine und 
 Bernd, Kristina und Matthias, Gesine und Markus, Melanie und Jan, Frauke und Volker, 
Claudia und Ansgar, Muffin und Ruth, Maryana, Viktor und Hennes 
 Elisabeth und Ulrich für ihre Freundschaft und Unterstützung 
 allen Schwiegerschwestern und –Brüdern 
 meinen Eltern (   	
   ,       	
     ﬀ	  ﬂﬁﬃ , 	
  
   !ﬁ   ﬀ   ﬁ  
ﬂ
ﬀ"#

 ﬃ
%$
 , 


  &  
'
 
ﬀ)(

 

 "ﬁﬁ ) 
 und ganz besonders bei meinem Mann, besten Freund und auch Kollegen, Christian (geb. 
Weidenfeller) für sein „da sein“ (   $    *
  ) !!!  
 
 
 
 
 
 
1 Summary  1 
1 Summary .................................................................................................................................3 
2 Introduction ............................................................................................................................3 
2.1 Barriers of the central nervous system (CNS) .........................................................................3 
2.1.1 Organization of the blood-brain barrier (BBB) ..................................................................................... 3 
2.1.2 Brain capillary endothelial cells (BCEC) .............................................................................................. 3 
2.2 Glial cells .................................................................................................................................3 
2.2.1 Astrocytes.............................................................................................................................................. 3 
2.2.2 Pericytes ................................................................................................................................................ 3 
2.3 Disorders of the blood-brain barrier ........................................................................................3 
2.4 Porcine aorta endothelial cells (PAEC) as a macrovascular endothelium...............................3 
2.5 The extracellular matrix (ECM) of the central nervous system...............................................3 
2.5.1 Integrins: cell receptors of the ECM ..................................................................................................... 3 
2.5.2 The basement membrane (BM) ............................................................................................................. 3 
2.5.3 Importance of the ECM for the BBB functionality ............................................................................... 3 
2.6 Matrixmetalloproteinases (MMPs) ..........................................................................................3 
2.6.1 Overview of metalloproteinases ............................................................................................................ 3 
2.6.2 Structure and function of MMPs ........................................................................................................... 3 
2.6.3 Regulation of MMP activity.................................................................................................................. 3 
2.6.4 Tissue inhibitors of matrixmetalloproteinases (TIMPs) ........................................................................ 3 
3 Objectives of the project..........................................................................................................3 
4 Impact of individual ECM molecules on cell adhesion and tight junction 
formation.................................................................................................................................3 
4.1 Electric cell-substrate impedance sensing (ECIS) ...................................................................3 
4.2 Experimental conditions for time resolved measurements of attachment and 
spreading..................................................................................................................................3 
4.2.1 Serum addition induces attachment of PBCEC in vitro ........................................................................ 3 
4.2.2 Trypsin delays the re-attachment of suspended cells after subculture................................................... 3 
4.2.3 Trypsin inhibitor stops the residual trypsin activity in cell suspensions ............................................... 3 
4.3 The importance of individual ECM proteins for cell adhesion and tight junction 
formation..................................................................................................................................3 
4.3.1 Individual ECM proteins promote cell-cell contacts formation in PBCEC........................................... 3 
4.4 The role of integrins in attachment and spreading of PBCEC.................................................3 
4.4.1 The expression of integrin subunits in PBCEC measured by FACS ..................................................... 3 
2 1 Summary 
5 The functional impact of endogenously-derived ECM for BBB phenotype ........................ 3 
5.1 The characterization of ECM expression on protein and RNA level...................................... 3 
5.1.1 PBCEC secrete special ECM in vitro ....................................................................................................3 
5.1.2 PAEC secrete special ECM in vitro.......................................................................................................3 
5.1.3 Glial cells produce special ECM in vitro ...............................................................................................3 
5.1.4 The sub-cellular ECM composition differs from the ECM level in the whole cell lysate .....................3 
5.1.5 ECM expression in PBCEC compared to PAEC on RNA level ............................................................3 
5.2 Endogenously derived ECM influences the time course of cell adhesion and tight 
junctions formation ................................................................................................................. 3 
5.2.1 Optimization of the cell lysis method to obtain substrates coated with endogenous ECM ...................3 
5.2.2 Endogenously-derived ECM promotes cell adhesion and tight junction formation ..............................3 
5.3 Influence of endogenous matrices on mature cell-cell and cell-matrix contacts..................... 3 
5.3.1 PAEC express the main tight junction proteins in vitro.........................................................................3 
5.3.2 Modification of cell-cell and cell-substrate contacts in PAEC cultured on PBCEC-derived 
ECM ......................................................................................................................................................3 
5.3.3 Endogenously-derived ECM alters the morphology of cell-cell and cell-substrate contacts 
of PBCEC and PAEC ............................................................................................................................3 
5.3.4 Alteration in cell shape of PBCEC mediated by different endogenous matrices...................................3 
5.3.5 Expression of the main tight junction proteins in PBCEC compared to PAEC on protein 
level .......................................................................................................................................................3 
5.3.6 Expression of the main tight junction proteins in PBCEC compared to PAEC on RNA 
level .......................................................................................................................................................3 
6 MMPs regulate barrier properties in vitro by ECM degradation......................................... 3 
6.1 The production of matrix metalloproteinases and their inhibitors by glial cells in 
vitro ......................................................................................................................................... 3 
6.1.1 Localization of MMP-9 secreted by pericyte and astrocytes cultures in vitro .......................................3 
6.1.2 Secretion of MMP-2 and MMP-9 by pericyte and astrocyte cultures into the supernatant ...................3 
6.1.3 The expression of MMP-2 and MMP-9 by pericyte and astrocyte cultures on RNA level ...................3 
6.1.4 Localization of TIMP-1 and TIMP-2 secreted by pericyte and astrocyte cultures ................................3 
6.1.5 Secretion of TIMPs by pericyte and astrocyte cultures on RNA level ..................................................3 
6.2 Aorta endothelial cells exhibit a different profile of MMP-2 and MMP-9 secretion.............. 3 
6.3 MMP-9 secretion by PBCEC is modulated by the presence of pericytes ............................... 3 
6.3.1 Purity optimization of PBCEC primary culture.....................................................................................3 
6.3.2 Zymographic studies of MMP-9 secretion by PBCEC after puromycin treatment ...............................3 
6.4 Secretion of MMP-2 and MMP-9 by PBCEC is regulated by glial cells in co-
culture conditions.................................................................................................................... 3 
1 Summary  3 
6.4.1 Zymographic analysis of PBCEC conditioned medium after co-culture with pericytes and 
astrocytes............................................................................................................................................... 3 
6.4.2 MMP-9 is detected in a complex with TIMP-1 in brain endothelial and glial cells .............................. 3 
6.4.3 Fluoremetric measurements of active MMPs in PBCEC supernatants after co-culture with 
pericytes and astrocytes......................................................................................................................... 3 
6.4.4 The transcellular electrical resistance (TEER) of PBCEC in co-cultures with glial cells ..................... 3 
6.5 Functional role of MMP-9 for the adhesion and spreading of PBCEC ...................................3 
7 General discussion and perspectives......................................................................................3 
7.1 Functional significance of purified and endogenously-derived ECM for BBB 
formation in vitro .....................................................................................................................3 
7.2 ECM and tight junction proteins expression in PBCEC differs from that found in 
PAEC on protein and RNA levels ...........................................................................................3 
7.3 Modulation of cell-cell and cell-substrate contacts in PBCEC and PAEC cultured 
on endogenously-derived ECM ...............................................................................................3 
7.4 The role of ECM degrading matrix metalloproteinases at the BBB ........................................3 
8 Experimental...........................................................................................................................3 
8.1 Cell culture...............................................................................................................................3 
8.1.1 Isolation and culture of porcine brain capillary endothelial cells (PBCEC).......................................... 3 
8.1.2 Subcultivation of the cells ..................................................................................................................... 3 
8.1.3 Isolation and culture of porcine aorta endothelial cells (PAEC) ........................................................... 3 
8.1.4 Culturing of rat astrocytes and porcine pericytes .................................................................................. 3 
8.1.5 Storage of cells ...................................................................................................................................... 3 
8.1.6 Hypotonic lysis of the cells ................................................................................................................... 3 
8.1.7 Subcultivation of PBCEC on transpermeable filters ............................................................................. 3 
8.1.8 Culture of PBCEC on the electric cell-substrate impedance sensing (ECIS) electrodes ....................... 3 
8.1.9 Transmission electron microscopy (TEM) ............................................................................................ 3 
8.1.10 Fluorescence activated cell sorting (FACS) .......................................................................................... 3 
8.2 Protein biochemistry................................................................................................................3 
8.2.1 Isolation of proteins from cultured cells................................................................................................ 3 
8.2.2 Determination of protein concentration................................................................................................. 3 
8.2.3 SDS-polyacrylamide gel electrophoresis............................................................................................... 3 
8.2.4 Coomassie Blue staining ....................................................................................................................... 3 
8.2.5 Protein blotting and immunodetection .................................................................................................. 3 
8.2.6 Stripping of nitrocellulose membranes.................................................................................................. 3 
8.2.7 Immunocytochemistry........................................................................................................................... 3 
4 1 Summary 
8.2.8 Zymographic analysis ............................................................................................................................3 
8.2.9 Fluorimetric measurement of the activity of MMPs in the supernatant of the cell cultures ..................3 
8.3 Molecular biology ................................................................................................................... 3 
8.3.1 Quantification of nucleic acids ..............................................................................................................3 
8.3.2 Agarose gel electrophoresis ...................................................................................................................3 
8.3.3 Isolation of DNA from agarose gels ......................................................................................................3 
8.3.4 Isolation of plasmid DNA......................................................................................................................3 
8.3.5 Isolation of RNA ...................................................................................................................................3 
8.3.6 cDNA synthesis .....................................................................................................................................3 
8.3.7 Polymerase chain reaction methods.......................................................................................................3 
8.3.8 Nucleic acid blotting and hybridization.................................................................................................3 
8.3.9 Cloning and ligation ..............................................................................................................................3 
8.4 Microbiology........................................................................................................................... 3 
8.4.1 Preparation of competent E. coli cells ...................................................................................................3 
8.4.2 Transformation of E.coli cells ...............................................................................................................3 
8.4.3 Cultures of E. coli cells..........................................................................................................................3 
8.4.4 Storage of E. coli cells ...........................................................................................................................3 
9 References .............................................................................................................................. 3 
Appendix A: Abbreviations ............................................................................................................ 3 
Appendix B: Materials and devices ............................................................................................... 3 
Appendix C: WWW links ............................................................................................................... 3 
Appendix D: DiIC18(3) structure ................................................................................................... 3 
Appendix E: Genotypes of Escherichia coli K12 strains.............................................................. 3 
Appendix F: Sequences.................................................................................................................. 3 
Primer sequences: PCR ................................................................................................................. 3 
Primer sequences: QRT-PCR........................................................................................................ 3 
Appendix G: clone charts............................................................................................................... 3 
Appendix H: List of table and figure captions.............................................................................. 3 
Table captions................................................................................................................................. 3 
Figure captions............................................................................................................................... 3 
Lebenslauf.................................................................................................................................... 3 
 
 
1 Summary  5 
1 Summary 
In vivo brain capillary endothelial cells, which constitute the blood-brain barrier, are separated 
from neuroglia cells by a basement membrane (BM). It consists of specialized extracellular 
matrix (ECM) proteins, which are involved in the regulation of specific endothelial functions. 
The molecular mechanisms through which both, ECM and glial cells affect the blood-brain 
barrier function, are still poorly understood. The objective of this project was to clarify the 
role of ECM proteins for the expression of BBB phenotype in microvascular endothelial cells 
in vitro. In order to analyze the specific features of the microvascular ECM, porcine aorta 
endothelial cells (PAEC) and endogenous ECM derived from these cells have been used as a 
reference representing the macrovascular endothelium without BBB properties. 
Three main proteins of the BM (fibronectin, laminin and collagen type IV) were shown to 
modulate the attachment and spreading as well as tight junction formation of porcine brain 
capillary endothelial cells (PBCEC). This has been performed by means of electric cell-
substrate impedance sensing (ECIS) that allows to monitor the formation of cell-matrix and 
cell-cell contacts as a function of time. Fluorescence activated cell sorting (FACS) analysis 
revealed that PBCECs express the following integrin subunits (α1, α2, α3, α5, α6 and β1). 
This pattern of integrin expression is consistent with the observed modulation of endothelial 
cell adhesion by certain ECM components.  
Furthermore, endogenously derived ECM from astrocytes and pericytes has been tested 
functionally in order to promote adhesion, spreading and tight junction formation in brain 
endothelial cells. The results indicated that astrocytes-derived ECM efficiently supports the 
attachment and spreading of PBCEC as well as tight junction formation as determined from 
their electrical tightness. PBCEC also attached, spread and formed tight junctions on 
pericytes- and PBCEC-derived ECM. However, the resistance values as indicator for barrier 
tightness were much lower for PBCEC cultured on the aorta-derived ECM. Moreover, the 
investigations of the cell-cell and cell-substrate contacts of PAEC also indicated alterations 
caused by different ECM. These studies support the view of a direct involvement of specific 
ECM components in the barrier properties of endothelial cells. 
In order to clarify the influence of endogenous glia-derived ECM on the expression of tight 
junctions, expression of these proteins have been compared in aorta and brain endothelial 
cells on RNA and protein levels dependent on the composition of the ECM. Occludin and 
ZO-1, but not claudin-5 were shown to be up-regulated in PBCEC cultured on endogenous 
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pericytes- and astrocytes-derived ECM compared to the collagen type I+III coating used as a 
reference.  
Matrix metalloproteinases (MMPs) are involved in regulation mechanisms of BBB function. 
These enzymes are able to degrade ECM components and thus, influence the differentiation 
process of microvessel endothelial cells that compose the BBB. An individual secretory 
profiles of MMPs and endogenous tissue inhibitors of metalloproteinases (TIMPs) for primary 
cultured microvascular (brain) and macrovascular (aorta) endothelial cells as well as for 
pericytes and astrocytes have been found in this work. Secretion of MMP-9 by PBCEC is 
upregulated by pericytes, when the glial cells are directly co-cultured with PBCEC. 
Furthermore, PBCEC production of MMP-9 was also shown to be regulated by glial cells in a 
filter co-culture setup, in which the cells have no physical contact. Fluorimetric analysis of 
enzymatic activity revealed that both a direct (with physical contact) and an indirect filter co-
cultures of microvessel endothelial cells with pericytes increase MMP activity. This suggests 
an influence of the surrounding glial cells on MMPs secretion by capillary endothelial cells. 
TIMPs were also detected at the BBB by immunocytochemical and western blot analysis. 
They are secreted by PBCEC both into the medium and ECM. Astrocytes and pericytes only 
partly secrete and target TIMPs into the ECM, which suggests the release of soluble TIMPs 
into the brain tissue in vitro. 
Thus, the involvement of endogenous glia-derived extracellular matrix and the role of balance 
between MMPs and their inhibitors (TIMPs) for BBB function have been presented in this 
thesis.  
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2 Introduction  
Brain capillary endothelial cells build up the blood-brain barrier (BBB), a very selective 
interface that regulates the transport of substances between the blood and the brain interstitial 
fluid, thus guarantees undisturbed neuronal function. The BBB is formed morphologically by 
specialized endothelial cells (ECs) lining the intraluminal portion of brain capillaries. These 
ECs are separated from other neuroglia cells by a basement membrane (BM) and are 
characterized by specialized regions of intercellular contacts (tight junctions) that prevent 
leakage of blood substances into the brain parenchyma (Grant et al., 1998). Although it is 
known that extracellular matrix proteins (ECM) can modulate the expression of tight junction 
(TJ) proteins and regulate barrier function, the molecular mechanism of ECM regulation at 
the BBB is not yet clear. 
Furthermore, microglia-cells are resident cells of the central nervous system (CNS) that 
contribute to the formation of the BBB (Janzer and Raff, 1987; Prat et al., 2001; Tao-Cheng et 
al., 1987). Since brain capillaries are covered by endfeet of astrocytes, they are very likely a 
modulator of BBB-properties (Isobe et al., 1996). But there is also evidence that pericytes are 
involved in the regulation of vascular permeability and transport processes across the BBB 
(Allt and Lawrenson, 2000).  
As it was mentioned before there is a basement membrane between capillary endothelial cells 
and astrocytes, which is probably involved in the differentiation of brain capillary 
endothelium leading to the formation of a functional barrier (Tilling et al., 1998). The BM is a 
30-60 nm thin sheet of specialized extracellular matrix proteins and proteoglycans, which can 
be found wherever cells meet connective tissue (Soroka and Farquhar, 1991). Cell adhesion to 
the surrounding ECM is a vital function necessary for cell survival, migration, proliferation 
and differentiation.  
The ECM proteins can be degraded by matrix metalloproteinases (MMPs) during 
angiogenesis, or injury repair. The MMPs have been shown to degrade components of the 
basement membrane in the central nervous system (CNS), leading to a disruption of the BBB 
(Rosenberg, 1995). The activity of MMPs is regulated by endogenous tissue inhibitors of 
metalloproteinases (TIMPs). For example, ECM breakdown occurs if the proteolytic activity 
of MMPs is higher than the inhibition by TIMPs. If the inhibitors are excessively expressed 
and proteolysis is restricted, increase of the ECM proteins synthesis with following fibrosis 
appears (Rosenberg, 2002). 
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Thus, it is important to understand the interactions between the capillary endothelial cells, the 
endfeet of astrocytes, contribution of pericytes and the ECM produced by all these cells. The 
influence of the MMPs which are involved in the degradation of the ECM leading to a 
dysfunction of the BBB has also to be clarified. 
 
2.1 Barriers of the central nervous system (CNS) 
 
Historical background. In 1885, Paul Ehrlich found that intravenous injection of acidic 
dyes into experimental animals caused staining of various organs, with the notable exception 
of the brain (Pachter, 2003). Somewhat later, in 1898, Roux and Borrel observed that tetanus 
toxin injected into cerebrospinal fluid caused marked cerebral symptoms but produced no 
discernible cerebral effect in these animals, when administered intravenously (Roux, 1889). 
These experiments initiated the earliest consideration of a blood-brain barrier that restricted 
the passage of substances into and out of the brain. 
Subsequent experiments to test this concept were conducted by Emil Goldmann. In 1913, 
Goldmann injected the dye tryptan blue directly into the cerebrospinal fluid of rabbits and 
dogs and found that the dye readily stained the whole brain, but did not enter the bloodstream. 
Thus, Goldman showed that the central nervous system is somehow separated from the blood 
by a kind of a barrier (Goldmann, 1913). He concluded that there must be a barrier between 
the blood and the brain tissue that is impermeable to trypan blue. He placed the site of this 
barrier at the small, highly vascular tufts of choroid plexus epithelia within each of the 4 
ventricles of the brain. His findings correlated with the results of other researchers 
(Lewandowsky, 1900; Roux, 1889), who attributed their results to special permeability 
properties of small blood vessels within the brain. But the hypotheses that capillaries provide 
the anatomical base of the barrier properties could not be approved at that time since no 
technique was available to investigate the ultrastructure of the blood vessels in the brain.  
The first insights into the anatomical structures of the brain were provided in the 1950´s with 
the development of an electron microscopy and its approach to investigate biological samples. 
Today, detailed information about the cellular organization of different permeability barriers 
of the central nervous system is available (Saunders et al., 1999a; Saunders et al., 1999b).  
Thus, two principal barriers were found in the CNS: the blood-brain barrier (BBB), which 
covers 99% of the capillary endothelium of the brain, and the blood-cerebral spinal fluid 
barrier (BCSFB) that is located at the choroids plexus epithelium of the 4th ventricles.  
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Anatomy.  Brightman and Reese were the first to show that the capillary endothelial cells 
are the anatomical basis of the blood-brain barrier (Brightman and Reese, 1969).  
Both barriers of the CNS, the BBB and the BCSFB, could be identified 
immunohistochemically in tissue sections of the CNS using different antibodies against 
barrier proteins. An example of such a marker is the glucose transporter protein (GLUT-1), 
which is present in brain capillary endothelium (Pardridge et al., 1990). Anatomical mapping 
of BBB characteristics demonstrates that there are variations in the level of BBB restriction in 
different areas of the CNS. The absence of the BBB at the area postrema allows the diffusion 
of some compounds from the blood into the brain tissue and, thus, providing an important 
area of the brain with a neuroendocrine feedback mechanism.  
However, both systems are unique, the BBB having a 5000-fold greater surface area than the 
BCSF barrier. The concentration of substances in the brain interstitium, which is determined 
by transport through the BBB, can differ markedly from concentrations in CSF, the 
composition of which is determined by secretory processes in the choroid plexus epithelia 
(Sukriti Nag, 2003). The capillaries entering the choroid plexus are different from those of the 
brain parenchyma, in the way that choroidal vessels do not express tight junctions (section 
2.1.2.2) and are porous (fenestrated) (Brightman, 1977). The epithelial cells of the choroid 
plexus express the microvilli and thus expanding a large surface area ensuring that the brisk 
blood flow through the plexus can replace the total CSF volume every 3 to 4 hours (Keep and 
Jones, 1990). The barrier function of the plexus is connected with strong cell-cell contacts, 
which prevent the paracellular diffusion of small hydrophilic molecules (figure 2-1). 
Homeostasis.  Both the BBB and the BCSFB systems control cerebral homeostasis. 
This is crucial for neuronal activity and function. For example, fluctuating differences in pH 
in the blood flow do not have an influence on the interstitial fluid of the brain. The changes in 
the ion concentrations (K+, Na+ and Ca2+) in the interstitial space have an influence on the 
membrane potential of the neurons since they provide the electrical signal (Bradbury, 1993). 
Furthermore, an introduction of xenobiotics is dangerous for the neurons and surrounding 
neuroglia. They must be hindered from entering the brain. The chemical composition of the 
blood fluctuates in the body especially after meals or bouts of exercises. If the brain is 
exposed to such fluctuations, the result might be uncontrolled nervous activity, since some 
hormones and amino acids serve as neurotransmitters. There are different structures in the 
brain, which are able to control these processes maintaining the balance of the brain 
interstitium: 
a. a large network of cerebral capillaries, which separates the bloodstream from the 
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brain interstitial fluid (BBB); 
b. an arachnoid membrane that covers the outer surface of the brain; 
c. a highly vascularized choroid plexus (BCSFB) (figure 2-1).  
While the last two systems (b and c) protect the central nervous system at its macroscopic 
border, the BBB controls the entry and exit of compounds within the brain and is mainly 
responsible for providing the brain with necessary nutrients. The choroid plexus produces the 
cerebrospinal fluid, which contains nutrients, ions and other essential molecules. These 
substances flow around the spinal chord through the ventricular system into the subarachnoid 
space, surrounding the brain and drain back into the blood. As the cerebrospinal fluid freely 
exchanges substances with the interstitial fluid, which surrounds the neurons of the brain, the 
BCSF barrier must also keep toxic compounds out of the brain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-1. Schematic view of the mammalian brain.  
Overview of the anatomy of the brain and localization of the ventricles of the choroid plexus. (Spector, 
1989) 
 
While the subarachnoidal membrane is generally impermeable for water-soluble substances 
and its role in forming the BCSF barrier is largely passive, the choroid plexus, however, 
actively regulates concentrations of molecules in the CSF. Active transport system of BCSFB 
provides an ion gradient across the epithelial cell layer, which results in a net transport of 
NaCl and thereby induces an osmotically driven water flow into ventricles forming the CSF. 
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Additionally, the CSF is enriched in small amounts with substances derived from the blood, 
which are essential for the brain, like vitamin C, folates, vitamin B6 and 
desoxiribonucleosides (Spector, 1989). The importance of the unique homeostasis system of 
the brain appears to be particularly relevant to the pathophysiology of stroke, a brain disorder, 
in which perturbations of homeostasis pathways are prominent (Pardridge, 1998)  
 
Brain metabolism. During evolution the brain of all mammalians has developed special 
properties with a strong impact on a constant and intensive nutrition and oxygen supply. Thus, 
the human brain needs 20% of the energy provided by the metabolism of the whole organism, 
although it occupies only about 2% of the whole body weight (eg. 1300 g). This corresponds 
to a demand of 75 mg of glucose and 50 ml of oxygen per minute. The blocking of oxygen 
supply, which lasts 8-10 seconds can lead to the irreparable damage of the CNS after several 
minutes because of a complete interruption of oxygen provide. The partial injure of the brain 
areas due to an interruption of oxygen supply in the particular region of the brain causes the 
same effect.  
In addition, the metabolic barrier consists of enzymatic steps, by which compounds are 
modified in the endothelium and rendered unable to enter the brain. The combination of a 
permeable barrier and selective transport mechanisms is not the only ability of the blood-brain 
barrier to prevent the brain from uncontrolled chemical fluctuations within the interstitial 
fluid. Compounds that enter the endothelial cells either due to their lipophilic nature or to 
their affinity to one of the transport proteins can be converted by metabolic processes into a 
chemical compound incapable of traversing the abluminal membrane. For example, 4-
hydroxy-tryptophane and L-dopa are carried by the L-system of amino acid transporters to the 
cytosol of the endothelial cells. An uncontrolled passage across the abluminal membrane 
would be dangerous because these compounds are precursors of the neurotransmitters 
serotonin and dopamine. Once in the endothelium these substances are converted to dopamine 
and dihydroxyphenylacetic acid (DOPAC) they cannot cross the luminal membrane into the 
brain. This phenomenon, which is found for a lot of compounds (Goldstein and Betz, 1986; 
Johansson, 1990; Vorbrodt, 1988) is called the metabolic blood-brain barrier. 
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2.1.1 Organization of the blood-brain barrier (BBB) 
 
Localization. With development of electron microscopic technique the localization of BBB 
was firstly shown by Reese and Karnovsky (1967). After injection of horseradish peroxidase 
into the blood stream the enzyme penetrated the capillary wall of most organs through 
channels and gaps between endothelial cells or it was engulfed in pinocytotic vesicles. In the 
brain, the infiltration of peroxidase was stopped by the tight connections between adjacent 
endothelial cells. Later, Brightman and Reese injected horseradish peroxidase into one of the 
cerebral ventricles and observed that the enzyme was distributed in the extracellular space of 
the brain, but it was prevented from leaving the brain by the tightly joined endothelial cells 
(Brightman and Reese, 1969). 
Structure. The blood-brain barrier consists of a layer of endothelial cells that line the 
blood vasculature throughout the brain.  
A cross-section of a brain capillary and adjacent glial cells are shown in figure 2-2 A. The 
capillary lumen (1) is completely surrounded by endothelial cells (2), which are inter- and 
intracellular connected by tight junctions (3). These junctions seal off the intercellular cleft 
against smallest molecules and actually convert the endothelial cell layer into a closed 
interface between the blood and the brain interstitium. At the abluminal (basolateral) side the 
cells are surrounded by a 100 – 150 nm thick basement membrane built up by the 
extracellular matrix molecules (4). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-2. Micrograph of a brain capillary in a cross-section (A) and a three 
dimensional view with astrocytes (B) (Krstic, 1988). 
 
 
 
 
4 
3 6 
1 
2 
5 
2 
6 
7 
B. A. 
2 Introduction  13 
Laminins A and B, fibronectins, collagen type IV and proteoglycans are the main molecules 
of the basement membrane (Krause et al., 1991). Pericytes are embedded within this basement 
membrane (5). Different from smooth muscle cells of the larger vessels, the pericytes are not 
assembled in capillaries but their cell bodies are orientated parallel to the capillaries (Shepro 
and Morel, 1993). Their exact function is unclear, but experimental evidence indicates that 
they influence cell proliferation (Balabanov and Dore-Duffy, 1998; Orlidge and D'Amore, 
1987) and play a role in phagocytotic procedures of neuronal immune defence (Balabanov 
and Dore-Duffy, 1998) and other transport processes (Krause et al., 1991; Sims, 1991). 
Finally, they participate in endothelial cell differentiation (Balabanov and Dore-Duffy, 1998). 
The brain capillary is separated from the surrounding tissue by so-called Membrana limitans 
gliae perivascularis, which consists of the astrocytic endfeet (6). The astrocytic endfeet cover 
99% of the surface of the capillaries and form cell-cell contacts to the surrounding neurons (7) 
(Pardridge, 1993). They ensure a rapid recovery of the resting membrane potential of the 
neurons by an uptake of potassium ions directly after an action potential was triggered (Matz 
and Hertz, 1989). Furthermore, the astrocytes were shown to play an important role in the 
induction of the blood-brain barrier phenotype (Holash and Stewart, 1993; Minakawa et al., 
1991; Stewart and Wiley, 1981b; Svendgaard et al., 1975) 
 
2.1.2 Brain capillary endothelial cells (BCEC) 
 
In vitro BBB models:  In order to further understand the underlying mechanisms that 
induce and retain the unique phenotype of the BBB as well as the development of new 
pharmaceuticals taht are able to penetrate the brain, it is of great interest to establish a reliable 
in vitro model system. The isolated cells in culture are a suitable model system to investigate 
molecular mechanisms in the absence of the complexity of whole organisms. A sufficient  in 
vitro model of the BBB should display most properties of the barrier of living animals (Audus 
et al., 1996). It is very important to mimic the in vivo situation as good as possible. But the 
cells in vitro lack some specific brain-derived factors that are necessary for them to keep up a 
differentiated BBB phenotype in vitro (Beuckmann et al., 1995). Therefore, the identification 
of these brain-derived properties is important for in vitro studies. Although the specific 
mechanism of gene expression of BBB-specific proteins appears to be directed by factors 
released by surrounding brain cells (including astrocytes and pericytes), it is still under the 
controversial discussion, which factors lead to a BBB-specific phenotype formation 
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(Boado, 1998). 
In general, during the isolation procedure the brain tissue is either enzymatically or 
mechanically dispersed followed by filtration and centrifugation steps. The cultured cells 
show the typical properties of microvascular endothelial cells, which include the typical 
protein pattern, attenuated pinocytosis, lack of fenestrations and tight junctions (Audus and 
Borchardt, 1986; Audus and Borchardt, 1987; Bowman et al., 1983). However, the isolation 
of pure endothelial cells as a blood-brain barrier model is fraught with a number of problems. 
Even though there have been improvements in isolation and cell growing techniques, the 
process is still time consuming, labour intense and expensive. The isolation of primary 
endothelial cells is prone to preparation variations, the cells are fastidious in their growth 
requirements and they have a limited life and utility span. Furthermore, very often cells de-
differentiate in vitro. These facts lead to the difficulties in comparing results from 
experiments with different cell preparations or cell passages. 
In 1978, Panula and co-worker demonstrated that isolated rat brain microvessel endothelial 
cells could be kept in culture (Panula, 1978). Today, most research groups use a primary 
culture of brain capillary endothelial cells (Audus et al., 1996) derived from rat (Abbott et al., 
1992; Barrand et al., 1995), dog (Speth and Harik, 1985), cattle (Audus and Borchardt, 1987; 
Cecchelli et al., 1999; Dehouck et al., 1990; Meresse et al., 1989; Rubin et al., 1991), pig 
(Hoheisel et al., 1998a; Mischek et al., 1989), primate (Shi and Audus, 1994) or human brain 
(Stanimirovic et al., 1996). 
Isolated brain capillaries are also referred to as isolated brain microvessels, because these 
preparations invariably contain pre-capillary arterioles, which are comprised of endothelial 
and smooth muscle cells. In addition, these capillaries are comprised of pericytes. The 
abluminal surface of isolated brain capillaries is also rich of astrocyte foot connections that 
remain adhered to the basement membrane of the capillary (White et al., 1981). The distance 
separating the astrocyte foot process and the ablumenal surface of the endothelial cells in vivo 
is only approximately 20 nm (Paulson and Newman, 1987), as a space filled with the 
microvascular extracellular matrix. More than 1 cm is a space between the apical (blood side) 
chamber with endothelial cells and basolateral (brain side) chamber with cultured astrocytes 
in vitro system (Cecchelli et al., 1999). Thus, in vitro systems are necessarily simplified 
versions of the system in vivo, so precluding simple extrapolation back to the more complex 
situation in vivo.  
Different co-cultures have also been developed to study the induction of morphological 
phenotype specific properties of the BBB by neuroglia cells (Isobe et al., 1996). A lot of the 
2 Introduction  15 
cell-adhesion molecules and extracellular matrix components are considered to be involved in 
the cell-cell contacts between endothelial and other neuroglial cells in vivo (Sobue et al., 
1999). Whether the neuroglia cells or a part of the extracellular matrix are influencing the 
differentiated BBB phenotype is still under controversial discussion.  
By the isolation of the BCEC from pigs a primary culture of capillary endothelial cells was 
developed and characterized under serum-free culture conditions supplied with physiological 
concentration of hydrocortisone (HC) (Hoheisel et al., 1998b; Tewes et al., 1996). These cells 
retain their endothelial phenotype, displaying the main properties of the BBB-specific 
features. They keep these characteristics during the cultivation period and form confluent 
monolayers of high transendothelial electrical resistance (TEER) that restrict the paracellular 
passage of macromolecules.  
More recently, another in vitro culture system characterized by intraluminal flow (dynamic in 
vitro BBB (DIV-BBB) has been developed. This system also closely mimics the BBB 
phenotype in vivo (Stanness et al., 1997). It consists of cerebral or peripheral ECs cultured 
intraluminally in the presence of abluminally cultured astrocytes using hollow fiber tubes 
inside a sealed chamber. The system is suitable to study the effects of fluid flow and shear 
forces on long term cultures of ECs as well as their interplay with neurons in a dynamic triple 
culture setup. 
Several in vitro models of the BBB are currently used to explore the influence of diseases on 
the dynamic barrier on cellular, biochemical and molecular levels. Each model attempts to 
mimic the complexity of the mammalian BBB, but each is characterized by different selective 
permeability to different compounds and may manifest a broad range of TEER values. A 
critical feature in any model system is the ability to discriminate between a compound of high 
permeability through the lipid bilayer (transcellular) and a compound such as sucrose or 
mannitol, that traverses (albeit poorly) via a paracellular pathway.  
The new knowledge and technologies are important to develop refined in vitro models for 
studying not only the molecular and biochemical functions of the normal BBB, but also the 
specific involvement of the BBB in neurological disorders. 
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2.1.2.1 Permeability of BCEC  
 
Features that distinguish cerebral endothelial cells from those of non-neural vessels and form 
the structural basis of the BBB include the presence of tight junctions between cerebral 
endothelial cells, reduced endothelial plasmalemmal vesicles or caveolae, and increased 
number of mitochondria.  
The innovative experiments of Paul Ehrlich more than a century ago demonstrated that the 
permeability properties of cerebral vessels were different from those of non-neural vessels 
(Ehrlich, 1885). The permeability of cerebral microvessels to exogenous protein tracers 
decreases during the brain development. This decrease in permeability appears to be a gradual 
process and occurs at different times in different locations of the brain. A possible measure of 
tightness in capillary endothelial cells is transendothelial resistance. Rutten et al. were the first 
to report an elevated electrical resistance of endothelial cells in vitro (Rutten, 1987). A 
permeability barrier for low molecular weight compounds such as sucrose or inulin were 
shown by Dehouck et al. (Dehouck, 2002).  
As the tight junctions completely seal the paracellular cleft of adjacent brain capillary 
endothelial cells, each transfer across the brain endothelium has to be transcellular 
(figure 2-3).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2-3. Transcellular and paracellular ways of the permeability through the 
endothelial cell monolayer  
The paracellular permeability is regulated by a tight junction complex. The transcellular permeability 
limits diffusion of small lipophillic substances.  
 
There are numerous transfer mechanisms that are essential for the stabilization of the internal 
environment of the normal adult brain, as well as mechanisms important for the supply of 
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adequate nutrients. The most decisive factor for passive diffusion across the brain 
endothelium is the lipid solubility, enabling the hydrophobic molecules to dissolve in the lipid 
core of cell membranes and, thus to traverse them. Several studies have shown a clear 
correlation between the octanol/water partition coefficient and penetration into the brain as 
long as the regarded compounds are not substrates for any specific transport system (Levin, 
1980; Pardridge, 1993; Lohmann et al., 2002).  
D-glucose as the main source of energy for the brain is a water-soluble substance that enters 
the brain via facilitated diffusion. In the brain the glucose transport via the GLUT-1 protein 
(Crone, 1965) is highly stereospecific for D-glucose (Johansson, 1990) and directed from a 
region of high concentration (blood) to a region of low concentration (brain). In such 
movement the energy of transport is provided by the concentration gradient itself and the 
carriers merely facilitate the diffusion that would take place. In the same way the 
stereospecific transport of large amino acids is mediated, which are required for the synthesis 
of neurotransmitters and proteins (Oldendorf and Szabo, 1976).  
In contrast to the facilitated diffusion active transport systems transfer substrates from regions 
of lower to regions of higher concentration powered by external energy. The fourth way to 
transfer the substances across the endothelium is given by receptor-mediated endocytosis.  
The control of the transcellular and paracellular permeability is a specific feature of the BCEC 
at the blood-brain barrier. The unspecific transcellular permeability for soluble substances is 
associated with strongly reduced pinocytotic activity of cerebral endothelial cells. Whereas 
the paracellular permeability is controlled by the tight cell-cell contacts between the BCEC, 
tight junctions. This special type of cell-cell connections is described in the next section.  
 
2.1.2.2 Tight junctions  
 
The specialized brain microvessel endothelial cells do not only exhibit different metabolic 
characteristics in comparison to endothelial cells of other organs, but also possess well-
developed intercellular tight junctions. (Staddon and Rubin, 1996). The studies of Brightman 
and Reese (1969) using horseradish peroxidase as a tracer suggested that tight junctions 
extend circumferentially around cerebral endothelial cells in an area called zonula occludens. 
Tight junctions provide a continuous seal around the apical regions of lateral membranes of 
the brain endothelial cells. Certain areas of the brain, most of which are situated close to the 
ventricle and are therefore called circumventricular organs, have endothelial cells that do not 
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form tight junctions.  
In electron micrographs of freeze fracture replicas the tight junctions appear as a network of 
small ridges on one side and complementary grooves on the opposite side (Dermietzel, 1975). 
Most of tight junction particles appear at the protoplasmic fracture (P) face, accordingly, the 
exocytoplasmic fracture (E) leaflet exhibits grooves containing only few particles. Although a 
variety of integral proteins specifically localized within these contact points are known, it is 
not clear, whether these proteins are sufficient to build up a barrier as postulated in a pure 
protein model. The protein model is based on transmembrane proteins located at the cell-cell 
contacts. Lipids as well may be involved to seal the cleft by an especially designed lipid-
protein-complex. This idea was firstly published by Kachar and Reese, who postulated that 
the exoplasmatic membrane-domains of the lipid bilayers of two adjacent cells fuse (Kachar 
and Reese, 1982). As a consequence of this, a continuous lipid-layer is formed at the apical 
part of the junctions. The tight junction strands are formed by lipidic cylinders, in which lipids 
are arranged in inverted micelles (Grebenkamper and Galla, 1994; Hein et al., 1992; Kachar 
and Reese, 1982). Wegener and Galla proposed a combination of the lipid and the protein 
models (Wegener and Galla, 1996). In this model the proteins are responsible for the 
formation of inverse micellar structures within the tight junction strands. Wolburg et al. have 
suggested that the protoplasmic (P)-face association of tight junction particles in electron 
micrographs from freeze fracture micrographs is an indication of a functional barrier (Kniesel 
and Wolburg, 2000; Wolburg, 1994). Besides of these morphological investigations, 
substantial data imply that the phosphorylation state of the junctional proteins is involved in 
the restricted permeability characteristics in brain capillary endothelial cells rather than their 
quantity (Kniesel and Wolburg, 2000; Rubin and Staddon, 1999). Furthermore, there is a 
logarithmic relationship between the number of strands and the TEER values. The high 
electrical resistance of cerebral endothelial cells is accompanied by an expression of tight 
junction proteins associated with P-face. In contrast, in non-BBB endothelial cells, tight 
junctions are almost completely associated with the extracellular (E-) face. This means that 
the morphologic features of tight junctions reflect their physiologic properties.  
Tight junctions are composed of an intricate combination of transmembrane and cytoplasmic 
proteins linked to an actin-based cytoskeleton that allows these junctions to form a seal while 
remaining capable of rapid modulation and regulation (figure 2-4). Two main transmembrane 
protein classes of the tight junctions have been identified: occludin (Furuse et al., 1993) and 
the claudins (Furuse et al., 1998). Occludin spans the membrane 4 times with both the amino 
and carboxy termini located intracellulary and it is one of the primary sealing proteins in tight 
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junctions (Tsukita and Furuse, 1999). Occludin is a regulatory protein, whose presence at the 
BBB is correlated with increased electrical resistance across the barrier and decresead 
paracellular permeability. 
However, there is strong evidence that occludin is not essential for the integrity of the tight 
junctions, as occludin knockout mice are still capable of forming these inter-endothelial 
connections (Saitou et al., 2000), while claudin knockout mice are nonviable (Gow et al., 
1999). Huber et al. found that both claudin-1 and claudin-5 are expressed in the brain 
endothelium (Huber, 2001). Claudins form dimers and bind homotypically to claudins on 
adjacent endothelial cells to form the primary seal of the tight junction.  
 
 
 
 
 
 
 
 
 
 
Figure 2-4. Molecular structure of tight junctions.  
The cellular cleft is sealed with the transmembrane proteins occludin and different claudins. ZO-1 is 
directly associated and belongs to the family of membrane-associated guanylate kinases (MAGUK). 
The tight junctional zone is linked to the cytoskeletal elements (actin stress fibres). Figure taken from 
Fanning et al., 1999. 
 
The carboxy-terminal cytoplasmic tail of occludin and claudins interact with a number of 
cytoplasmatic zonula occludens proteins (ZO), like ZO-1, ZO-2 and ZO-3 (Fanning, 1998; 
Haskins, 1998). These proteins belong to the membrane-associated guanylate kinase 
(MAGUK) protein family that interact with other plaque domain molecules such as cingulin 
(Stevenson, 1989) and 7H6 antigen (Zhong, 1993). The ZO proteins can also interact with 
signalling molecules and cytoskeletal proteins such as cortactin and actin. Junctional adhesion 
molecules (JAMs) are transmembrane molecules that co-localize with tight junctions.  
JAM-1 is a member of the immunoglobulin superfamily (IgSF) and co-distributes with tight 
junction components at the apical region of the junction. Three different members of the JAM 
family have been identified, which are heterogeneously expressed throughout epithelial and 
endothelial cells (Aurrand-Lions, 2001). Tight junction proteins are coupled to the actin 
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cytoskeleton and are under the control of a number of intracellular signalling molecules. Thus, 
the organization of tight junction-associated proteins may be directly or indirectly targeted by 
signalling molecules, thereby providing the regulation of permeability of the BBB.  
As it was already mentioned in section 2.1.2, the barrier properties of a cell monolayer can be 
determined by a transendothelial electrical resistance (TEER) measurement across the 
endothelium with values up to 2000    cm2 (Butt et al., 1990). In vitro models often monitor 
both intercellular tightness and paracellular diffusion of marker molecules as the sum of the 
integrity of the endothelial monolayers. A lot of physiological processes such as inflammatory 
conditions can drastically decrease the TEER (de Vries et al., 1996; de Vries et al., 1997). 
 
2.2 Glial cells 
 
Using chick-quail transplantation experiments Stewart and Wiley were the first to 
demonstrate that the blood-brain barrier characteristics can be induced in endothelial cells that 
had invaded brain transplants (Stewart and Wiley, 1981a; Stewart and Wiley, 1981b). The 
expression of the BBB-specific antigen HT7 was observed in chick endothelial cells that had 
invaded embryonic mouse brain transplanted to the chick chorioallantoic membrane. 
Conversely, brain capillaries became permeable after invasion of somite transplants. This 
indicates that organ-specific characteristics of endothelial cells may be induced and 
maintained by their local environment. Structurally, the cell type closest to brain capillary 
endothelial cells is the astrocyte, whose endfeet cover much of the basal surface of capillaries. 
Janzer and Raff investigated that astrocytes might induce endothelial cells to adopt a brain 
phenotype (Janzer et al., 1987). The authors purified and cultured astrocytes from neonatal rat 
brain and transplanted them onto the chick chorioallantoic membranes and into the rat eyes. 
Their experiments showed that rat astrocytes, in the absence of other cell types, are capable of 
causing even chick peripheral endothelial cells to become less leaky to large molecules. This 
suggests that astrocytes are also necessary for the maintenance of the blood-brain barrier. In 
addition, it supports the concept that endothelial cell differentiation can be modulated by 
organ and tissue environments.  
A peculiar membrane specialization is found at the gliovascular interface in astrocytic 
endfeet, the so-called orthogonal arrays of particles (OAP) or assemblies. The function of the 
OAPs is unknown. As both the OAP and potassium conductance are distributed over the glial 
surface in a similar pattern, particularly in astrocytes and retinal Müller cells, these data 
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support the idea that OAPs correspond to symmetric high conductance potassium channels. 
Potassium homeostasis is crucial for the brain function and is an important aspect of the 
blood-brain barrier. Interestingly, OAPs appear during ontogenesis when the BBB matures, 
suggesting that astrocyte differentiation, defined by general markers such as glial fibrilliar 
acidic protein (GFAP) and specialized properties of astrocytes such as the polarized 
distribution of OAPs in their plasma membrane, are coupled with BBB differentiation. 
However, there are a lot of contradictions for the importance and functional role of the 
astrocytes. For example, the studies of Krum et al. showed that some grafts of embryonic 
brain into host brain do not show tight endothelium, and destruction of glial cells and neurons 
does not always cause barrier breakdown (Krum, 1996; Krum et al., 1997; Krum et al., 2002). 
The understanding of the contribution of the microglia within the BBB is of high demand.  
In the central nervous system, there are three kinds of glial cells other than neurons: 
astrocytes, oligodendrocytes and microglia (Nakamura, 2002) (figure 2-5). 
 
 
 
 
 
 
 
 
 
 
Figure 2-5. Glial cells in the CNS 
A: Astrocytes; B: Oligodendrocytes and C: Microglial cells. (adapted from Purves et al. at 
eatworms.swmed.edu/~leon) 
 
Microglia (brain macrophages) are believed to be consequently activated after neuronal 
damage to phagocytose the damaged neurons. Afterwards, the postneuronal space is occupied 
by the proliferation of reactive astrocytes (gliosis or astrocyte scarring). However, Morioka 
et al. observed that the microglial activation begins prior to a neuronal degeneration in an 
animal model of transient brain ischemia (Morioka, 1991). Under physiological conditions, 
residential microglia are quiescent and scattered throughout the CNS. Occasionally, microglia 
are moderately activated to play the classical role as “scavengers” for the maintenance and 
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restoration of the CNS. They begin to proliferate, change their morphology into an amoeboid 
shape and phagocytose cells that are pathologically damaged or developmentally unnecessary. 
These functions of microglia are controlled by communication with cytokines, chemokines, 
trophic factors and other neuromodulating molecules among neurons, astrocytes and 
microglia. However, imbalanced microglial activation may cause neurodegeneration.  
For many years the importance of the different glial cells on the induction of BBB phenotype 
has been discussed and transferred into numerous co-culture systems in vitro. It is known that 
the signals that induce endothelial cells to express the BBB phenotype result from specific 
interactions between capillary endothelial cells and surrounding neuroglia cells.  
In the central nervous system, neuron-glia and neuron-endothelial interactions are involved in 
the development of specialized functions of each cell via the secretion of ECM molecules. 
Astrocytes and microglia are also able to secrete the extracellular matrix proteins – a complex 
mixture of high-molecular-weight molecules – which are supposed to have a contribution into 
the formation of the BBB. Pericytes, the other type of neuroglia cells, are also actively 
involved in the contact with cerebral capillaries. They not only reside in proximity to the 
cerebral endothelial cells, but also have several different types of direct contacts with these 
cells. The question, whether these cells also produce the factors that are necessary to induce 
certain BBB properties in BCEC, is still unresolved. 
Therefore, a lot of efforts are focused on clarifying the influence of endogenous factors 
secreted by different glial cells. Savettieri et al. have shown for the immortalized cell-line 
RBE4 that the tight junction protein occludin is only expressed and correctly targeted when 
these cells have been cultivated on the collagen type IV substrate in co-culture (without a 
physical contact) with neurons from the cortex (Savettieri et al., 2000). There is a lot of 
evidence that the formation of tight junctions between capillary endothelial cells is supposed 
to be maintained by astroglial cells  
 
2.2.1 Astrocytes  
Anatomical examination of the brain microvasculature shows that the endfeet of astrocytic 
glia form a lacework of fine lamellae closely apposed to the outer surface of the endothelium 
(Kacem et al., 1998) (see figure 2-6). 
Davson and Oldendorf suggested that inductive influences from astrocytic glia could be 
responsible for the development of the specialized BBB phenotype of the brain endothelium 
(Davson and Oldendorf, 1967). In vitro cell culture models have provided a great deal of 
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information about the induction of the BBB phenotype in brain endothelium and have 
generally confirmed an inductive role of astrocytes (Bauer and Bauer, 2000).  
 
 
 
 
 
 
 
 
Figure 2-6. Schematic draw showing some features of the perivascular astrocytic 
endfeet, which form „rosette“ like structures on the brain capillary surface.  
This arrangement would be expected to be optimal for two-way induction and communication between 
the astrocytes and endothelium (based on Kacem et al., 1998). 
 
Freshly isolated brain endothelial cells and some immortalized brain endothelial cell lines 
grow as a monolayer on plastic or on porous filter inserts retaining features of a BBB 
phenotype, but generally with some loss of full barrier expression (e.g. leakier tight junctions, 
down-regulation of enzyme and transport systems). Some of these properties can be up-
regulated by co-culture with cells of glial origin, such as primary astrocytes, astrocytic cell 
lines or glioma cells. Thus, up-regulation of tight junctional proteins and tightness of cerebral 
endothelial cell monolayers grown in a co-culture with astrocytes has already been 
demonstrated (Dehouck et al. 1990; Rubin et al. 1991; Rist et al. 1997; Sobue et al. 1999). 
Gamma-glutamyl transpeptidase (  -GTP) is highly expressed in the brain endothelium in situ 
and appears to play a role in amino acid transport. Expression of γ-GGT is lower in primary 
cultured brain endothelium, but it is partly restored in brain endothelium co-cultured with 
glial cells (el Hafny, 1996). Several specific transport systems are up-regulated in brain 
endothelial models exposed to glial influence. This has been documented for GLUT-1, the L- 
and A-systems of amino acid carriers, and P-glycoprotein (Bauer and Bauer, 2000; El Hafny, 
1997). Interestingly, the multidrug resistance-related protein (MRP1), which is low expressed 
in brain endothelium in situ, shows higher expression in cultured brain endothelium. This may 
be a hint that neighbouring glial cells cause suppression of endothelial MRP1 expression 
under physiological conditions (Regina, 1998). Glial-mediated suppression of some clotting 
factors (tissue plasminogen activator and anticoagulant thrombomodulin) in brain 
astrocyte 
astrocyte 
 
 
   endothelial cells 
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endothelium has also been shown (Tran, 1999). Expression of transferrin receptor and low-
density lipoprotein (LDL) are also up-regulated by astrocytic influence (Dehouck, 1994). An 
induction of junctional tightness and upregulation of BBB markers could be detected on other 
model systems, including endothelial cells from non-brain sources such as human umbilical 
vein and bovine aorta, and the ECV304 cell line used as a model with a strong endothelial 
phenotype (Kuchler-Bopp, 1999; Hurst, 1996). Bovine aorta endothelial cells (BAEC) 
develop robust growth and differentiation associated with low TEER values when cultured 
alone. In the presence of glial cells the TEER of BAEC was shown to be increased (Stanness, 
1999; Cucullo, 2002). Thus, the ability to respond to the glial inductive signals is not confined 
only to the brain endothelial cells. 
The nature of the glial influence that is responsible for an induction of BBB features is still 
not completely understood. Some but not all of the inductive effects reported above can be 
produced by application of conditioned medium taken from growing glial cells (Hurst and 
Fritz, 1996; Sobue, 1999). However, induction is generally more effective in co-cultures, in 
which glial cells are grown on the basolateral side of filter system, with an endothelium on the 
apical side. This suggests that induction of BBB properties depends on the correct 
apical-basal polarity between endothelium and glia, and either direct glial–endothelial 
contacts, extracellular matrix-associated chemical signalling or a high local concentration of 
(labile) glial-secreted signals acting on the abluminal endothelial membrane (Abbott, 2002). 
The chemical nature of the glial-produced inductive signals is currently unclear, although 
several candidate molecules have been identified, with evidence suggesting that different 
agents may regulate different aspects of the BBB phenotype. Thus, transforming growth 
factor (TGF-  ) (Tran et al., 1999), glial cell lines derived neurol trophic factor (GDNF) 
(Igarashi et al., 1999), basic fibroblast growth factor (bFGF) (Sobue et al., 1999), interleucine 
(IL-6) and hydrocortisone (Hoheisel et al., 1998b) can mimic particular aspects of the 
inductive up-regulation or suppression caused by glial cells.  
Due to the complexity of BBB induction by glial cells, it is clear that close communication 
between endothelium and glial cells must occur. The observed up-regulation of γ−GTP in 
endothelial cells by glial cells involves a two-way exchange of signals and an extracellular 
matrix-mediated effect, while the up-regulation of alkaline phosphatase in the same system 
involves only a diffusive signal (Mizuguchi et al., 1997). Co-culturing of endothelial and glial 
cells leads to reciprocal effects on receptor phenotype. Leukaemia factor (LIF) released by 
endothelial cells of the optic nerve has been shown to induce astrocytic differentiation 
(Mi et al., 2001). In addition, Webersinke et al. compared the gene expression of ECM 
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molecules in brain microvascular endothelial cells with astrocytes and concluded that the 
astrocytes are likely to be involved in endothelial differentiation and function in the central 
nervous system via ECM molecule secretion (Webersinke, 1992). 
 
2.2.2 Pericytes 
 
Pericytes are perivascular cells that are associated with capillaries and postcapillary venules. 
Since pericytes have some features of smooth muscle (SM) cells and SM cells are absent from 
these microvessels, it has long been proposed that pericytes are their contractile counterparts. 
They are embedded in the abluminal basement membrane of endothelial cells and extend long 
processes around the capillary tubes. Pericyte coverage of microvessels varies and in rat 
capillaries coverage is 22-32% (Sims, 1991). 
Pericytes are closely associated with endothelial cells already at very early stages of brain 
development. It is unclear whether brain pericytes differentiate from neuroectodermal, 
meningeal, or endothelial cells. In other tissues, pericytes, like SM cells, have been shown to 
differentiate from perivascular fibroblasts.  
Although there are a lot of data about pericytes (Diaz-Flores et al., 1991; Sims, 1991; Tilton, 
1991) the function of these cells is still unclear. However, three major functional roles have 
been ascribed to pericytes associated with CNS microvasculature. They include contractility, 
regulation of endothelial cell activity and a role in inflammation.  
Furthermore, pericytes in the brain seem to express certain proteins that are not present in 
pericytes in other organs, suggesting that pericytes may have specific functions in brain 
capillaries (Allt and Lawrenson, 2001). Contraction (and reciprocal relaxation) appears to be 
the way that pericytes regulate microvascular flow (Allt and Lawrenson, 2001; Hirschi and 
D'Amore, 1996) (see figure 2-7).  
The demonstration of contractile elements in pericytes support their contactile role. In the 
CNS α-smooth muscle actin expressed by pericytes is the predominant contractile protein 
(Bandopadhyay et al., 2001). SM-actin has been determined in pericytes by 
imunocytochemistry (Skalli, 1989; Herman, 1985). In relation to this feature, the contraction 
process of pericytes could be a modulator of ECs permeability.  
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Figure 2-7. Pericyte function.  
Pericytes are enveloping the ablumenal surface of the endothelial cells and sharing a common 
basement membrane with the underlying endothelium. They provide a mechanical support for 
underlying microvessels. During the contraction and attenuation processes they modulate a blood flow 
and pressure in microvessels and regulate permeability by varying an extent coverage of microvessel 
surface (Dr. Roger C. Wagner, University of Delaware). 
 
The contact between the pericytes and the ECs is build up by cytoplasmic processes of the 
pericyte covering the ECs and vice versa, forming so-called “peg and socket” contacts 
(Matsusaka, 1975). In brain and retina, the adhesive glycoprotein, fibronectin, has been 
characterized at junctional sites between pericytes and ECs adjacent to “adhesion plaques” at 
the pericytes plasma membrane (Courtoy and Boyles, 1983). The plaques suggest a 
mechanical linkage between the two cells, which would permit contractions of the pericyte to 
be transmitted to the ECs resulting in the reduction of the microvessel diameter.  
Angiopoietin and γ-GGT, the frequently used endothelial markers are also present in 
pericytes. The unexpected presence of GGT in brain pericytes supports the idea that not only 
endothelial cells but also pericytes are important for the blood-brain barrier function (Risau, 
1998).  
 
2.3 Disorders of the blood-brain barrier 
 
The failure of BBB structural integrity and function plays an important role in the 
pathogenesis of many diseases of the central nervous system (see table 2-1). During ischemia, 
inflammation, hypertension and epilepsy altered BBB permeability is commonly observed 
(Grant et al., 1998). The extravazation of plasma proteins associated with BBB dysfunction 
pericyte 
endothelium 
attenuation contraction 
pressure and blood flow  
permeability  
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may occur through a number of different transcellular or paracellular routes including altered 
junctional tightness, induction of pinocytosis and transcytosis, formation of transendothelial 
channels or disruption of the endothelial cell membrane. Understanding the mechanism of 
cerebral diseases is very important in establishing new methods for treatment of the BBB 
pathology. 
The involvement of the BBB into the viral and bacterial CNS diseases is not completely 
defined and is currently being explored both in vivo and in vitro. Barrier dysfunction caused 
by viral or bacterial pathogens may exacerbate the severity of the neurological injury, whereas 
an intact barrier may prevent recovery from disease by delaying the entry of immune 
complexes or therapeutic agents into the infected CNS. Much is known about bacterial 
infections of the CNS (Quagliarello and Scheld, 1997). Bacteria such as meningococci 
colonize the nose, enter the vascular system and bind via pili to the endothelium of both the 
brain and the choroid plexus. In the cases of pneumococci, bacteria bind to the endothelial cell 
surface via platelet-activating factor receptors (Neuwelt, 2004). The infection induces an 
increased vesicular transport across the cells and a separation of the tight junctions leading to 
the release of interleukin-1, tumor necrosis factors and metalloproteinases (Paul et al., 1998). 
Corticosteroids could be administered to decrease the inflammation damage and restore the 
BBB integrity.  
Some viruses (such as herpesvirus) enter the CNS via the olfactory nerves, and others (such as 
rabies virus) enter via spinal nerves. In the case of HIV, brain endothelial cells lack the CD4 
and galactosylceramide binding sites that are used by the virus to enter most cells. After HIV 
has penetrated the BBB, it can proliferate in microglia and other non-neuronal parenchymal 
cells. In general, the BBB integrity varies with the type of infective agent (table 2-1).  
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Table 2-1. Central nervous system disorders involving BBB dysfunction. 
 
Infections and other immuno-logical stimuli can cause experimental allergic 
encephalomyelitis (EAE) in animals. EAE is widely, but not uniformly considered to be a 
model of multiple sclerosis (MS). In both MS and EAE increased BBB permeability and 
lymphoid cell extravasation across the BBB are early events in the inflammation process 
(Prat, 2002). Corticosteroids can decrease the BBB leakiness in MS (Gasperini, 1998). BBB 
compromise an extravasation of lymphoid cells via adhesion molecules with modulation by 
cytokines and chemokines, which are the key events in the pathogenesis of autoimmune 
inflammatory diseases.  
The integrity of the BBB in cerebrovascular disease attributable to hypertension (Johansson, 
1999) or cardiac bypass (Selnes and McKhann, 2001), because the underlying cerebral 
ischemia varies with respect to mechanism, severity and duration (Rosenberg, 1999). During 
ischemia, decreasing nutrient levels can lead to endothelial membrane failure, as can nitric 
oxide, which may be produced by the free radicals formed as a result of oxygen deprivation. 
Ischemia can also have effects similar to those of inflammatory disorders, leading to the 
activation of cytokines such as tumor necrosis factor (TNF-α ) and IL-1 and to the up-
Classification Disorder type 
Neoplasia Brain tumors (histamine, tissue necrosis factor, interferons, interleukins, permeable     
tumor vessels) 
Meningiomas (vascular endothelial growth factor) 
Vascular Ischemia, hypoxia (glutamate, free radicals, vasodilatation, lactic acidosis, 
prostaglandins, glial dysfunction) 
Hypertension (mechanical damage of the endothelium, free radicals, vasopressin, 
angiotensin) 
Subarachnoid hemorrhage (complement system-C3a, ECs damage, vasospasm) 
Arteriovenous malformations (endothelial damage due to ischemia and high flow 
state) 
Migraines (serotonin) 
X-irradiation (endothelial damage) 
Trauma Open and closed head injury (intracranial hypertension, endothelial disruption, 
vascular spasm and loss of cerebral autoregulation) 
Brain edema Vasogenic (EC damage, intracranial hypertension, arachidonic acid metabolites, 
histamine, oxygen free radicals, polyamines) 
Cytotoxic 
Metabolic Diabetes (hyperglycemia, ischemia) 
Toxins: lead, aluminum, mercury, dimethyl sulfoxide (endothelial damage) 
Epilepsy Seizures (glutamate, glial dysfunction following neuronal activation, hypertension) 
Inflammation Multiple sclerosis/experimental allergic encephalomyelitis  
Meningitis: bacterial, viral, fungal (bradykinin, ATP, histamine, serotonin, 
interleukins) 
Dementia: AIDS demential complex, Alzheimer’s (β-amyloid) 
BBB, blood-brain barrier, EC, endothelial cell 
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regulation of cell adhesion molecules. White blood cells can penetrate the BBB, afterwards 
releasing proteases (particularly matrix metalloproteinases (MMPs) resulting in both cytotoxic 
and vasogenic edema. Biochemical studies of MMPs in permanent and temporary ischemia 
have shown that the MMPs contribute to the disruption of the BBB that leads to vasogenic 
cerebral ischemia and hemorrhage (Rosenberg, 2002). Astrocytic endfeet and tightly 
connected endothelial cells act in collaboration with the basement membrane and the 
microglia to form a neurovascular unit (see section 2.2). During cellular stress caused by 
ischemia or hypoxia, the expression of macromolecules of the basement membrane is 
reduced, presumably by the action of the ECM-degradating proteases and, thus increases the 
rate of hemorrhage. Proteolysis of the ECM could be contributed to brain tissue damage either 
by directly attacking the lining of the blood vessel and increasing the permeability, or by 
loosing the connections between the cells, breaking communication channels for signalling 
molecules and nutrients and causing cell death. The build-up of ECM with fibrosis is another 
way, in which the changes in the ECM lead to a cell death.  
A consistent pattern of protease-mediated cell damage from animal and human studies is 
shown in figure 2-8. The disruption by proteases occurs early in inflammation, when the 
white blood cells enter the brain, mediating the release of MMPs by astrocytes and pericytes. 
In the absence of hypoxia, the cells remain intact and once the inflammatory response 
subsides, a recovery is possible. During an ischemic or hypoxic insult the endothelial cells are 
damaged by the induction of MMPs activity by endogenous brain cells. There is an increased 
risk of bleeding and recoverage is impaired due to the extensive hypoxic injury of the cells.  
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Figure 2-8. Schematic representation of the multiple pathways activated by hypoxia 
and ischemia that lead to brain edema, hemorrhage or cell death.  
White blood cells, microglia and macrophages release a series of proteases including the matrix 
metalloproteinases (MMPs) and caspases, which directly participate in the breakdown of the BBB with 
edema and hemorrhage and in the apoptosis/necrosis that results in cell death (Rosenberg, 2002) 
 
 
2.4 Porcine aorta endothelial cells (PAEC) as a macrovascular endothelium  
 
Blood vessels form the circulatory system carry blood from and to the heart through a 
branching system of arteries and veins. The vessels differ in size, biochemical properties and 
histological features. The largest arteries such as aorta are the principal vessels that receive 
blood from the heart. The elastic arteries branch into smaller muscular arteries which 
distribute blood to the organs and tissues. The arteries branch to even smaller vessels, the 
arterioles and capillaries, to distribute blood within the tissue.  
The larger (elastic) and medium sized (muscular) arteries consist of three distinct layers: 
intima, media and adventitia (see figure 2-9). These layers are less distinct in the smaller 
arterioles and absent in capillaries. The intima forms a layer next to the circulation and is 
composed of endothelial cells and an underlying connective tissue space containing 
specialized extracellular matrix structures such as a basement membrane and a mixture of 
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collagens, proteoglycans, elastin and a number of different glycoproteins. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-9. Schematic view of an arterial wall in cross-section.  
The wall consists of three layers that can be recognized histologically – the intima, the media and the 
adventitia. Each layer has a distinctive composition of cells and matrix. The basement membrane of 
the intima has supportive and barrier functions, whereas the matrices of the media and the adventitia 
provide elasticity (Expert Reviews in Molecular Medicine, 2002 (Cambridge University Press).  
 
At birth, the intima is thin but progressively thickens over the time due to the accumulation of 
ECM macromolecules and cells. The major cell types in the thickened intima are the smooth 
muscle cells, but other cells such as lymphocytes, macrophages, mast cells and other 
inflammatory cells from the blood are occasionally present. The intima is separated from the 
media by a thick band of elastic tissue – the integral elastic lamina (IEL) (see figure 2-9). The 
components of the ECM between medial smooth muscle cells aid in minimizing the energy 
loss during pressure changes, which occur during a pulsatile flow of blood throughout the 
circulation. The media is separated from the adventitia by another band of elastic tissue – the 
external elastic lamina (EEL).  
The adventitia itself is a connective tissue sheet composed of nerves, small blood vessels and 
fibroblasts, embedded in a network of collagen, elastic fibers, proteoglycans and assorted 
glycoproteins. The adventitia provides rigidity and aids in maintaining the shape of blood 
vessels. The endothelial cells form the intima, which is underlined by connective tissue space 
with a specialized extracellular matrix (Wight, 1996). Blood is returned to the heart trough 
venules, which branch into small, medium and large sized veins. Veins differ from arteries in 
being thin-walled and possessing weak defined layers. They are more easily deformed and 
less rigid than arteries and can withstand abnormal irregular dilation. Thus, the ECM of veins 
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endothelial cell layer and 
basement membrane 
(collagen type IV, laminin, 
nidogen) 
 
Media: 
smooth muscle cells, elastic 
connective matrix (collagen 
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Adventitia: 
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contains molecules that create hydrated tissue space. The loose and hydrated nature of vein 
ECM makes these vessels more susceptible to tumor invasion and penetration of blood 
derived cells creating disease conditions such as venous thrombosis.  
Many of the pathological changes that are developed in arteries occur in the intima. An 
atherosclerosis, the major disease of blood vessels, is exemplary localized to the arterial 
intima.  
In order to understand the involvement of the capillary endothelial cells at the BBB function 
(see section 2.1.2.1) a primary culture model of porcine aorta endothelial cells (PAEC) has 
been established. With the help of PAEC the differences between aorta and brain endothelial 
cells have been implemented in this work. The culture of PAEC allows to clarify, which 
proteins are important in the formation of the BBB and how the regulation of these proteins 
might work. It is also important to investigate the differences in the ECM expression in 
different tissues to elucidate the specific ECM properties of the cerebral endothelial cells. 
This might help to find specific ECM compounds, which are essential for the tight junction 
formation process in the brain endothelium. 
The composition of the aorta ECM differs from the ECM found in the brain capillary 
endothelial cells. It is controlled by differential regulation of synthesis and turnover of each of 
its components. The differences in ECM composition lead to the formation of various 
properties in endothelial cells from different organs. The components of the ECM bind 
plasma proteins, growth factors, cytokines as well as enzymes and modulate many of the 
processes that occur in the vascular wall. Thus, vascular ECM does not only maintain the 
structural integrity of the vascular wall, but it also regulates key events in vascular 
physiology.  
Due to the high permeability of endothelial cell layers derived from macrovascular vessels, a 
precise determination of their barrier function requires refined experimental techniques. 
Electrical impedance analysis, which is capable of performing high-precision measurements 
of TEER and capacitance, was already applied in a recent work on monolayers of bovine 
aorta endothelial cells (BAEC) (Wegener et al., 1999). Another work of Janigro et al. allowed 
to measure an elevated TEER of BAEC grown in the presence of glial cells in a dynamic in 
vitro culture system (Cucullo, 2002).  
The identification of functional differences of the endogenously derived ECM from the 
macrovascular endothelium compared to the microvascular-derived ECM could help to clarify 
the importance of the special ECM for the BBB formation phenotype of cerebral endothelial 
cells. 
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2.5 The extracellular matrix (ECM) of the central nervous system 
 
The brain ECM has multiple roles in the CNS structure and function. Dynamic changes are 
occurring continuously in the ECM through their turnover under normal conditions, which is 
accelerated during times of cell growth and injury. Recovery from injury requires remodelling 
of the ECM, which depends on the balance between proteolytic enzymes and their inhibitors.  
The extracellular matrix can be defined as a network of secreted extracellular 
macromolecules. Depending on the tissue this network varies in its form and compounds 
(section 2.4). In the adult CNS the extracellular matrix acts as both specific and general 
connection between specific receptor components on the surface of neurons and glial cells.  
In vivo the capillary endothelial cells of the brain are surrounded by an extracellular matrix, 
which forms a basement membrane (Goldstein and Betz, 1986). The interactions between 
cells and the ECM initiate a flow of information regulating cell proliferation, differentiation, 
phenotypic expression and cell polarization.  
Brain ECM provides the structure for the tissue, keeps water molecules within complex 
molecular scaffold and impedes movement of large molecules. The ECM anchors a variety of 
molecules that are important in normal brain function such as integrins, growth factors, 
laminin and other glycoproteins (Lukes, 1999). Matrix macromolecules include the 
glycosaminoglycans, hyaluronic acid, heparin sulfate, chondroitin sulfate and the large 
complex glycoproteins (Rutka, 1988). 
 
2.5.1 Integrins: cell receptors of the ECM 
 
The binding of cells to the ECM is mediated by cell surface receptors (Ruoslahti, 1991). The 
primary class of these receptors is a family of transmembrane proteins known as integrins. 
The integrins bind to extracellular matrix proteins at specialized cell attachment sites that 
often have the tripeptide sequence Arg-Gly-Asp (RGD) as the target sequence for integrin 
binding (see figure 2-10). 
Integrins are heterodimers comprised of two α- and β-subunits, which span the plasma 
membrane (Longhurst and Jennings, 1998). They act as mechanoreceptors and provide a 
force-transmitting physical link between the ECM and the cytoskeleton (Boudreau and 
Bissell, 1996). The cytoplasmic domain of the α−subunits are intimately associated with 
cytosceletal proteins such as vinculin and talin (Hynes, 1992). 
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Figure 2-10. Schematic representation of integrins. 
Both, integrin α and β subunits have a single large extracellular domain, one transmembrane region 
and a short cytoplasmic tail without known enzymatic activity. Integrins bind to a variety of extracellular 
matrix proteins. The binding of ligands can modulate a number of intracellular processes including 
activation of focal adhesion kinase (FAK) and reorganization of the actin cytoskeleton. In addition, 
integrins also mediate inside-out signalling, whereby cytoplasmic molecules such as protein kinase C 
(PKC) can modify the affinity of integrins for their ligands (Hynes, 1999). 
 
Up to 19 different heterodimeric combinations are possible with a particular combination of 
α- and β-subunits showing different specifities for binding to individual ECM components. 
The overlapping binding affinities and the presence of multiple integrin receptors for a given 
ECM component on individual cell types suggest specialized functions of the receptors.  
Despite the intensive biochemical characterization of integrins, the nature of the resulting 
cytoplasmic signal pathways generated from ECM components binding to their respective 
integrin receptors are still poorly understood. Treatment with function-blocking anti-integrin 
antibodies often alters ECM-induced gene expression indicating an ECM-directed gene 
activity. Hynes et al. reported that integrin-mediated signals are necessary in normal cells to 
block apoptosis (Hynes, 2002). Many integrins are not constitutively active, but are often 
expressed on the cell surface in an inactive or “OFF” state without binding the ligands and 
taking part in signal transduction. This is very important for their biological functions. In most 
cases the integrin function is regulated within the cells by the principle called “inside-out” and 
“outside-in” signalling. The nature of these signalling pathways is still not completely 
understood (Hynes, 1992).  
Although the ability of integrins to regulate distinct biochemical signals in response to the 
ECM has been demonstrated in numerous studies, a direct link between these intracellular 
outside 
inside 
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signals and subsequent changes in the ECM expression remain to be established. However, it 
is known that integrins not only bind cells to the matrix, but are also able to modify the shape 
of the matrix. 
 
2.5.2 The basement membrane (BM) 
 
Basement membranes are found wherever parenchymal cells are in direct contact to 
connective tissue. The sheets are 20-30 nm thick and consist of specialized extracellular 
matrix proteins and glycoproteins, glycosaminoglycans and proteoglycans. The functions of 
the basement membrane are listed in the table 2-2.  
Table 2-2. Functions of the basement membrane (modified from Lindblom et al.) 
Type Function 
physical 
formation of a barrier and regulation of passive diffusion 
contribution to the compartmentalization in the organism 
support as a mechanical substrate for the cells 
impact attachment and polarization of the cells 
biological 
regulation of cellular phenotype 
providing an interaction to the cytoskeleton through the transmembrane receptors 
activation of second messenger systems 
deposition of growth factors 
 
The composition of the ECM is cell-specific, but the major protein components are shared by 
many tissues and include fibronectin, laminin, collagen, entactin–nidogen complex, heparin 
sulphate and vitronectin (Giese et al., 1995). Ultrastructurally, at least two basement 
membranes can be identified in association with larger blood vessels in the brain, an 
endothelial and an astroglial basement membranes. In addition, the epithelium of the 
meninges coinvaginates with blood vessels form the surface of the brain and contributes to the 
astroglial BM (Alcolado et al., 1988; Risau and Wolburg, 1990; Zhang et al., 1990). 
Collectively, the astroglial and the meningial epithelium BMs are known as the parenchymal, 
since they delineate the border to the brain parenchyma.  
The BM functions as a part of the blood-brain barrier by providing a charge and molecular-
size filter that modulates the movement of molecules from the blood into the brain across the 
endothelial cell layer. As it is seen in figure 2-11 (A) an astrocytic foot processes and 
pericytes come across the endothelial cell layer onto the BM providing a connection among 
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the microvascular endothelium, smooth muscle cells and the neuropil. Arterioles have smooth 
muscles which are ensheathed with ECM. This ECM is contiguous with the BM between the 
endothelial cells and astrocytes. Formation of new fastenings and breakdown of other 
connections are dynamic processes that are necessary for the cell growth, the spread of tumors 
and the movement of brain cells to a site of inflammation. 
 
 
 
 
 
 
 
 
 
Figure 2-11. Schematic view of the capillary separated from the other cells by a 
basement membrane (A) and the scanning electron microscopic image of the BM (B). 
Astrocytic endfeet and pericytes separated from the microvascular endothelium by a basement 
membrane which is contributing into the BBB formation.  
 
Different compounds of the ECM have distinct influences on the pattern of gene expression in 
a particular cell. A detailed examination of the ECM involvement in the transfer of the signals 
into the nucleus to elicit tissue-specific gene expression is crucial for an understanding of the 
maintenance of the differentiated phenotype (Boudreau and Bissell, 1996). The reconstruction 
of the basement membrane has shown that the molar ratio of BM components may determine 
the behaviour of basal cells within the wound healing microenvironment, which is probably 
regulated either by extracellular matrix deposition or degradation (Yi et al., 2001). The most 
important compounds present in the basement membrane of the CNS will be discussed in 
more detail in the next sections.  
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2.5.2.1 Collagen type IV 
 
Collagen type IV is an abundant and specific collagen of the basement membrane. The 
molecule is composed of three α chains that contain the repeating Gly-X-Y sequence and 
form collagen triple-helices. Collagen type IV is the fourth genetically distinct molecule that 
was identified from basement membranes from Engelbreth-Holm-Swarm (EHS) (Lindblom 
and Mats, 1996). It forms a thin sheet structure that separates the cells and extracellular 
matrices. Each monomer consists of two α1(IV) chains and one α2(IV) chain. Different forms 
of collagen molecules are presented in table 2-3.  
Table 2-3. The structures of collagen molecules. 
 
Collagen type IV molecules appear to assemble into a complex network through noncovalent 
hydrophobic interactions. The network becomes rigid and cross-linked through disulfids and 
lysyl oxidase-derived bridges. Reconstitution studies have revealed two binding interactions 
that contribute to a twork formation: 1) C-terminal dimerization of collagen molecules with an 
exchange of disulfide interaction, and 2) 7S tetramer formation of four collagen molecules at 
their amino-termini.  
Four molecules of collagen IV interact via their 7S domains to form a spider-like structure 
Types Chains Structural details Localization 
I [a1(I)]2[a(I)]  300nm, 67nm banded fibrils 
skin, tendon, bone, 
etc. 
II [a1(II)]3  300nm, small 67nm fibrils cartilage, vitreous humor 
III [a1(III)]3  300nm, small 67nm fibrils skin, muscle, frequently with type I 
IV [a1(IV)2[a2(IV)]  390nm C-term globular domain, nonfibrillar 
all basement 
membranes 
V [a1(V)][a2(V)][a3(V)]  390nm N-term globular domain, small fibers 
most interstitial tissue, 
assoc. with type I 
VI [a1(VI)][a2(VI)][a3(VI)]  
150nm, N+C term. globular 
domains, microfibrils, 
100nm banded fibrils 
most interstitial tissue, 
assoc. with type I 
VII [a1(VII)]3  450nm, dimer epithelia 
VIII [a1(VIII)]3  ?, ? some endothelial cells 
IX [a1(IX)][a2(IX)][a3(IX)]  
200nm, N-term. globular 
domain, bound 
proteoglycan 
cartilage, assoc. with 
type II 
X [a1(X)]3  150nm, C-term. globular domain 
hypertrophic and 
mineralizing cartilage 
XI [a1(XI)][a2(XI)][a3(XI)]  300nm, small fibers cartilage 
XII a1(XII)  ?, ? interacts with types I 
and III 
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(Kuhn et al., 1981). In general, there are six different α-chains, which have been recently 
identified. Thus, collagen type IV exists at least in three different trimeric forms. In contrast 
to fibronectin or laminin, which seem to have only few well-defined cell binding sites, 
collagen has triple cellular interaction sites along its helix. Besides such “repetitive” sites 
however, a preferential integrin binding site has been identified in the CB3 fragment of the 
α1(I) collagen chain (von der Mark et al., 1992). Cellular interactions with collagen and 
fibronectin in some cases may also be mediated by a membrane-intercalated heparin sulphate 
proteoglycan. One of these molecules, syndecan, has been shown to bind to fibronectin and 
native collagen type I, II and III through a heparin sulphate side chain (Koda et al., 1985). 
Recent evidences have shown that the major collagen receptors belong to the family of 
integrins. In concert with other constituents of basement membranes, collagen type IV 
provides mechanical strength and serves as a scaffold for endothelial cells. It is also involved 
in a cell binding process.  
 
2.5.2.2 Laminin  
 
Laminin is the major adhesive glycoprotein of basement membranes. It does not only serve as 
an adhesive substrate for various epithelial and mesenchymal cells, but it is also able to 
induce and control a number of biological activities. Laminin stimulates neurite outgrowth, 
enhances proliferation and motility of tumor cells and skeletal myoblasts and induces 
polarization and differentiation of different cells (Kuhn et al., 1981; Martin and Timpl, 1987). 
Laminin was firstly purified from a mouse EHS tumor (Timpl et al., 1979). This glycoprotein 
has a molecular weight of 800 kDa and is dissociated into one 400 kDa and two 200 kDa 
subunits. The laminin is often accompanied by entactin/nidogen complex. The antigen of 
laminin can be detected already at the two-cell stage in embryogenesis, suggesting his role in 
the early development among the extracellular proteins (Leivo et al., 1980). Electron 
microscopic, physico-chemical and sequence data indicate three chains assembled with their 
α-helical domains to a triple-stranded coiled-coil structure, corresponding to the long arm of 
the molecule (Parry, 1982) (figure 2-12).  
Laminin with its multiple interactions with other components of the basement membrane such 
as nidogen/entactin (Dziadek and Timpl, 1985), heparin sulphate proteoglycan and collagen 
type IV on one side and with cells through cell receptors on the other side, appears as a key 
molecule in mediating cell interactions with basement membranes.  
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Several members of the integrin family, including α1β1, α2β1, α3β1, α6β1, α7β1 and 
α6β4 heterodimers serve as laminin receptors on a surface of variety of cell types (Belkin and 
Stepp, 2000). The specifity of integrins for different laminin isoforms has been determined for 
only a few of laminin-integrin interactions. Thus, it has been found that α3β1 binds stronger 
to laminin–5 (α3β3γ2), –10 (α5β1γ1) and –11 (α5β2γ1) than to laminin–1 (α1β1γ1) or 
laminin–2 α2β1γ1 (Eble et al., 1998). These data indicate that the laminin α chain is widely 
responsible for determining how laminins interact with integrins.  
 
 
 
 
 
 
 
 
 
Figure 2-12. Laminin is a trimer of α, β and γ-subunits .  
The subunits comprise a protein family of interchangeable α,β, and γ isoforms (Parry, 1982). The short 
arms consist of two or three smaller globules separated by a short, rodlike segment, whereas the long 
arm consists of a long rod, terminated by a larger globule. The oligomeric composition of laminin with 
one 400 kDa α–chain and two distinct 200 kDa β- and γ-chains was deduced from molecular mass 
and subunit patterns observed after metabolic labelling of parietal endoderm cells (Cooper et al., 
1981). 
 
Laminin–5 is a major component of the extracellular matrix of the blood-brain barrier (Jones 
et al., 1991). Its interactions with endothelial cells and astrocytes are mediated by the 
members of integrin family of extracellular matrix receptors (Hynes, 1992). Wagner et al. 
have found that astrocytes are bound to the basement membrane of cerebral microvessels by 
integrin α6β4 (Wagner, 1997). Astrocytic endfeet are part of the microvasculature and are in 
close apposition to laminin–5. The cerebral ischemia breakdown of the BBB was found to be 
associated with loss of both immunoreactive laminin–5 at the capillary BM and α6β4 receptor 
at the astrocytic endfeet (Wagner et al., 1997).  
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2.5.2.3 Fibronectin 
 
The glycoprotein fibronectin is a major component of the extracellular matrix and is essential 
for normal development. This large glycoprotein consists of two disulfide-linked subunits 
(A and B chains) and is found in several splice variants (Akiyama and Yamada, 1987; 
Ruoslahti, 1988). Fibronectin is a cell surface protein of most mesenchymal cells that is 
involved in a broad range of biological activities. It promotes adhesion and spreading of 
mesenchymal and epithelial cells, stimulates proliferation and migration of embryonic and 
tumor cells, and controls cell differentiation, cell shape and cytosceletal organization.  
Biochemical and molecular biological characterization of fibronectin revealed a multidomain 
structure, which is typical for most large extracellular matrix proteins, such as laminin, 
tenascin and chondroitin sulfate proteoglycan (aggrecan). By limited proteolysis fibronectin 
can be cleaved into separate, functionally independent subunits that are aligned in a linear 
fashion: a collagen (gelatin) binding domain, two heparin-binding domains, proteoglycan- and 
fibrin-binding domains, and at least two cell-binding domains (Akiyama and Yamada, 1987; 
Ruoslahti, 1988). The interaction sites for other macromolecules are important for the matrix 
assembly (McDonald, 1988). The isolation of the cell binding fragments of fibronectin by 
limited proteolysis revealed RGD sequences as the smallest cell-binding sequences of 
fibronectin and other matrix proteins and led to the discovery of the fibronectin receptor 
(Pierschbacher and Ruoslahti, 1984). The α5β1 was the first isolated and characterized 
integrin and is now often referred to as the “classical” fibronectin receptor (Pytela et al., 
1985). It appears to be the main integrin, which induces the attachment of the cells to 
fibronectin and at least partially controls the assembly of a fibronectin matrix around cells. 
Integrin binding to the ECM is not only required for the transduction of signals from the 
matrix to cells but also initiates responses within the cell that make the organization of a 
fibrillar matrix possible (Wu et al., 1995). Inside-out signalling through the integrin 
cytoplasmic domain indicates a conformational change in the integrin-binding domain that 
switches the integrin affinity from a low to a high state (Takagi et al., 2001). Such integrin 
activation is necessary for effective fibronectin binding but is still not sufficient for 
fibronectin matrix assembly. The organization and insertion of oriented actin filaments (stress 
fibers) into focal adhesion sites, at which integrins bind to the ECM, allow cells to exert 
tension on the surrounding ECM. In normal brain, fibronectin is not only highly expressed, 
but it can be found at the gliomesenchymal junction of tumours and in tumour associated 
blood vessels (Novak and Kaye, 2000). 
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2.5.3 Importance of the ECM for the BBB functionality  
 
The close proximity of the astrocyte endfeet to the brain capillaries allows a communication 
across the basement membrane with endothelial cells to induce and maintain the blood-brain 
barrier formation. The nature of this communication within the BBB and the involvement of 
the basement membrane are still poorly understood.  
As already referred the basement membrane influences many different cell functions. Such 
effects can be seen by analyzing the phenotype, shape, motility and substrate attachment. 
These properties are mediated through the interactions between cell surface receptors and 
molecules of the basement membrane.  
The meaning of the components of the basement membrane for the BBB formation has been 
described in different works. Savettieri et al. found that the RNA-expression of occludin in 
RBE4 cells depends on the specific ECM protein expression (Savettieri, 2000). Thus, 
occludin was expressed neither in the cells cultured on collagen type I, nor on laminin 
substrates. However, the cells cultured on collagen type IV showed a high expression of 
occludin. Neurons, when co-cultured with RBE4, are able to induce endothelial cells to 
synthesize occludin (without requirement to strict physical contacts between cells). These 
results once more underline the importance of the ECM in the control and stimulation of tight 
junction proteins expression in BCEC. Rascher et al. have shown a co-distribution of ECM 
molecules with occludin and the disappearance of the tight junction molecules in the absence 
of important ECM (Rascher, 2002). Shivers et al. observed that the formation of the barrier 
properties in non-brain ECs can also be induced when the cells are cultivated in the presence 
of astrocyte conditioned medium on the ECM substrate (Shivers, 1988). Furthermore, glia-
derived ECM is able induce the activity of specific enzymes in cultured bovine aorta ECs 
(non-brain) causing further differentiation into ECs with BBB properties (Mizuguchi et al., 
1995; Mizuguchi et al., 1997). As it was already discussed in section 2.2.1 Webersinke et al. 
showed an importance of the basement membrane suggesting that the astrocytes are likely to 
be involved in endothelial differentiation and function in the central nervous system via ECM 
molecule secretion (Webersinke, 1992). 
To summarize, the blood-brain barrier is mainly determined by the endothelial tight junctions, 
the formation of which is influenced by the brain microenvironment including the basement 
membrane of the microvessels and other surrounding cells (astrocytes and pericytes) 
(Rascher et al., 2002). 
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2.6 Matrixmetalloproteinases (MMPs) 
 
2.6.1 Overview of metalloproteinases  
Historical background. Gross and Lapiere showed that diffusible enzymes produced by 
fragments of involuting tadpole tail could degrade gels made of native fibrillar collagen 
(Gross and Lapiere, 1962). A family of special enzymes has been identified in species from 
hydra to humans and collectively called matrix metalloproteinases (MMPs) because of their 
dependence on metal ions for catalytic activity. These enzymes are able to degrade structural 
proteins of the ECM and have specific evolutionary amino acid sequences that distinguish 
them from other closely related metalloproteinases (Stöcker et al., 1995). In addition to their 
ECM substrates, MMPs also cleave cell surface molecules and other pericellular non-matrix 
proteins, thereby regulating cell behaviour (Sternlicht et al., 2000). Thus, the MMPs influence 
diverse physiological and pathological processes, including aspects of embryonic 
development, tissue morphogenesis, wound repair, inflammatory diseases and cancer (Nelson 
et al., 2000; Sternlicht and Werb, 2001).  
Structure and substrate specifity.  MMPs comprise a family of at least 28 secreted or 
transmembrane enzymes collectively capable of processing and degrading various ECM 
proteins. To date, 22 forms of MMPs have been found in human tissues. MMPs share high 
amino acid sequence homology and consist of defined domains. According to their 
localization, MMPs are classified either as secreted or membrane anchored. The latter are 
further divided into eight discrete subgroups. Based on their substrate specifity and domain 
similarity, MMPs have been classified into interstitial collagenases, gelatinases (MMP-2 or 
72 kDa gelatinase A and MMP-9 or 92 kDa gelatinase B), stromelysins, and membrane-bound 
(membrane type (MT-) MMP subfamilies (Benaud et al., 1998) (table 2-4). Secreted MMPs 
include minimal-domain, simple hemopexin domain-containing, gelatin-binding, furin-
activated secreted and vitronectin-like insert, while membrane bound MMPs include type I 
transmembrane, glycosyl-phosphatidyl inositol (GPI)-linked and type II transmembrane 
MMPs. 
In spite of the diversity of exsisting MMP molecules, there are some common structural 
domains and functional properties of the matrix metalloproteinases (Birkedal-Hansen, 1995; 
Woessner, 1991) : 
- specific amino acid sequences, which form the domain structures; 
- expression in an inactive proenzyme form; 
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- activation of MMPs through proteolysis; 
- active center of MMPs contains a Zn2+ – ion; 
- enzymatic activation occurs at neutral pH and in the presence of Ca2+; 
- degradation of the extracelullar matrix components; 
- function is regulated by the tissue inhibitors of metalloproteinases (TIMPs).  
Matrix metalloproteinases are considered to be the key enzymes in the turnover processes of 
the ECM (Alexander and Werb, 1989; Benaud et al., 1998). They are required for numerous 
development and disease related processes. The ability to degrade extracellular proteins is 
essential for any individual cell to interact properly with its immediate surrounding and for 
multicellular organisms to develop and function normally. 
 
 
 Table 2-4. Classification of known Matrixmetalloproteinases (Cawston, 1996; Chandler et al., 1997; Yong et  
al., 1998) 
Substrate 
Type Name Group kDa lat. 
kDa 
act. Collagen Type pro-MMP Other substrates 
MMP-1 Collagenase-1 
Fibroblast Collagenase 
Interstitial Collagenase 
Tissue Collagenase 
Vertebrate Collagenase 
Collagenases 55 45 1, 2, 3, 6, 7, 8, 10 2, 9 Agg, Casein, Entactin/Nidogen, Gelatine, PG, L-Selectin, 
MBP, VS 
 
MMP-2 Gelatinase A 
72 kDa Gelatinose, TBE-1 
Type IV Collagenase 
72 kDa 
Gelatinases 72 66 1, 3, 4, 5, 7, 10, 11, 
12, 14 
1, 9, 13 Agg, EL, FN, Gelatine (Typ 1, 2, 3), MBP, VS, VN, PG 
MMP-3 Stromelysin-1 
Procollagenase (Activator) 
Transin-1, SL-1 
PTR1 Protein 
Proteoglycanase 
Stromelysines 57 45 3, 4, 5, 9, 10, 11 1, 2, 7, 8, 9, 
13 
Agg, Casein, EL, FN, Gelatine (Typ 1, 3, 4, 5), LM, 
MBP, Proteoglycan, PG, PL, VN, VS 
 
MMP-7 Matrilysin 
PUMP-1 Protease, Matrin, 
Uterine Metalloproteinase 
Stromelysines 28 19 4, 10 1, 2, 9 Agg, Casein, EL, Entactin, FN, Gelatine (Typ 1, 3, 4, 5), 
LM, MBP, Proteoglycan, PG, Serpine 
MMP-8 Collagenase-2 
Neutrophil Collagenase 
PMNL-Collagenase 
Collagenase 75 58 1, 2, 3, 5, 7, 8, 10  Agg, EL, FN, Gelatine, LM 
MMP-9 Gelatinase B 
92 kDa Gelatinase 
Type IV (V) Collagenase 
92 kDa  
Gelatinases 92 86 4, 5, 7, 10, 12, 14  Agg, EL, Entactin,  FN, Gelatine (Typ 1, 5), MBP, PG, 
VN, VS 
 
MMP-10 Stromelysin-2 
Transin-2; SL-2 
Stromelysines 57 44 3, 4, 5  1, 8 Agg, Casein, EL, FN, Gelatine (Typ 1, 3, 4, 5), LM, PG 
MMP-11 Stromelysin-3 
SL-3, ST-3 
Stromelysines 55 
51 
44   Serpine, Casein (N-Terminus der MMP-11) 
Maus-Enzym: weitere. 
MMP-12 (Macrophage) 
Metalloelastase 
MME, HME 
 54 45+2
2 
4  Casein, EL, FN, Gelatine, LM, MBP, PG, VN 
 
MMP-13 Collagenase-3 Collagenases 60 48 1, 2, 3, 4, 7, 9, 10, 
14 
9 Agg, FN, Gelatine, PL 
MMP-14 MT1-MMP 
Membrane-type 
Metalloproteinase-14 
MT-MMPs 66 56 1, 2, 3 2, 13 Agg, Casein, EL, FN, Gelatine, LM, VN 
 
  
 
 
 
Abbreviations: 
Agg: Aggrecan   MBP: Myelin Basic Protein 
Coll: Collagen   PG: Proteoglycan Link Protein 
EL: Elastin     PL: Perlecan 
FN: Fibronectin   VN: Vitronectin 
LM: Laminin   VS: Versican 
MT: membrane type 
 
MMP-4, -5 and -6 were found as similar enzymes to other MMP molecules and that is why are not depicted in the table.  
 
MMP-15 MT2-MMP 
Membrane-Type MMP-15 
MT-MMPs 72 60  2 Agg, FN, Gelatine, LM 
 
 
MMP-16 
MT3-MMP 
Membrane-Type MMP-16 
MT-MMPs 64 52 3 2 FN, Gelatine 
MMP-17 MT4-MMP 
Membrane-Type MMP-17 
MT-MMPs 57 53   Fibrinogen 
Fibrin 
MMP-18 Collagenase-4 (Xenopus), 
xCo14 
 70 53 1   
MMP-19 RASI-1  54 45 4  FN, Gelatine, LM 
MMP-20 Enamelysin  54 22   Amelogenin (Dentin), Gelatine 
MMP-21 XMMP (Xenopus)  70 53    
MMP-22 CMMP (Chicken)  51 42   Casein, Gelatine 
MMP-23        
MMP-24 MT5-MMP 
Membrane-Type MMP-24 
MT-MMPs  62  2 Gelatine 
MMP-25 MT6-MMP MT-MMPs    2 Gelatine 
MMP-26 Matrilysin-2 
Endometase 
Stromelysines 28 19   Gelatine 
MMP-27 Human MMP-22       
MMP-28 Epilysin  56 45   Casein 
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2.6.2 Structure and function of MMPs 
 
As already mentioned the MMPs are devided into 8 classes according to their modular 
domain structure (Egeblad and Werb, 2002) (figure 2-13).  
The minimal domain-MMPs (class 1) have an N-terminal sequence (Pre), which is directed 
intracellular into the endoplasmatic reticulum. The “pre” domain is followed by a propeptide 
“pro” domain with a Zn2+ binding thiol group (SH) that maintains enzyme latency until it is 
removed or disrupted. The “pro” domain ends with a catalytic domain that contains a zinc-
binding active centre. This is a common structure for all MMP molecules.  
Another class of MMPs (class 2) has an additional hemopexin-domain, which is bound 
through a hinge-region (H) with a catalytical domain. These MMPs are involved in the 
reaction with TIMPs, cell adhesion molecules and proteolytic substrates. The first and the 
fourth structure elements of the hemopexin-domain are bound through the disulfide bridges. 
This hemopexin-domain is found in all MMPs classes except of classes 1 and 8. 
The gelatine-binding MMPs (class 3) have additional structure segments, which are similar to 
the collagen-binding repeats of fibronectin. They are distinguished by the insertion of three 
head-to-tail cystein-rich repeats within their catalytic domain. Gelatinases A and B (MMP-2 
and MMP-9, respectively) are the members of this class. Their inserts resemble the collagen-
binding type II repeats of fibronectin, and they are required to bind and cleave collagen 
molecules.  
Class 4 represents furin-activated MMPs, which have a recognition site for the intracellular 
furin containing serin proteinases (Fu) between their propeptide and catalytic domains This 
Fu recognition sequence is present in all MMPs (figure 2-13) and could be supplemented 
through a vitronectin analogue sequence like in the class 5. 
The membrane-type (MT) MMPs contain a signal transmembrane domain and a short carboxy 
terminal transmembrane tail (TM) with a short cytoplasmic unit (Cy) (class 6), or a C-
terminal hydrophobic region that acts as a glycosyl-phosphotidyl-inositol- (GPI) membrane-
anchoring signal (class 7). These domains play an essential role in the localization of several 
important proteolytic events to specific regions of the cell surface. 
Class 8 represents only one molecule - MMP-23. This membrane associated enzyme has a 
particular N-terminal signal anchor (SA) as well as a cystein-array (CA) and an 
immunoglobulin like region instead of hemopexin-domain.  
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Figure 2-13. Domain structure of the MMPs. 
Pre, signal sequence; Pro, propeptide with a free zinc-ligating thiol (SH) group; F, furin-susceptible 
site; Zn, zinc-binding site; II, collagen-binding fibronectin type II inserts; H, hinge region; TM, 
transmembrane domain; C, cytoplasmic tail; GPI, glycophosphatidyl inositol-anchoring domain; C/P, 
cysteine/proline; IL-1R, interleukin-1 receptor. The hemopexin/vitronectin-like domain contains four 
repeats with the first and last linked by a disulfide bond (modified from Egeblad and Werb, 2002).  
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2.6.3 Regulation of MMP activity  
 
To accomplish their normal (or pathological) functions, MMPs must be present in the right 
cell type and pericellular location, at the right time, and in the right amount. Furthermore, they 
must be activated or inhibited appropriately. Thus, MMPs are tightly regulated at the 
transcriptional and post-transcriptional levels and are also controlled at the protein level via 
their activators, inhibitors, and their cell surface localization (figure 2-14). Since MMPs have 
the fundamental ability to degrade virtually all types of matrix components, they are very 
precisely regulated at the transcriptional level (Sternlicht and Werb, 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2-14. Regulation of the MMPs.  
MMP regulatory mechanisms include inductive and suppressive signaling (1), intracellular signal 
transduction (2), transcriptional activation and repression (3), post-transcriptional mRNA processing 
(4), mRNA degradation (5), intracellular activation of furin-susceptible MMPs (6), constitutive secretion 
(7), regulated secretion (8), cell surface expression (9), proteolytic activation (10), proteolytic 
processing and inactivation (11), protein inhibition (12), ECM localization (13), cell surface localization 
(14), and endocytosis and intracellular degradation (15) (adapted from Sternlicht and Werb, 2001). 
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MMP-Transcription.  Because MMP substrate specificities tend to overlap, the 
biological function of individual MMPs is largely dictated by their differential patterns of 
expression. Accordingly, most MMPs are closely regulated at the transcription level, with the 
notable exception of MMP-2, which is often constitutively expressed and controlled through a 
unique mechanism of enzyme activation (Strongin et al., 1995) and some degree of post-
transcriptional mRNA stabilization (Overall et al., 1991). Nevertheless, data indicate that the 
basal expression of MMP-2 and TIMP-2 is co-regulated (Lohi et al., 2000). Otherwise, MMP 
gene expression is regulated by numerous stimulatory and suppressive factors that influence 
multiple signaling pathways. For example, the expression of various MMPs can be up- or 
down regulated by phorbol esters, integrin-derived signals, extracellular matrix proteins, cell 
stress and changes in cell shape (Kheradmand et al., 1998; Sternlicht and Werb, 2001).  
In addition, MMP expression is regulated by several cytokines and growth factors, including 
interleukins, interferons, endothelial growth factor (EGF), basic fibroblast growth factor 
(bFGF), vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), 
tumor necrosis factor (TNF-α), transforming growth factor (TGF-β) and the extracellular 
matrix metalloproteinase inducer (EMMPRIN) (Fini M.E, 1998). Many of these factors 
induce the expression and/or activation of c-fos and c-jun proto-oncogene products, which 
heterodimerize and bind activator protein-1 (AP-1) sites within several MMP gene promoters 
(Sternlicht and Werb, 2001). 
Secretion.  Most MMPs are constitutively secreted once they become translated. MMP-8 
and MMP-9 are synthesized by differentiating granulocytes in the bone marrow, stored in the 
specific and gelatinase (teriary) granules of circulating neutrophils, respectively, and are 
released following neutrophil activation by inflammatory mediators (Hasty et al., 1990). In 
macrophages, plasmin and thrombin induce the secretion of MMP-12, but do not alter its rate 
of transcription (Raza, 2000).  
Activation of Pro-MMPs.  A majority of the MMPs are secreted as latent zymogens, 
achieving catalytic properties in the ECM milieu. Therefore, another level, at which the ECM 
proteolysis can be controlled by MMPs, is the activation of latent zymogene in several 
biological processes including physiological tissue remodeling of bone and cartilage, and 
several pathological conditions. Some MMPs are processed intracellularly, whereas others are 
processed at the cell membrane into fully active enzymes. Their latency is maintained by an 
unpaired cysteine sulfhydryl group near the C-terminal end of the propeptide domain. This 
sulfhydryl group acts as a fourth ligand for zinc ion bound at the active site. The activation 
requires that an opening of the cysteine-to-zinc switch by normal proteolytic removal of the 
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propeptide domain or by ectopic perturbation of the cysteine-zinc interaction (Van Wart and 
Birkedal-Hansen, 1990). Once displaced, the thiol group is replaced by a water molecule that 
can then attack the peptide bonds of MMP targets. Such an activation pathway is shown in 
figure 2-15 for MMP-2 as a typical example. This MMP-2 is refractory to activation by serine 
proteinases and activated at the cell surface through a unique multistep pathway involving 
MT-MMPs and TIMP-2. 
 
 
 
 
 
 
 
 
 
Figure 2-15. Mechanism of pro-matrix metalloproteinase 2 (pro-MMP-2) activation. 
(a) Membrane-type-1 matrix metalloproteinase (MT1-MMP) on the cell surface acts as a receptor for 
tissue inhibitor of metalloproteinase 2 (TIMP-2). TIMP-2 binds via its N-terminal domain to the active 
site of the MT1-MMP. This binary complex then acts as a receptor for pro-MMP-2, with the TIMP-2 C-
terminal domain binding to the C-terminal domain of pro-MMP-2. A free MT1-MMP molecule in close 
proximity can then cleave the propeptide of pro-MMP-2, generating an intermediate species. Further 
proteolysis of the propeptide through an autocatalytic mechanism results in the generation of the fully 
active enzyme. Activation of pro-MMP-2 in this model is only possible if the TIMP-2 concentration is 
low, with sufficient TIMP-2 to generate the trimolecular complex but not enough to saturate all the 
MT1-MMPs required for proteolysis of the propeptide. 
(b) At high levels of TIMP-2, TIMP-2 will bind to and inhibit all MT1-MMP activity, preventing pro-MMP-
2 activation.  
 
In the first step, a cell surface MT-MMP binds to the C-terminal domain of TIMP-2, which 
can be inhibited by the N-terminal domain of TIMP-2. The C-terminal domain of bound 
a) low TIMP-2 b) high TIMP-2 
extracellular extracellular 
intracellular intracellular 
Key TIMP-2 pro-MMP-2 MT1-MMP 
N    C 
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TIMP-2 acts as a receptor for the hemopexin domain of ProMMP-2. An adjacent, uninhibited 
MT-MMP cleaves and activates the tethered ProMMP-2. Following the initial cleavage of 
ProMMP-2 by MT1-MMP, a residual portion of the MMP-2 propeptide is removed by 
another MMP-2 molecule to yield a fully active, mature form of MMP-2 (Deryugina et al., 
2001). Some of the MMPs contain an RXK/RR furin-like enzyme recognition motif between 
their propeptide and catalytic domains. This recognistion morif allows them to be activated by 
intracellular subtilisin-type serine proteinases before they reach the cell surface or before they 
are secreted (Pei and Weiss, 1995). This is characteristic for MMP-11, MMP-28, and all 
MT-MMPs. All other MMPs lack furin-susceptible insert and are, thus, activated outside of 
the cell following their secretion. 
2.6.4 Tissue inhibitors of matrixmetalloproteinases (TIMPs) 
 
The third level of restricting the proteolytic activities of MMPs includes endogenous tissue 
inhibitors of MMPs (TIMPs). TIMPs specifically inhibit active forms of MMPs, and in some 
cases, latent MMPs as well. Disturbance in this balance may lead to pathological situations in 
tissues. Active MMPs may also be inactivated by   -macroglobulins, particularly   2-
macroglobulin (Sottrup-Jensen, 1989; Sottrup-Jensen et al., 1989). Recent findings indicate 
that serine proteinase inhibitor called tissue factor pathway inhibitor-2 (TFPI-2), inhibits 
MMP-1, MMP-2, MMP-9 and MMP-13 (Herman et al., 2001). Calcium-binding 
proteoglycans (N-Tes, testican-1 or testican-3) are able to inhibit MT1- or MT3-MMP 
mediated proMMP-2 activation (Nakada et al., 2001). In addition, there are many exogenous 
inhibitors. Some examples include flavonols in green tea such as epigallocatechin-3-gallate or 
catechins, which inhibit MMP-2, MMP-9, MMP-12 activities and proMMP-2 activation 
(Demeule et al., 2000).  
In general, the TIMPs represent a family of at least four 20–29 kDa secreted proteins 
(TIMPs 1–4) that reversibly inhibit the MMPs in a 1:1 stoichiometric fashion (Sternlicht and 
Werb, 2001; Whiteside et al., 2001). They share 37–51% overall amino acid sequence 
identity, a conserved gene structure, and 12 similarly separated cysteine residues. These 
invariant cysteines form six intrachain disulfide bridges to yield a conserved six-loop two-
domain structure. Truncated “tiny” TIMP-1 and TIMP-2 retain their inhibitory activity despite 
containing only the first three loops, thus, indicating that portions of the N-terminal domain 
interact with the MMP catalytic site (Murphy and Willenbrock, 1995).  
Individual TIMPs differ in their ability to inhibit various MMPs. For example, TIMP-2 and 
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TIMP-3 inhibit MT1-MMP, whereas TIMP-1 does not. On the other hand, TIMP-1 is a 
relatively poor inhibitor of MT3-MMP, and TIMP-3 appears to be a more potent inhibitor of 
MMP-9 than other TIMPs. TIMP-3 is also unique in its ability to inhibit ADAMs-10 and -17, 
ADAMTS-4, andADAMTS-5 (Kashiwagi et al., 2001), whereas TIMP-1 can inhibit 
ADAMTS-1 (Tortorella et al., 1999). The ADAMS are transmembrane cell surface proteins 
that have a disintegrin and metalloproteinase domain. Unlike the ADAMS, the secreted 
ADAMTS proteins have a trombospondin (TS) type I repeat which follows common for all 
disintegrin domain. In addition, the TIMPs differ in terms of their gene regulation and tissue-
specific patterns of gene expression. TIMP-3 also has the unique ability to bind via its C-
terminal domain to heparan sulphate proteoglycans within the ECM, thereby concentrating it 
to specific regions within tissues and basement membranes.  
Although it is still unclear how TIMPs promote cell growth, this activity may explain several 
unexpected associations between TIMPs and cancer progression. However, TIMPs may also 
promote cell death or suppress mitogenic signals. For example, apoptosis is induced in 
various cell types by TIMP-3, but not by TIMP-1, TIMP-2 or synthetic MMP inhibitors, thus 
suggesting that the mechanism may not rely on the inhibition of metalloproteinases (Bond, 
2000). 
There is another recently recognized class of MMP inhibitors, which exhibit protein 
subdomains and have a structural similarity to the TIMPs. A primary amino acid sequence 
alignment search also uncovered similarities between the TIMPs and the noncollagenous NC1 
domain of type IV collagen (Netzer, 1998). Moreover, functional analysis indicate that the 
NC1 domain has MMP inhibitory activity (Netzer, 1998) and can inhibit angiogenesis and 
tumor growth (Petitclerc, 2000). Nevertheless, the physiological targets of these inhibitory 
fragments remain uncertain. Although their activity against MMP-2 is substantially lower 
than that of the TIMPs (Mott, 2000; Netzer, 1998), other MMPs or metzincins may be their 
real physiological targets. 
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3 Objectives of the project  
It was the major goal of this project to scrutinize a functional role of the extracellular matrix 
compounds on the BBB formation and integrity. For this reason, the importance of 
endogenously produced ECM from brain capillary endothelial cells (BCEC), astrocytes and 
pericytes for the formation of the BBB need to be clarified. In order to identify the factors that 
may affect the barrier properties through the ECM-derived from the brain capillary and 
neuroglial cells, the results have to be compared with ECM components obtained from non-
brain endothelial cells (aorta). 
It is commonly known that ECM proteins are able to modulate the expression of tight junction 
proteins. Therefore, the impact of ECM composition on the cell culture model of BBB was 
examined in vitro. Thus, the expression level of ECM as well as tight junction proteins has to 
be studied in the micro-(brain) compared to the macrovascular (aorta) endothelial cells. The 
involvelment of the ECM components derived from the glial cells, such as pericytes and 
astrocytes in the BBB formation process could be shown by culturing BCEC on 
endogenously-derived ECM from glial cells. Culturing the BCEC on collagen type I+III 
should serve as a reference culture substrate. An impact of endogenously produced ECM 
components on the adhesion and barrier forming properties could be mainly shown by means 
of electric cell-substrate impedance sensing technique (ECIS). This method is capable to 
analyse the cell-cell and cell-matrix connections in a quantitative way leading to the 
extraction of the dynamics of tight junction formation and spreading processes. The 
alterations of protein and gene expression levels under the ECM influence in the brain 
compared to non-brain endothelial cells should be compared by immunocytochemical, 
western blot and quantitative real-time (QRT) PCR analysis. 
Additionally, it is known that the dynamic changes which occur in the ECM through the 
turnover of these proteins under normal conditions can be accelerated during cell growth in 
vitro. Recovery processes require remodeling of the ECM, which depends on the balance 
between matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs). 
Therefore, the influence of the matrix metalloproteinases secreted by different cell types used 
in this cell culture model should be resolved in order to investigate at which degree the MMPs 
and TIMPs are involved in the modulation of the brain ECM. Therefore, the expression 
pattern of the main MMP molecules in BCEC as well as in pericytes and astrocytes compared 
to aorta endothelial cells need to be characterized by zymographic, immunocytochemical and 
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QRT-PCR analysis.  
The data derived from all these experiments should help to understand the involvement of 
ECM components in BBB formation and regulation processes through the secreted MMPs, 
which are able to degrade the synthesized ECM. 
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4 Impact of individual ECM molecules on cell adhesion and tight junction 
formation  
 
4.1 Electric cell-substrate impedance sensing (ECIS) 
 
Among the wide range of factors and mechanisms, which may be involved in the induction of 
a BBB-phenotype, the extracellular matrix could be an important candidate. The influence of 
these proteins on cellular behaviour could be studied when ECM is immobilized on a culture 
substrate. The experimental means to monitor attachment and spreading of the cells involved 
in BBB formation is referred to as electric cell-substrate impedance sensing (ECIS) 
measurements (section 8.1.8).  
ECIS is an experimental method that reads the electrical impedance as a function of frequency 
of cells covered gold-film electrodes. Attachment and spreading of cells on the electrode 
surface change the impedance in such a way that morphological information of the attached 
cells can be inferred. The ECIS device is based on an alternating current (AC) impedance 
measurements using weak and noninvasive AC signals as described in more details elsewhere 
(Lo, 1995). The analysis of the data allows conclusions about the resistance Rb between 
adjacent cells, which is a measure of the integrity and barrier function of the layer, the 
parameter    that describes the impedance contribution from the cell substrate adhesion zone 
and the capacitance of the cell membrane (CM). Together, these parameters permit 
characterization of the barrier and adhesion properties of cells in one experimental setup. 
The measurement system consists of an eight-well cell culture dish with electrodes deposited 
upon the bottom of each well. Each well consists of 10 active electrodes at the bottom of the 
dish, electrically in parallel (section 8.1.8). Each electrode well contains a small working 
electrode (area = 5.10-4 cm2) and a large counter electrode (area = 0.15cm2). Due to the 
differences in surface area, the total impedance of the system is determined by the impedance 
of the small electrode. An oscillator applies an AC signal of 70 mV amplitude to the two-
electrode system using culture medium as the electrolyte. The data analysis had been 
described elsewhere (Wegener, 2000).  
To monitor the morphological characteristics of the endothelial cells ECIS data were recorded 
as a function of time. The resistance of the system at 400 Hz frequency was followed as a 
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measure for endothelial cell-cell contacts. The capacitance measured at 40 kHz can be used as 
an indicator for the establishment and modulation of cell-substrate contacts. The rational for 
this approach has been described elsewhere (Wegener et al., 2000).  
During ECIS measurements the resistance and capacitance of the cells seeded on the 
electrodes were followed for a given period of time. The extracted data depicted in 
figure 4-1 A and B show the initial increase of the resistance reflecting the attachment and 
spreading of the cells, whereas the later changes (t > 8 h) reflect the establishment of tight 
junctions. These tight intercellular connections restrict the current flow between neighboring 
cells. Cultured cells with a high differentiated BBB properties exhibit the elevated electrical 
resistance values. 
 
 
 
 
 
 
 
 
 
Figure 4-1. The changes in resistance (A) and capacitance (B) as a function of 
frequency and time during the attachment and spreading of brain capillary endothelial 
cells on ECIS electrodes.  
In this experiment the cells were grown in serum-free medium on the electrodes coated with collagen 
type I+III.  
 
At the same time due to complete cell attachment and spreading the capacitance continuously 
drops. As sketched in figure 4-2, the cells reach the substrate with an almost spherical 
morphology. The area of the closest contact between the basement membrane and surface is 
therefore rather small but increases continuously while the cells spread. 
 
 
 
 
Figure 4-2. Time course of cell spreading on a culture substrate and the 
concomitant increase of the adhesion area´s projection on the substrate  
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Thus, the establishment and alterations of cell-matrix and cell-cell contacts by cerebral 
capillaries as well as aorta endothelial cells could be measured by ECIS technique. Since 
ECIS readings also allow to extract the kinetics of tight junction formation, the dynamics of 
cerebral endothelial cells differentiation could be followed with time. The time interval 
between the cell adhesion and tight junction formation processes will help to clarify when the 
cells start the differentiation program after cell-matrix contacts have been established.  
In order to show the importance of individual ECM components as well as endogenously 
produced matrices for the induction of BBB properties in endothelial cells two different 
approaches were applied:  
1) seeding the porcine brain capillary endothelial cells (PBCEC) on the culture surface 
pre-coated with purified ECM proteins; 
2) seeding PBCEC on endogenously produced ECM substrate (pericytes-, astocytes-
derived ECM in comparison to PAEC-derived ECM); 
3) seeding PAEC as non-BBB forming cells on endogenously produced PBCEC-derived 
ECM to “stimulate” the BBB formation properties in comparison to a reference 
substrate (collagen type I+III). 
The detection of the cell surface receptors anchoring the endothelial cells to extracellular 
matrices and known as integrins (section 2.5.1) could help to understand the dynamics of 
spreading and tight junction formation as revealed by ECIS analysis. Integrins are able to 
mediate and regulate cell-surface signals from the ECM to the intracellular compartments. 
Based on the knowledge of integrins secreted by PBCEC it is possible to clarify the dynamics 
of attachment and spreading of the cells on purified ECM. This can help to study the 
informational exchange between the ECM and cytoskeleton of the cells.  
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4.2 Experimental conditions for time resolved measurements of attachment 
and spreading  
The TEER is a quantitative indicator for the integrity of blood-brain barrier culture systems in 
vitro. The PBCEC system established in our group expresses high resistances when the cells 
are cultured under serum-free (SFM) conditions and in hydrocortisone (HC)-supplemented 
medium (Hoheisel et al., 1998b). The applied concentration of this hormone is in the 
physiological range and comprises 550 nM (Karlson, 1994). 
The cell culture conditions should be precisely defined before studying the properties of the 
ECM proteins. This is mainly important with respect to the culture medium applied to the 
cells. Thus, it is commonly known that fibronectin molecule besides of other functions, is a 
coagulation factor of the blood plasma and thus, a compound within serum-containing 
medium. Furthermore, this medium contains growth factors, hormones and other extracellular 
matrix proteins, which all can influence the results obtained in the culture. Due to this fact, all 
experiments for the determination of the functional significance of the ECM for the BBB 
function should be carried out in serum-free medium supplied with HC.  
 
4.2.1 Serum addition induces attachment of PBCEC in vitro  
 
The directly subcultured endothelial cells revealed a very weak adhesion process and fast 
detachment from the substrate cultured in serum-free medium. Initial ECIS experiments have 
demonstrated that serum addition could be necessary for the attachment and spreading of the 
endothelial cells. Before further adhesion studies could be performed the serum effect on cell 
spreading or ECM secretion has been investigated.  
Thus, the microvascular endothelial cells were directly subcultured on the ECIS-electrodes 
with and without serum- supplementation (0.02%). Figure 4-3 demonstrates that PBCEC were 
not able to attach and spread on the available substrate as long as no serum was added to the 
culture SFM. Serum addition gradually induces the attachment of PBCEC in a concentration 
dependent manner (data not shown). These experiments indicated that either serum itself, or 
the factors released in response to serum induction lead to the induced attachment and 
spreading processes and thus improve the BBB properties of PBCEC.  
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Figure 4-3.  The time course of capacitance measured at 40 kHZ for PBCEC freshly 
subcultured on collagen type I+III in SFM. 
The cells were cultured with (—   —) and without (—  —) serum (0.02%) supplementation.  
 
4.2.2 Trypsin delays the re-attachment of suspended cells after subculture  
 
As it was already mentioned that serum addition is able to induce the adhesion of the cells 
during the subculture procedure in serum-free medium (figure 4-3). The selective subculture 
of the cells was however performed by a trypsinization process. The residual trypsin is known 
to be able to degrade the components of the extracellular matrix secreted by the cells. The 
question if addition of serum-supplemented medium is able to saturate the remaining trypsin 
activity after collecting the cells was resolved by further ECIS experiments. The 
measurements represented in figure 4-4 were performed in both fractions of the cells saturated 
before with and without serum-containing medium. Aftewards, the cells were centrifuged and 
resuspended again in SFM. Although both populations of the cells were further cultured in 
SFM, the cells saturated before with serum-supplemented medium attached faster. This means 
that the inactivated by the addition of serum-free medium residual trypsin could still degrade 
the components of ECM leading to the delayed onset of the cells on the ECM coating. These 
data verifiying that PBCEC are able to attach on the collagen type I+III after the termination 
of the remaining trypsin activity by serum-supplemented medium, whereas an addition of 
SFM to the cell suspension led to the delayed cell attachment (figure 4-4).  
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Figure 4-4. The time course of capacitance measured at 40 kHz for PBCEC cultured 
on collagen type I+III mixture.  
The trypsinisation was terminated by addition of serum-supplemented (—  —) or serum-free medium 
(—   —). Cells were then collected and resuspended in SFM for plating.  
 
4.2.3 Trypsin inhibitor stops the residual trypsin activity in cell suspensions  
 
The question if the addition of the serum into the culture medium induces the cells to 
synthesize or adsorb important ECM components, or inhibits the residual trypsin activity 
within the cell suspension that was prepared by trypsinization could be resolved by the 
addition of trypsin inhibitor.  
Figure 4-5 indicates that both an addition of normal calf serum or trypsin inhibitor to the cell 
suspension after the cells have been collected and resuspended in SFM lead to the same 
results in the adhesion processes. This means that the cells are able to attach and spread 
building a cell monolayer without serum components except for the inhibition of a residual 
trypsin activity in the cell suspension. Different experiments with various modes of blocking 
residual trypsin activity in the freshly prepared cell suspensions have shown that as long as 
trypsin activity was stopped the cells attached and grew very well. 
Thus, it is necessary to inhibit the remaining trypsin activity for obtaining the spreading and 
attachment of the cells onto the ECIS-electrode surfaces coated with ECM.  
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Figure 4-5. The time course of capacitance measured at 40 kHz for PBCEC cultured 
on collagen type I+III mixture. 
The trypsinisation was terminated by the addition of the normal calf serum (0.02%) (—   —) or soybean 
trypsin inhibitor (Sigma) (—  —).  
 
Conclusion 1 
In order to show the influence of extracellular matrix components on the differentiation 
process of endothelial cells in vitro culture conditions have to be well-defined. Due to the fact 
that ECM proteins are known to be present in serum-supplemented culture medium, and thus, 
are able to influence the impedance measurements, all following experiments were carried out 
in serum-free medium. Initial ECIS-experiments demonstrated that primary cultured 
endothelial cells attach and grow weakly in serum-free medium. Serum addition was found to 
positively affect the cell adhesion and spreading on ECIS electrodes. Furthermore, serum was 
shown to be able to saturate the residual trypsin activity in cell suspensions. Additionally, it 
was demonstrated that trypsin inhibitor substitutes the serum effect and thus, prevents the 
residual trypsin activity leading to the best valued subculture conditions for PBCEC in serum-
free medium. 
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4.3 The importance of individual ECM proteins for cell adhesion and tight 
junction formation 
 
Further experiments were performed to clarify the importance of individual ECM proteins for 
cell adhesion and tight junction formation by ECIS technology. As shown in chapter 4.1 it is 
possible to monitor the attachment and spreading of the cells by reading the capacitance of the 
electrodes at 40 kHz. Capacitance readings at this frequency show a linear dependency on 
fractional electrode coverage and are thus, a direct measure for cell spreading. The formation 
of tight junctions is monitored in readings of the electrical resistance at 400 Hz. These values 
are, however, not identical with TEER readings but allow easy comparison of tight junctions 
formation under different experimental condtions.  
Firstly, the means of the resistance and capacitance of cell monolayers were determined for 
PBCEC cultured on recombinant ECM proteins.  
Figure 4-6 A represents the adhesion of the PBCEC on different ECM proteins. The time 
course of the capacitance indicates much lower spreading rate for laminin than for any other 
proteins examined. PBCEC spread significantly faster on a fibronectin-coated substrate 
compared to collagen type IV or collagen type I+III. The initial increase of the resistance 
shown in figure 4-6 B for first 7-10 h is also due to the attachment and spreading of the cells, 
whereas the later changes reflect the establishment of tight intercellular contacts, that restrict 
the current flow between adjacent cells (tight junctions) (Wegener et al., 2000b). The higher 
resistance measured for the cells seeded on fibronectin coating reveals the faster formation of 
tight junctions. Thus, fibronectin could be one of the most important ECM proteins for 
PBCEC adhesion and spreading. 
The time course of the measured capacitance for laminin-coated electrodes is also interesting. 
According to the data depicted in figure 4-6 A, it takes more time in comparison to the other 
coatings before the PBCEC start to spread on a laminin-coated substrate. At the same time 
these cells develop the resistance compared to the other protein coatings indicating reduced 
tight junctions formation. It is quite likely that the cells need the delay time in order to modify 
the non-adhesive laminin substrate by secreting self-produced extracellular matrix proteins. It 
is known that laminin shows the adhesive properties and is required for cell polarization in 
epithelial cells (Klein et al., 1988; Zinkl et al., 1996).  
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Figure 4-6. (A): Time course of the capacitance measured at 40k Hz. (B): The 
resistance measured at 400 Hz for PBCEC cultured on different ECM coatings. 
PBCEC were seeded into ECIS arrays on the electrodes coated with different ECM proteins: collagen 
type IV (blue line); fibronectin (green); laminin (red) and collagen type I+III (black).  
 
4.3.1 Individual ECM proteins promote cell-cell contacts formation in PBCEC 
 
As it has been shown in the preceding chapter (4.3) that ECM proteins may be important for 
the adhesion and spreading as well as tight junction formation in PBCEC, the influence of one 
of the ECM components – collagen type IV – was studied in a concentration dependent 
manner (figure 4-7).  
Figure 4-7 depicts the development of cell-substrate (A) and cell-cell (B) contacts of PBCEC 
cultured on collagen type IV. For this purpose, the surface of the electrodes was coated with 
recombinant collagen type IV protein (Sigma) at different concentrations. The results indicate 
that PBCEC attach and spread at the same rates on the electrodes when these are coated with 
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concentrations of 20 and 100 µg/ml of protein (A). Whereas the transedothelial electrical 
resistance at 400 Hz developed by these cells cultured on 100 µg/ml reaches more than 
20000 Ω, the PBCEC cultured on 20µg/ml of collagen type IV coating are only capable of 
developing 7000 Ω . 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-7. Collagen type IV accelerates the development of the transendothelial 
electrical resistance in PBCEC. 
The electrodes were coated with 100 µg/ml (—  —), 20 µg/ml (—   —), 5 µg/ml (—+—) and 
1,25 µg/ml (—x—)of collagen type IV substrate (Sigma). The time course of capacitance measured at 
40 kHz indicates that although the cells attach on 20 µg/ml coated electrode (A), they could not 
develop as high transendothelial electrical resistances (400 Hz) as the cells cultured on collagen type 
IV at 100 µg/ml (—  —) (B).  
 
Thus, the elevated electrical resistance of PBCEC is dependent on the concentration of 
proteins on the ECM substrate. Therefore, these results suggest that collagen type IV among 
other ECM components is involved in tight junction formation between endothelial cells. One 
possible explanation is that the ECM proteins provide an informational cue that is transmitted 
to the inside of the cell either mechanically by the cytoskeleton or chemically via signal 
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transduction pathways directing tight junction proteins to the apical-basolateral boundary, as 
has been also shown by Wang et al (1990). On the other hand, proteins like collagen type IV 
may also bind to their cellular receptors and activate intracellular signal transduction 
pathways leading to the expression of tight junction associated proteins. Hynes et al. have 
suggested that integrins act synergistically with soluble agonists in stimulating intracellular 
responses such as tyrosine phosphorylation and cytoplasmic alkalinization (Hynes, 1992). At 
this context, it should be mentioned that the ECIS experiments were all carried out in serum-
free medium supplied with hydrocortisone. Although the effects of hydrocortisone are 
mediated mainly by intracellular receptors (Evans, 1988), a synergistic action with 
extracellular matix proteins cannot be excluded.  
The involvement of the ECM molecules in tight junction formation on the example of 
collagen type IV detected by ECIS experiment was verified in this work.  
 
 
Conclusion 2 
ECIS-experiments revealed that the cell-cell and cell-substrate contacts of PBCEC could be 
influenced by basement membrane proteins. In particular, fibronectin promotes the formation 
of tight junctions of PBCEC in vitro. The delayed time course of PBCEC attachment on 
laminin coating leads to the lowest values of TEER. 
Decreasing concentrations of collagen type IV coatings gradually delayed the onset of cell 
spreading on the electrode surfaces. TEER values were reduced corresponding an induction 
dependency of cell-cell contacts formation on the concentration of ECM proteins on the 
surface. 
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4.4 The role of integrins in attachment and spreading of PBCEC 
 
The functional BBB requires the establishment of tight cell-cell interactions as well as the 
activation of cell membrane receptors by components of the extracellular matrix. The 
identification and characterization of molecules which mediate cell-matrix interactions is of 
great importance for an understanding of cell attachment and spreading processes. The 
character of such interactions depend on the expression of particular receptors on the surface 
of the endothelial cells. As it was shown in section 4.3.1 such interactions can also facilitate 
the dependence of cell-cell contacts formation on the matrix coating. By demonstrating the 
presence of certain integrin subunits on the surface of the primary cultured capillary 
endothelial cells it is possible to clarify the specifity of the endothelial cell adhesion on a 
molecular level. 
 
4.4.1 The expression of integrin subunits in PBCEC measured by FACS  
 
To identify cell surface receptors, which are important in the adhesion process of endothelial 
cells, the expression of these receptors was measured by flow cytometry after 
immunolabelling.  
Integrins are not only able to link cells to their extracellular environment but also possess 
cytoplasmic domains that function in cellular signaling and activate signal transduction 
pathways. Their cytoplasmic domains also play an essential structural role; they interact with 
the cytoskeleton and thus, regulate cell shape and migration (Hynes, 1999). Most cells bind to 
more than one matrix component and utilize different integrins to attach to different 
macromolecules (von der Mark et al., 1992).  
The specificity of integrins for different ECM proteins has already been analyzed and the 
major receptors for fibronectin is α5β1, for laminin α3β1 and α6β1, for collagen molecules 
α1β1 and α2β1 (section 2.5.1).  
FACS analysis revealed highest expression of the integrins with α6 and α1-subunits 
indicating the potential of PBCEC to bind to collagen and laminin isoforms with respect to 
receptors expression (figure 4-8).  
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Figure 4-8. The expression of the main integrin α subunits in PBCEC measured by 
FACS.  
α1 (green line); α2 (black line); α3 (yellow line); α6 (blue line) and α5 (violet line).  
 
These measurements will help to interpret the adhesion dynamics of PBCEC found in the 
ECIS experiments. There is an abundance of α3−subunit in PBCEC, which is known to bind 
to laminin-5 (Eble et al., 1998) but not to laminin-1, which was used as a coating protein in 
ECIS experiments (4.3).  
As integrins are composed of two subunits the presence of the β1-subunit was studied by 
FACS analysis as well. Figure 4-9 shows the expression of β1-subunit in PBCEC measured 
by flow cytometry. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4-9. The expression of the β1 integrin subunit in PBCEC measured by FACS. 
β1 (green line); second antibody control (red line) and isotype control (blue line).  
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The presence of β1 subunits on the PBCEC surface is obvious indicated by a right shift of 
fluorescence intensity for anti human β1 antibody compared to the controls representing the 
secondary (fluorescence labelled) and another irrelevant anti rat antibodies (figure 4-9). 
β1 integrin subunit is shared by the receptors for laminin, fibronectin and collagen type IV 
and thus, is also important for the adhesion and spreading of the cells.  
 
Conclusion 3 
Individual integrins, which are mainly responsible for attachment and spreading of animal 
cells, were identified on the surface of PBCEC by FACS analysis after specific 
immunolabelling.  
FACS results revealed that PBCEC carry all important integrin subunits for adhesion on 
fibronectin coated surface  − α5β1, on laminin - α3β1 and α6β1, and on collagen type IV- 
α1β1 and α2β1 units. 
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5 The functional impact of endogenously-derived ECM for BBB 
phenotype  
5.1 The characterization of ECM expression on protein and RNA level 
 
The serum-free porcine cell culture model used in this work is well characterized and mimics 
the in vivo situation at the BBB as indicated by high TEER and low permeability. These high 
values of TEER are not based on the presence of astrocytes in the culture like it was shown 
before by other groups, who have co-cultured endothelial cells and astrocytes in a filter setup 
(Dehouck, 1990), used astrocyte conditioned medium (ACM) (Rubin, 1991), or primary 
cultured BCEC in either filter co-culture or in ACM (Wolburg, 1994). The question whether 
glia-secreted soluble or ECM bound factors are necessary to induce the BBB properties in 
vitro was investigated in this work.  
The expression of the major ECM molecules by cerebral endothelial cells, astrocytes and 
pericytes was compared with the expression level of these proteins found in the aorta (non-
brain) endothelial cells.  
 
5.1.1 PBCEC secrete special ECM in vitro 
 
The basement membrane which is found in the nervous tissue is composed of collagen type 
IV, laminin, entactin, heparan sulfate, fibronectin and vitronectin (section 2.5.2). Tilling et al. 
have suggested that collagen type IV, fibronectin and laminin are involved in the tight 
junction formation between cerebral capillary endothelial cells and thus, enhance the 
reliability and suitability of primary microvascular endothelial cell cultures as an in vitro 
model of the blood-brain barrier (Tilling, 1998). In order to show the importance of the main 
ECM proteins on the BBB formation process, the secretion and localization of collagen type 
IV, fibronectin and laminin have been examined here in PBCEC by means of 
immunocytochemistry. 
Figure 5-1 A, B and C depict the immunostaining directed against collagen type IV, 
fibronectin and laminin secreted by PBCEC. The peculiarity of the secretion of all 
components of the basement membrane of PBCEC is that all these proteins are secreted into 
the outside of the cells forming a protein network of extracellular environment.  
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Figure 5-1. Detection of extracellular matrix proteins by immunofluoresecence 
staining in PBCEC. 
Micrographs show immunofluorescence labeling of cells cultured in serum-free medium on collagen 
type I+III using antibodies against collagen type IV (A), fibronectin (B) and laminin (C).  
 
5.1.2 PAEC secrete special ECM in vitro  
 
Micro- and macrovascular endothelial cells cultured under reference conditions (on collagen 
type I+III coatings) have been further compared with the cells seeded on the glia-derived 
ECM substrates. Therefore, the expression pattern of ECM molecules in PAEC has been 
further detected by immunocytochemistry as well. 
Figure 5-2 depicts the expression of collagen type IV (A), fibronectin (B) and laminin (C) in 
PAEC. Thus, the immunofluorescence staining shows that macrovascular endothelial cells are 
also able to secrete extracellular matrix proteins in vitro. The secretion pattern of the ECM 
differs from that found before in PBCEC in its lateral organization of fibronectin 
(figure 5-2 B) and laminin (figure 5-2 C). Aorta in contrast to brain endothelial cells produce 
ECM molecules not into the extracellular network but intracellulary without their further 
excretion. Perhaps, they keep synthesized ECM molecules in the Golgi complex not allowing 
complete protein secretion to the outside of the cells.  
The functional and morphological importance of such ECM secretion for macrovascular- 
compared to microvascular endothelial cells could be one of the aspects leading to the 
different inputs of their ECM into the specially developed phenotype.  
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Figure 5-2. Detection of extracellular matrix proteins by immunofluorescence 
staining in PAEC. 
Micrographs show immunofluorescence labeling of cells cultured in serum-free medium on collagen 
type I+III substrate using antibodies against collagen type IV (A), fibronectin (B) and laminin (C).  
 
5.1.3 Glial cells produce special ECM in vitro 
The involvement of glia-derived ECM molecules in the induction of BBB features in 
endothelial cells is described elsewhere (Bauer and Bauer, 2000; Robert and Robert, 1998; 
Savettieri et al., 2000; Tontsch and Bauer, 1991; van der Laan et al., 1997; Wagner et al., 
1997; Webersinke et al., 1992). In order to investigate an impact of these proteins on BBB 
formation properties of PBCEC, the secretion of main components of the basement membrane 
has been studied in pericytes and astrocytes by immunocytochemistry. The 
immunofluorescence stainings of collagen type IV (A), fibronectin (B) and laminin (C) in 
glial cells are depicted in figures 5-3 and 5-4.  
Figure 5-3 A, B and C show that the secretion of different ECM components by pericytes 
does not always mirror the shape of the cells like it was in previously shown PBCEC 
(figure 5-1) or PAEC (figure 5-2). Only collagen type IV is secreted to the borders of the 
pericytes (figure 5-3 A), although the secretion of fibronectin as well as laminin is more 
diffuse and spead not only through the cell bodies but also into the extracellular environment 
of the pericytes (figure 5-3 B and C).  
 
 
 
 
 
 
 
50 µm 
A B 
 
C 
72 5 The functional impact of endogenously-derived ECM for BBB phenotype 
 
 
 
 
 
 
 
 
Figure 5-3. Detection of extracellular matrix proteins by immunofluorescence 
staining in pericytes. 
Micrographs show immunofluorescence labeling of cells cultured in serum-free medium on collagen 
type I+III mixture substrate using antibodies against collagen type IV (A), fibronectin (B) and laminin 
(C).  
 
The secretion of special ECM molecules by astrocytes is shown in figure 5-4. In contrast to 
pericytes all immunostained ECM proteins in astrocytes mirror the shape of these cells 
indicating the synthesis of collagen type IV, fibronectin and laminin inside of the cells 
(figure 5-4 A, B and C).  
 
 
 
 
 
 
 
 
Figure 5-4. Detection of extracellular matrix proteins by immunofluorescence 
staining in astrocytes. 
Micrographs show immunofluorescence labeling of cells cultured in serum-free medium on collagen 
type I+III substrate using antibodies against collagen type IV (A), fibronectin (B) and laminin (C). 
 
Astrocytes have previously been shown to produce ECM molecules (Price and Hynes, 1985). 
Under the normal conditions (non-injury) astrocytes do not express abundant extracellular 
matrix molecules, as judged by immunocytochemical analysis (Sobel and Mitchell, 1989; van 
der Laan et al., 1997). In the experimental conditions applied here (serum-free medium) rat 
astrocytes showed a high quantity of secreted ECM in vitro.  
Thus, pericytes and astrocytes were further cultured to extract the complex of the extracellular 
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matrix components synthesized by these cells. This endogenously derived ECM was further 
applied as a substrate for a new generation of PBCEC in a cell adhesion assays and 
quantitative detection of protein and mRNA expression levels in PBCEC. These studies were 
then performed in PBCEC under the influence of newly synthesized glia-derived matrix. That 
is the reason, why it was necessary to identify the ECM proteins produced and secreted by 
pericytes and astrocytes.  
 
5.1.4 The sub-cellular ECM composition differs from the ECM level in the 
whole cell lysate 
 
An individual expression pattern of ECM molecules, which are known to control the 
spreading and attachment of endothelial cells, was found in PBCEC compared to PAEC in 
this work. In order to understand the peculiarities of interactions between the ECM 
components and the brain endothelial cells (Gerhardt et al., 2000; Hellstrom et al., 1999) 
PBCEC were cultured on glia-derived ECM and protein expression level of collagen type IV, 
fibronectin and laminin were studied by western blot technique. The results were compared 
with ECM expression level found in PAEC.  
Previously, it has been shown that the way of secretion of special ECM molecules in PAEC 
differs from that found in PBCEC (sections 5.1.1 and 5.1.2). Whereas, PBCEC form a 
network of ECM fibrils by secreting their components subcellulary, aorta endothelial cells 
keep their ECM components inside of the cells. Perhaps, PAEC either secrete these molecules 
in response to the extracellular signals, or have different turnover times of these proteins. This 
means that at the time when PBCEC have already transported their ECM components out of 
the cells, the PAEC are still synthesizing or storing their matrix. That is why, 
immunocytochemical studies in chapters 5.1.1 and 5.1.2 revealed a different 
compartmentalization of the ECM components in PBCEC compared to PAEC (figures 5-1 
and 5-2).  
The existence of all these factors makes it clear that, at a given time and place, the 
extracellular matrix has the potential to provide specific environmental information to the 
cells. The modified protein isolation methods for characterization of sub-cellular ECM (in the 
extracellular space of the cells) and in the whole cell lysate were implemented (section 8.2.1). 
Protein loading was controlled by determining the protein concentration in the samples and 
staining the whole protein by Protogold Detection KitTM (Amersham). Figure 5-5 A and B 
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depict the expression pattern of sub-cellular ECM representing the level of these molecules 
synthesized and secreted at the basolateral side of the cells. The expression of collagen type 
IV and fibronectin was altered after seeding the cells on different ECM coatings. Collagen 
type IV (figure 5-5 A) shows an increased expression level in PBCEC (lane 1) in comparison 
to PAEC (lane 2) grown on collagen type I+III. The level of fibronectin expression (figure 5-
5 B) is higher in PAEC (lane 2) than in PBCEC (lane 1).  
 
 
 
 
 
 
Figure 5-5. Collagen type IV (A) and fibronectin (B) expression in PBCEC and PAEC 
cultured on different ECM. 
The cells were removed by treatment with 20 mM ammonium hydroxide. 1: PBCEC cultured on 
collagen type I+III; 2: PAEC cultured on collagen type I+III; 3: PAEC cultured on PBCEC-derived 
ECM; 4: PBCEC cultured on pericytes-derived ECM; 5: PBCEC cultured on astocytes-derived ECM. 
M – molecular weight marker. 
 
Interestingly, both molecules fibronectin and collagen type IV almost disappeared in PAEC 
upon culturing the cells on PBCEC-derived ECM. The explanation for this could be a striking 
modification of the endogenous matrix derived from PBCEC (lane 1) assuming an extremely 
rapid turnover of synthesized collagen type IV and fibronectin. The quantity of the collagen 
type IV (figure 5-5 A) is higher in PBCEC cultured on pericytes- (lane 4) than on astrocytes-
derived ECM (lane 5). The expression level of fibronectin (figure 5-5 B) is lower in PBCEC 
cultured on pericytes-derived ECM (lane 4) compared to the PBCEC grown on astrocytes-
derived ECM (lane 5).  
The expression level of ECM proteins in the whole cell lysate of PBCEC compared to PAEC 
is represented in figures 5-6 and 5-7. It was necessary to check if these proteins are removed 
from the culture surfaces with the cell bodies during the lysis procedure.  
The expression level of collagen type IV as well as fibronectin has been studied in whole cell 
lysates of both PAEC and PBCEC cultured on endogenously derived ECM and are compared 
to the reference coating (collagen type I+III). Both types of the cells secrete an individual 
pattern of extracellular matrix proteins dependent on the initial matrix coating. Since PBCEC 
175 kD 
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5 The functional impact of endogenously-derived ECM for BBB phenotype 75 
were previously shown to secrete higher amount of sub-cellular ECM than PAEC as detected 
by immunocytochemistry (figures 5-1 and 5-2) and western blot (figure 5-5), the same results 
were expected in a whole cell lysate.  
 
 
 
 
 
Figure 5-6. Collagen type IV expression in PBCEC and PAEC cultured on different 
ECM. 
The protein expression was studied in whole cell lysate. 1: PAEC cultured on collagen type I+III 
mixture; 2: PAEC cultured on PBCEC-derived ECM; 3: PBCEC on a mixture of collagen type I and III; 
4.: PBCEC cultured on pericytes-derived ECM and 5: PBCEC cultured on astocytes-derived ECM. M – 
molecular weight marker.  
 
According to the results depicted in figure 5-6 the expression level of collagen type IV as 
determined from whole cell lysate is higher in PBCEC (lane3) than in aorta endothelial cells 
cultured on collagen type I+III (lane 1). However, it is much lower than in PBCEC cultured 
on pericytes- or astrocytes-derived ECM (figure 5-6, lanes 4 and 5). There is no difference in 
the expression of collagen type IV in PBCEC grown on pericytes- compared to astrocytes-
derived ECM. 
 
 
 
 
Figure 5-7. Fibronectin expression in PBCEC and PAEC cultured on different ECM.  
The protein expression was studied in whole cell lysates. 1: PBCEC on the mixture of collagen type I 
and III; 2.: PAEC cultured on collagen type I+III; 3: PAEC cultured on PBCEC-derived ECM; 4.: 
PBCEC cultured on pericytes-derived ECM and 5: PBCEC cultured on astocytes-derived ECM. M – 
molecular weight marker.  
 
Fibronectin is significantly stronger expressed in PAEC compared to PBCEC when both are 
cultured on collagen type I+III in both fractions, sub-cellular after cell lysis (figure 5-5 B) as 
well as in whole cell lysate (figure 5-7). Interestingly, there is a slight down-regulation of 
1.        2.       3.     M       4.    5. 
175 kD 
175 kD 
1.      2.     3.          M             4.    5. 
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fibronectin in PBCEC cultured on pericytes-derived ECM compared to the astrocytes-derived 
ECM after cell lysis. However, the protein content is unchanged after the isolation of the 
whole cell lysate in both PBCEC grown on pericytes- as well as on astrocytes-derived ECM.  
 
5.1.5 ECM expression in PBCEC compared to PAEC on RNA level 
 
The mRNA expression level of collagen type IV, fibronectin and laminin were studied in 
PBCEC and compared to PAEC by quantitative real-time PCR. 
 
5.1.5.1 Analysis of the cDNA sequences of collagen type IV, laminin and fibronectin  
 
In order to compare the ECM gene expression in different cell types involved in the formation 
of BBB in a quantitative way the cDNA sequences of collagen type IV, fibronectin and 
laminin were firstly analyzed. The sequence data were observed by cloning and subsequent 
selecting of porcine DNA sequences for these proteins. Thus, mRNA encoding laminin 
(β1, γ1 and α4-chains), fibronectin as well as collagen type IV (α1-chain) were isolated from 
PBCEC and amplified by RT-PCR with selected primers. The primers for collagen type IV 
were selected based on published sequences of human and rat species, flanking a 283 bp 
sequence. After purification, target DNA fragments were cloned into PCR 2.1 and pT-Adv-
vectors respectively (see Appendix F and E). The plasmids were transformed in competent 
TOP10F’ E.coli, selected by blue/white-screening on LB-Amp/IPTG/X-Gal-plates. Positive 
clones were selected and plasmids were isolated with Spin Miniprep Kit®.  
Sequence analysis of cloned fragments and comparison in the databank of NCBI (National 
Center for Biotechnology Information) revealed that human collagen type IV (α1-chain) and 
rat (α1-chain) has a 95% homology in DNA sequences. Since the sequence data for sus scrofa 
collagen type IV were not known before the whole procedure for the DNA of collagen type 
IV was performed in this work. Therefore, the amplification of found sequence fragment 
(283 bp) of sus scrofa collagen type IV (α1-chain) DNA in both, PAEC and PBCEC is shown 
in figure 5-8. The comparison of sequence data of found sus scrofa collagen type IV fragment 
revealed 90 % agreement with homo sapiens collagen type IV, alpha1 (figure 5-9). 
Sequence analysis of all other clones with BLAST (basic local alignment search tool) 
revealed for laminin β1 a 98 % homology with correspondent sequence part of sus scrofa 
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laminin β1 (figure 5-10); for laminin γ1 a 90 % homology of homo sapiens laminin γ1 
(figure 5-11); for laminin α4 a 92 % homology of homo sapiens laminin α4 (figure 5-12) and 
for fibronectin a 93 % agreement with sequence data published for bos taurus fibronectin 
precursor (figure 5-13) or a 93 % - for canis familiaris fibronectin mRNA (data not shown). 
 
 
 
 
 
 
Figure 5-8. Detection of amplificated DNA message of  
sequenced sus scrofa collagen type IV (α1-chain) in 
PBCEC (1) and PAEC (2) with RT-PCR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-9. The comparison of sequence data of sus scrofa collagen type IV (α1-
chain)-fragment (283 bp) with mRNA of homo sapiens collagen type IV (α1-chain) 
Query: Sequence data of cloned collagen type IV (α1)-fragment in PCR 2.1-vector. Sbjct: mRNA-
sequences of homo sapiens collagen type IV, alpha1 (COL4A1), partial cds.  
 
 
 
 
 
 
 
100 bp  1      2 
283 bp 
Query: 99   gccttgaagttggacggcttgggcttcttgaacatctcgctccgctctatggtggcgagc 158 
            ||||| ||| |||||||| | |||||||||||||||||||||| |||||||||||||||| 
Sbjct: 5084 gccttcaaggtggacggcgtaggcttcttgaacatctcgctcctctctatggtggcgagc 5025 
                                                                         
Query: 159  cagaagctgtaggcgtttgcatagtaattgcaggtcccgcggccgtggcactcgatgaat 218 
            || |||||||| |||||||| ||||||||||||||||| |||||||| |||||||||||| 
Sbjct: 5024 caaaagctgtaagcgtttgcgtagtaattgcaggtcccacggccgtgacactcgatgaat 4965 
                                                                         
Query: 219  ggggcacttctgaactcctccagacaggagccgggggaagccagggcctggccagaacct 278 
            || |||||||| ||||||||||| |||||||||||||| |||||||| |||||||| ||| 
Sbjct: 4964 ggcgcacttctaaactcctccaggcaggagccgggggacgccagggcttggccagagcct 4905 
                                                                        
Query: 279  tcggcaccggcactggtgtgcatcacaaaggagtagccaatccagagggaggaccagccg 338 
           || ||||| || ||||||||||||||||| |||||||| ||||| || |||||||| ||| 
Sbjct: 4904 tctgcaccagcgctggtgtgcatcacaaaagagtagccgatccacagcgaggaccacccg 4845 
                                                   
Query: 339  ctggggcactgcgggatctggatggtctggctgtgcac 376 
            ||||||||| | |||||||| ||||||||||||||||| 
Sbjct: 4844 ctggggcacggtgggatctgaatggtctggctgtgcac 4807 
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Figure 5-10. The comparison of sequence data of laminin β1-fragment (442 bp) with 
mRNA of sus scrofa laminin β1-chain.  
Query: Sequence data of cloned laminin β1-fragment in PCR 2.1-vector. Sbjct: mRNA-sequences of 
sus scrofa laminin β1, partial cds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Query: 23  caaggcactcaggacatcttggtcaaagtccatggctttctgccaggcgctgtgtgcgac 82 
          |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 399 caaggcactcaggacatcttggtcaaagtccatggctttctgccaggcgctgtgtgcgac 340 
                                                                       
Query: 83  ggtgaccagcccaccacagccaggccccccacacttcttctgtccttcgtcagttctgca 142 
          |||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||| 
Sbjct: 339 ggtgaccagcccaccacagccaggccccccacacttctcctgtccttcgtcagttctgca 280 
                                                                        
Query: 143 gtttgggccgccacactctgtctcggaacaggaggcccctggaggcgttccacacgtcag 202 
           ||||||||||||||||||||||||||||||||||||||||||||| |||||||||||||| 
Sbjct: 279 gtttgggccgccacactctgtctcggaacaggaggcccctggaggtgttccacacgtcag 220 
                                                                        
Query: 203 ctcagcagcagttgaaaggtccagactctgtagtttgcccgccagttcatccagaaggcg 262 
           ||||||||||||||||||||||||||| ||||||||||| |||||||||||||||||||| 
Sbjct: 219 ctcagcagcagttgaaaggtccagactttgtagtttgcctgccagttcatccagaaggcg 160 
                                                                        
Query: 263 ggcctgctcctcctgtttgtccctgaattgggactcttgctccaacatcaagtcttccac 322 
           ||||||||||||||||||||||||||| |||||||||||||||||||||||||||||||| 
Sbjct: 159 ggcctgctcctcctgtttgtccctgaactgggactcttgctccaacatcaagtcttccac 100 
                                                                        
Query: 323 tctgtctcgaatgagggccgactgctccacagtgctgttggaatccgtggnggaagcatt 382 
           |||||||||||||||||||||||||||||||||||||||||||||||||| ||||||||| 
Sbjct: 99  tctgtctcgaatgagggccgactgctccacagtgctgttggaatccgtggtggaagcatt 40 
                                                  
Query: 383 caccctctcctctgcctccacagacatctggaaatact 420 
           |||||||||||||||||||| ||||||||||||||||| 
Sbjct: 39  caccctctcctctgcctccagagacatctggaaatact 2 
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Figure 5-11. The comparison of sequence data of laminin γ1-fragment (497 bp) with 
mRNA of homo sapiens laminin γ1-chain (formerly LAMB2). 
Query: Sequence data of cloned laminin γ1-fragment in PCR 2.1-vector. Sbjct: mRNA-sequences of 
homo sapiens  laminin γ1, partial cds.  
 
 
 
 
 
 
 
 
 
Query: 1    gcccaggatgtcaaagatgtagaccagaatttaatggatcgcctccagagagtgaataac 60 
            |||||||||||||||||||| ||||||||||| ||||||||||| ||||||||||||||| 
Sbjct: 3564 gcccaggatgtcaaagatgttgaccagaatttgatggatcgcctacagagagtgaataac 3623 
                                                                        
Query: 61   accttatccagccaaattagccgtttacagaatatccgcaataccattgaggagaccgga 120 
            ||  | |||||||||||||||||||||||||||||||| ||||||||||| ||||| ||| 
Sbjct: 3624 actctgtccagccaaattagccgtttacagaatatccggaataccattgaagagactgga 3683 
                                                                         
Query: 121  aacttggctgagcaagcacgtgcccgggtagaaagcacagagcagttgattgaaattgct 180 
           ||||||||||| ||||| |||||||  ||||| | |||||||| |||||||||||| ||  
Sbjct: 3684 aacttggctgaacaagcgcgtgcccatgtagagaacacagagcggttgattgaaatcgca 3743 
                                                                        
Query: 181  tccagagaactggagaaagcaaaggttgccattgccaacgtgtcgatcactcagccagag 240 
            ||||||||||| ||||||||||| || ||   |||||| |||||  |||||||||||||  
Sbjct: 3744 tccagagaacttgagaaagcaaaagtcgctgctgccaatgtgtcagtcactcagccagaa 3803 
                                                                         
Query: 241  tctacaggggacccaaacaacatgactcttttggcagaagaggcacgaaagcttgctgag 300 
            |||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||  
Sbjct: 3804 tctacaggggacccaaacaacatgactcttttggcagaagaggctcgaaagcttgctgaa 3863 
                                                                         
Query: 301  cgccataaacaagaagctgatgacatcgtacgagtggcaaagacagccaatgatacatca 360 
            || |||||||| |||||||||||||| || |||||||||||||||||||||||||| ||| 
Sbjct: 3864 cgtcataaacaggaagctgatgacattgttcgagtggcaaagacagccaatgatacgtca 3923 
                                                                         
Query: 361  actgaggcatataatctgcttttgaagaccctggcaggagaaaatcaaacagcttttgag 420 
            ||||||||||| || |||||| ||| ||| ||||||||||||||||||||||| |||||| 
Sbjct: 3924 actgaggcatacaacctgcttctgaggacactggcaggagaaaatcaaacagcatttgag 3983 
                                                                         
Query: 421  attgaagagctgaatagaaagtatgaacaagcgaagaacatctcacaggatctagagaaa 480 
            ||||||||||| ||||| ||||||||||||||||||||||||||||||||||| || ||| 
Sbjct: 3984 attgaagagcttaataggaagtatgaacaagcgaagaacatctcacaggatctggaaaaa 4043 
                               
Query: 481  caagctgcccgagtacat 498 
            |||||||||||||||||| 
Sbjct: 4044 caagctgcccgagtacat 4061 
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Figure 5-12. The comparison of sequence data of laminin α4-fragment (499 bp) with 
mRNA of homo sapiens laminin α4-chain (LAMA4). 
Query: Sequence data of cloned laminin α4-fragment in PCR 2.1-vector. Sbjct: mRNA-sequences of 
homo sapiens  laminin α4, partial cds.  
 
 
 
 
 
 
 
 
 
 
Query: 1    tctcagcaatctccagctcaacggagcctccatctcctctgcttctcagacatttagcgt 60 
            ||||||||||||||||||||| || ||||||||| ||||||||||||||||||| || || 
Sbjct: 5113 tctcagcaatctccagctcaatggggcctccatcacctctgcttctcagacattcagtgt 5172 
                                                                         
Query: 61   gactccttgttttgaaggtccaatggaaacaggaacatatttttcaacagaagggggata 120 
            ||| ||||| |||||||| || |||||||||||||| || |||||||||||||| ||||| 
Sbjct: 5173 gaccccttgctttgaaggccccatggaaacaggaacttacttttcaacagaaggaggata 5232 
                                                                         
Query: 121  tgtggttctagatgagtctttcaatattggattgaaatttgagattgcatttgaagtccg 180 
            |||||||||||||| |||||||||||||||||||| ||||| ||||||||||||||||| 
Sbjct: 5233 cgtggttctagatgaatctttcaatattggattgaagtttgaaattgcatttgaagtccg 5292 
                                                                        
Query: 181  tcccagaagcagttctggaatctttgttcatggccacagcgtcaacggggagtacctaaa 240 
            ||||||||||||||| |||| | | || || |||||||| ||||| |||||||||||||| 
Sbjct: 5293 tcccagaagcagttccggaaccctggtccacggccacagtgtcaatggggagtacctaaa 5352 
                                                                         
Query: 241  tgttcacatgaaaaatgggcaggtcatagtgaaagtcaacaatggcatcagagacttttc 300 
            |||||||||||||||||| |||||||||||||||||||| |||||||||||||| ||||| 
Sbjct: 5353 tgttcacatgaaaaatggacaggtcatagtgaaagtcaataatggcatcagagatttttc 5412 
                                                                         
Query: 301  cacttcagtggcacccaagcaaagtctctgtgatggccgatggcacagaattacagttat 360 
            ||| |||||  |||||||||| ||||||||||||||| |||||||||||||||||||||| 
Sbjct: 5413 cacctcagtaacacccaagcagagtctctgtgatggcagatggcacagaattacagttat 5472 
                                                                         
Query: 361  tagagattcaaatgtggttcagttggatgtagactctgaagtgaaccacgtggttggacc 420 
            ||||||||| |||||||||||||||||||| ||||||||||||||||| ||||||||||| 
Sbjct: 5473 tagagattctaatgtggttcagttggatgtggactctgaagtgaaccatgtggttggacc 5532 
                                                                         
Query: 421  tctgaatccaaaaccagttgatcacagggagcctgtgtttgttggaggtgttccagagtc 480 
            ||||||||||||||| |||||||||||||||||||||||||||||||||||||||| || 
Sbjct: 5533 cctgaatccaaaaccaattgatcacagggagcctgtgtttgttggaggtgttccagaatc 5592 
                                
Query: 481  tctactgacaccacgcttgg 500 
            |||||||||||||||||||| 
Sbjct: 5593 tctactgacaccacgcttgg 5612 
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Figure 5-13. The comparison of sequence data of fibronectin-fragment (780 bp) with 
mRNA of Bos taurus fibronectin precursor. 
Query: Sequence data of cloned fibronectin-fragment in pT-Adv-vector. Sbjct: mRNA-sequences of 
Bos taurus  fibronectin, partial cds.  
 
 
 
 
 
 
 
Query: 120  tctgccactgttctcccacatggtatgtcttcccatcatcataacacgtcgcttcatggg 179 
            ||||||| ||||||||||||||||||||||||||||| || |||||||| || ||||| | 
Sbjct: 1567 tctgccagtgttctcccacatggtatgtcttcccatcgtcgtaacacgttgcctcatgag 1508 
                                                                         
Query: 180  gatcacacttgaattctccttttccatttccgagacatgtgcagctcatcatctggccat 239 
            ||||||||||||||||||||||||||||||| |||||||||||||||||||||||||||| 
Sbjct: 1507 gatcacacttgaattctccttttccatttccaagacatgtgcagctcatcatctggccat 1448 
                                                                         
Query: 240  tctctccctgacgatcccacttctctccaatcttgtaattcacaccattgtcatggcacc 299 
            |||| |||||||||||||||||||| ||||||||||| ||||||||||| |||||||||| 
Sbjct: 1447 tctccccctgacgatcccacttctcgccaatcttgtagttcacaccattatcatggcacc 1388 
                                                                         
Query: 300  atttagatgaatcacatctgaaatgaccactgccaaagcctaagcactggcacgagagct 359 
            |||||||||| ||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct: 1387 atttagatgagtcacatctgaaatgaccactgccaaagcctaagcactggcacgagagct 1328 
                                                                         
Query: 360  taaagccagattcagataatcgctcccactcttctccgatggcataatgggaaaccgtgt 419 
            |||||||||||||||| || ||||||||||| ||||| |||||||||||||||||||||| 
Sbjct: 1327 taaagccagattcagacaaccgctcccactcctctccaatggcataatgggaaaccgtgt 1268 
                                                                         
Query: 420  aggggtcgaagcacgagtcatccgtgggttggcttaggccttggtcaacagaattgccca 479 
            |||||||||||||||||||||| || || ||| ||||||||||||| ||||| ||||||| 
Sbjct: 1267 aggggtcgaagcacgagtcatctgtaggctggtttaggccttggtccacagagttgccca 1208 
                                                                         
Query: 480  cagtaaccacctcctcccgaatcttgtgcctcttctggtcttttagtgcctccactatga 539 
            | ||||| ||||||||||||| ||||||||||||||||||||| |||||||| ||||||| 
Sbjct: 1207 cggtaacaacctcctcccgaaccttgtgcctcttctggtctttcagtgcctcgactatga 1148 
                                                                         
Query: 540  tgttgtaggtggcacctctggtgagacccgtcaaggtggcactagcagaagttccaggaa 599 
            ||||||||||||| |||||||| || || |||| |||||||||||||||||| ||||||| 
Sbjct: 1147 tgttgtaggtggcccctctggtaaggcctgtcagggtggcactagcagaagtgccaggaa 1088 
                                                                         
Query: 600  ctcggaactgcaagggttcttcatcaatgcccacgggatgacatgaaatgatatattcag 659 
            |||||||||| || ||||||||||||||||| || |||||||||||||||||||| |||| 
Sbjct: 1087 ctcggaactgtaaaggttcttcatcaatgccaactggatgacatgaaatgatatactcag 1028 
                                                                         
Query: 660  agctttcctggaatggggtccatgagaatggttgtctgagagagagcttcttgtcctgta 719 
            ||||||| |||||||| ||||| ||| ||||||||||||||||||||||||||||||||| 
Sbjct: 1027 agctttcttggaatggagtccaagag-atggttgtctgagagagagcttcttgtcctgta 969 
                              
Query: 720  gaagcatttggattgag 736 
            || |||||||||||||| 
Sbjct: 968  gaggcatttggattgag 952 
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5.1.5.2 Quantitative characterization of ECM gene expression in PBCEC compared to 
PAEC  
 
Figure 5-14 shows ECM gene expression in primary cultured brain compared to aorta 
endothelial cells. Due to the fact that different cell types were used in QRT-PCR the cycle 
number of detected cDNA-message and no marker were used for analysis of the results 
(section 8.3.7.2). The total amount of reverse transcribed RNA was adjusted to 1 µg/ml in 
each cell sample. A higher cycle value represents a lower expression level of mRNA. The 
values detected later than cycle 30 are not significantly higher than the background of the 
reaction.  
As shown in figure 5-14 the RNA expression level of collagen type IV and fibronectin is up-
regulated in PBCEC cultured on astrocytes- as well as on pericytes-derived matrix compared 
to PBCEC cultured on collagen type I+III. This verifies an influence of glia-derived ECM on 
the regulation of RNA expression of ECM molecules such as collagen type IV and fibronectin 
in PBCEC (figure 5-14 ).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5-14. Results of QRT-PCR.  
Expression of ECM proteins on mRNA level in PBCEC compared to PAEC on different extracellular 
matrix coatings. The values give the cycle where the templates reach a point in which the signal is first 
recorded as statistically significant above the background (Gibson, 1996). The significant changes in 
relation to the reference (PBCEC, collagen type I+III) are marked with asterisks. (n=3) 
 
 ColIagen type IV Fibronectin Laminin γ1 
PBCEC, colIagen type I+III  17.5 ± 0.1 16.4 ± 0.0 17.2± 0.2 
PBCEC, pericytes-ECM  16.3* ± 0.1 15.4* ± 0.0 16.7 ± 0.0 
PBCEC, astrocytes-ECM 16.2* ± 0.1 15.6* ± 0.1 16.3* ± 0.2 
PAEC, collagen type I+III 21.9 ± 1.7 14.6 ± 0.6 18.8 ± 0.6 
PAEC, PBCEC-ECM  19.5* ± 0.1 14.4 ± 0.0 17.6* ± 0.1 
0,0
5,0
10,0
15,0
20,0
25,0
Collagen type IV Fibronectin Laminin
Cy
c
le
PBCEC, colIagen type I+III 
PBCEC, pericytes-ECM 
PBCEC, astrocytes-ECM
PAEC, collagen type I+III
PAEC, PBCEC-ECM 
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Generally, the expression level of laminin mRNA is unchanged in PBCEC cultured on 
pericytes-derived ECM and increased in PBCEC grown on astrocytes-derived ECM compared 
to the reference coating. There is no difference in the mRNA level of these three ECM 
proteins between PBCEC cultured on pericytes-derived compared to astrocytes-derived ECM. 
The aorta endothelial cells show an increased expression level of mRNA of collagen type IV 
as well as laminin but not fibronectin upon culturing these cells on PBCEC-derived ECM 
(figure 5-14). 
The results shown above are in good agreement with literature data, with respect to the fact 
that the message for laminin mRNA in PBCEC cultured on glia-derived ECM is equally 
amplified one PCR cycle later than for fibronectin (figure 5-14). Jiang et al. have shown that 
astrocytes are able to induce fibronectin expression in differentiating endothelial cells to 
initiate vasculogenesis in vivo (Jiang, 1994). Furthermore, by culturing endothelial cells in 
conditioned medium (CM) from astrocytes, they proved that a soluble factor in astrocytes CM 
specifically induces endothelial cells to synthesize fibronectin, whereas endothelial cell 
laminin production was not affected (Jiang et al., 1994).  
 
Conclusion 4  
The major proteins of the basement membrane such as collagen type IV, fibronectin and 
laminin were shown to be expressed by micro- (brain) and macrovascular (aorta) endothelial 
cells, as well as by pericytes and astrocytes as detected by immunocytochemistry.  
The expression of collagen type IV and fibronectin is increased in PBCEC upon culturing 
these cells on pericytes- and astrocytes-derived ECM in both fractions whole cell lysate and 
sub-cellular matrix. The expression of collagen type IV is higher in PBCEC than in PAEC, 
whereas fibronectin - is higher in PAEC than in PBCEC cultured on collagen type I+III. Both 
collagen type IV and fibronectin are not present in whole cell lysate and in the sub-cellular 
matrix of PAEC grown on PBCEC-derived ECM  
The up-regulated expression level of collagen type IV and laminin, but not fibronectin mRNA 
was measured in PAEC cultured on PBCEC-derived ECM compared to PAEC grown on 
collagen type I+III by QRT-PCR analysis.  
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5.2 Endogenously derived ECM influences the time course of cell adhesion 
and tight junctions formation 
 
In order to study the impact of glia-derived ECM components on the BBB formation, brain 
endothelial cells were cultured on pericytes and astrocytes-derived ECM. The aorta 
endothelial cells and endogenously derived ECM from these cells were used as a reference 
model to analyze special features of the ECM derived from the brain capillary and glial cells.  
In the present study several methods of matrix denudation have been applied to optimize the 
preparation of surfaces coated with ECM derived from one cell type that could be used as a 
culture substrate for the next cell generation.  
Unless cultured cells can produce their own ECM, it is possible that unspecific contact to the 
plastic inhibits their proliferation or reduces their ability to express their correct phenotype.  
The most popular method of preparing the ECM produced by the confluent cell monolayer is 
the lysis of the cells by an ammonia solution (20 mM). This method has been broadly 
described in electron microscopic studies for bovine capillary endothelial ECM denudation 
(Gospodarowicz, 1984) or for glial ECM in order analyze of glia-endothelial cell interactions 
(Mizuguchi et al., 1997). This kind of treatment (8.1.6) was used in the present work for the 
analysis of RNA and protein expression level of endothelial cells cultured on ECM produced 
by other cell types. The ECM components were stained afterwards for the most important 
ECM components by immunocytochemical techniques showing an abundance of the ECM 
proteins (data not shown). This treatment works best with cells cultured in culture flasks. 
However, for ECIS experiments different methods had to be applied due to the fact that 
preliminary measurements on the arrays led to the conclusion that the ECM denudation was 
not complete by this procedure.  
 
5.2.1 Optimization of the cell lysis method to obtain substrates coated with 
endogenous ECM 
 
Figure 5-15 depicts the results of different lysis buffers applied for PBCEC lysis. After 
application of DLB (domain lysis buffer) solution the lipid membrane stained with the 
fluorescent membrane probe DiIC18 (Appendix D) remains on the substrate so that this buffer 
was used as a reference for cell lysis experiments (figure 5-15 A) (Tilling, 1998). After 
ammonia treatment the cell membrane remains partially on the culture surface so that it could 
5 The functional impact of endogenously-derived ECM for BBB phenotype 85 
not be applied to expose endogenous ECM on the small surfaces of ECIS electrodes 
(figure 5-15 C). The membrane and remaining cell debris affect the adhesion of the new 
generation of cells and thus, change the results of the experiment. Another lysis buffer tested 
in further experiments consists of two detergents (1% (w/v) desoxycholate and 1% (w/v) 
nonidet P-40), and proved to be the best lysis buffer as it is seen in the figure 5-15 E.  
      DLB         NH4OH          Lysis buffer 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-15. Different types of cell lysis for ECM denudation.  
The cells were lyzed with several approaches followed by washing of the culture flasks and stained 
with DiIC18 solution. A, B: Domain lysis buffer (DLB) solution; C, D: 20mM ammonia; E: lysis buffer 
containing 1% desoxycholate and 1% nonidet P-40. B, D and F: phase-contrast micrographs of the 
substrate after the cell lysis with DLB, NH4OH and Lysis buffer solutions respectively.  
 
Furthemore, figure 5-16 shows an immunostaining against the main integrin receptor present 
in PBCEC – α1β1 after cell lysis with 20 mM ammonia or DLB solutions. The micrographs 
revealed that the integrins are remaining on the ECM surface along the contoures of the 
formely attached cells.  
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Figure 5-16. A phase-contast micrographs (A) and immunostaining of α1β1-integrin 
(B) in PBCEC after cell lysis with 20 mM of ammonia solution. 
The integrins remaining on the substrate along the contoures of the formely attached cells. 
 
The absence of the α1β1-intergin and an abundance of the main ECM molecules have been 
also verified by immunostaining after the treatment of cell monolayers with a lysis buffer 
containing 1% desoxycholate and 1% nonidet P-40. This method allows to achieve the main 
components of extracellular matrix, which remain on the culture surface (figure 5-17 A) and 
detach the integrins (figure 5-17 B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-17. Immunostaining against collagen type IV (A) and α1β1-integrin (B) in 
PBCEC after the treatment of cell monolayers with a lysis buffer 
C and D: phase-contrast micrographs of the substrate after the cell lysis 
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Conclusion 5 
An individual denudation of endogenous ECM was performed dependent on the proceed type 
of subsequent experimental analysis. For western blotting, electron microcopy, 
immunofluorescence and quantitative real-time PCR analysis the ECM was derived using cell 
lysis by 20 mM ammonia solution. This method was shown to leave high quantities of ECM 
after the cell bodies have been lysed. Lysis buffer containing both 1% desoxycholate and 1% 
nonidet P-40, or only 1% nonidet P-40 were applied for preparation of endogenous ECM on 
gold-film electrodes as used in ECIS experiments. 
 
5.2.2 Endogenously-derived ECM promotes cell adhesion and tight junction 
formation  
 
To clarify the importance of the tissue specific origin of extracellular matrix proteins ECIS 
experiments with microvascular endothelial cells were performed on different endogenously-
derived ECM substrates. As it was already mentioned the formation of tight junctions 
between capillary endothelial cells is supposed to be promoted by astroglial cells (Wolburg et 
al., 1994). Fischer et al. found that signals from specific interactions between capillary 
endothelial cells and the surrounding neuroglia cells induce the BBB phenotype in endothelial 
cells (Fischer, 2000). Thus, the time course of cell adhesion and barrier formation of PBCEC 
cultured on astrocyte and pericyte- derived substrates was studied by means of ECIS 
experiments. The results of these studies were compared with adhesion and spreading 
processes of PBCEC on ECM produced by micro- and macrovascular endothelial cells.  
Figure 5-17 shows phase-contrast micrographs of the first generation of different cell types 
cultured on collagen type I+III-coated ECIS electrodes. The cells were directly cultured on 
the surface of ECIS electrodes in serum-free medium supplied with hydrocortisone. All cell 
types depicted in figure 5-17 are attached to one of the circular working electrode with 
250 µm diameter. The trypsinisation process was terminated by trypsin inhibitor to avoid 
degradation of the ECM components by remaining trypsin activity. The established confluent 
cell monolayers were examined by phase-contrast to demonstrate their individual cell 
morphologies. The astrocytes (figure 5-17 A) had their typical cell shapes including feet 
processes sprouting from the cell bodies and communicating with each others. The pericytes 
(figure 5-17 B) resembled the tensed and long-end cells forming a cell monolayer on the 
coating surface.  
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Figure 5-18. Phase-contrast images of rat astrocytes (A), porcine pericytes (B), 
PBCEC (C) and PAEC (D).  
 
After reaching confluence the different cell types were lysed by application of 1% nonidet P-
40 detergent and the remaining ECM coating of the surface was washed 10 times with water. 
The presence of the ECM molecules on the electrodes was checked by immunocytochemistry 
with antibodies against the main ECM proteins (figure 5-17). A freshly prepared suspension 
of PBCEC (second generation) was then seeded on the ECIS electrodes that are now coated 
with endogenous ECM produced by the respective cell types. 
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Figure 5-19. Time course of the capacitance measured at 40 kHz (A) and the 
resistance measured at 400 Hz for PBCEC cultured on endogenously-derived ECM (B). 
PBCEC were seeded on ECIS electrodes coated with: astrocytes-derived ECM (red line), pericytes-
derived ECM (green line), PBCEC-derived ECM (blue line) and PAEC-ECM (black line). (n=2) 
 
Interestingly, the endogenously produced ECM derived from PAEC affected not only the tight 
junction formation process but also the spreading of the PBCEC leading to the delay on the 
onset of these cells (figure 5-19 A and B, black line). 
The data indicate a direct effect of endogenously-derived ECM proteins derived from both 
astrocytes and pericytes on tight junction formation of PBCEC in comparison to the effect of 
ECM derived from PAEC (figure 5-19 B). Furthermore, there is a huge difference in the 
promotion of attachment and resistance development of PBCEC on endogenously produced 
ECM compared to purified individual ECM molecules (figure 4-6 A and B). This could be 
explained by that fact that the variety of ECM molecules available on the endogenously-
derived substrate is used more effectively by PBCEC than a mono-coating by one of the ECM 
A. 
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proteins. Obviously the cells of the first generation have modified the growth substrate in a 
way that adhesion and differentiation of PBCEC is induced.  
Thus, ECIS assisted to clarify the meaning of the native endogenous ECM and their 
regulation of differentiation processes. PBCEC had a high preference for the astrocytes-
produced ECM. These results are compared with TEER measurements derived for PBCEC 
cultured on purified ECM components such as collagen type IV, fibronectin and laminin and 
summarized in figure 5-20. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-20. The influence of different components of the basement membrane on the 
transendothelial electrical resistance (cell-cell contacts) of PBCEC. 
The cells were cultured in serum-free medium supplied with HC. The measurement values are 
depicted after 55 hours of culturing the PBCEC (n=2).  
 
As it was described in section 4.3, PBCEC attach and spread fastest on fibronectin-coated 
substrates and developed a high transendothelial resistance indicating differentiated BBB 
properties. Although the resistance values of PBCEC cultured on fibronectin coating rarely 
reached 20000 Ω (figure 4-6), the cells seeded on the astrocytes-derived ECM reached more 
than 30000 Ω (figure 5-19) in the same time after seeding of the cells.  
The production of some common integrin and ECM molecules in astrocyte-endothelial cell 
interactions was studied by Wagner et al. (Wagner and Gardner, 2000). They found that 
astrocytes secrete laminin-5, which is bound to the basement membrane of cerebral 
microvessels by its integrin receptor α6β1. The direct cellular contact possibly involving the 
α6β1 integrin and laminin-5 detected by the astrocytes is responsible for the induction of 
astrocytic laminin production by endothelial cells (Wagner and Gardner, 2000). Based on 
ECIS experiment performed in this thesis it could be not excluded that laminin-5 produced by 
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astrocytes may remain on the electrode surface after the astrocytes have been lyzed during 
ECM denudation. Since PBCEC secrete an elevated level of α6 and β1 receptors (figures 4-8 
and 4-9) as indicated by FACS, these cells are able to attach and spread on astrocytes-derived 
ECM leading to high transendothelial resistance.  
 
Conclusion 6 
ECIS-records revealed higher TEER values for PBCEC cultured on the endogenously 
produced ECM derived from astrocytes, pericytes and PBCEC compared to purified ECM 
molecules. This indicates that the BBB-formation process could be defined and accomplished 
by the endogenously-derived ECM. In particular, the astrocytes-derived coating leads to the 
most elevated TEER of PBCEC in vitro. The delayed time course of PBCEC attachment on 
PAEC-derived matrix leads to the lowest value of TEER indicating the lack of quality of 
ECM derived from this cell type and consequently the low-grade of the BBB phenotype. 
 
 
5.3 Influence of endogenous matrices on mature cell-cell and cell-matrix 
contacts  
 
5.3.1 PAEC express the main tight junction proteins in vitro  
 
Several aspects including endothelial cell morphology, physiology and biochemistry were 
compared between brain and aorta endothelial cells. As illustrated in figure 5-21 (A and B), 
both PAEC and PBCEC have characteristic cell shapes. In general, PAECs have a 
cobblestone-like appearance and PBCECs have a spindle-shaped morphology. However, after 
subculturing of the cells PBCEC can alter their appearance from spindle shape to the more 
cobblestone-shaped morphology. That is why, it is difficult to discriminate PAEC from 
PBCEC morphologically. This phenomenon was also observed by Isobe et al., when they 
tested a possible use of aorta endothelial cells as an in vitro BBB model (Isobe, 1996).  
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Figure 5-21. Phase-contrast photomicrographs of porcine aorta (A) and brain (B) 
endothelial cells. 
The cells were seeded on collagen type I+III coated flasks under serum-free conditions with HC. The 
micrographs display a spindle-shaped morphology for PBCEC and a cobblestone-like appearance for 
PAEC.  
 
The expression of BBB relevant tight junction proteins in aorta endothelial cells has been 
studied in this work by immunocytochemistry. As it is seen in figure 5-22 the macrovascular 
endothelial cells are able to express the main tight junction proteins – occludin, ZO-1 and 
claudin – 5. 
In contrast to the tight junction proteins expressed in PBCEC (figure 5-25 A, B and C), which 
exclusively line the borders of these cells, these proteins are more diffusely located in PAEC. 
 
Occludin    Claudin – 5     ZO – 1  
Figure 5-22. Immunofluorescence labelling of tight junction proteins in PAEC. 
The cells were cultured under serum-free conditions with HC. A: Immunostaining for occludin; B: 
claudin – 5; C: ZO – 1. 
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5.3.2 Modification of cell-cell and cell-substrate contacts in PAEC cultured on 
PBCEC-derived ECM 
 
Due to the high permeability of endothelial cell layers derived from macrovascular vessels, 
precise determination of their barrier function requires refined experimental techniques. 
Electrical impedance analysis capable of performing high-precision measurements of 
resistance and capacitance were already applied in recent work on monolayers of bovine aorta 
endothelial cells (Wegener et al., 1999). 
In the present thesis the hypothesis was tested, whether or not the blood-brain barrier 
properties may be induced in aorta endothelial cells by culturing these cells on an endogenous 
ECM-derived from microvascular endothelium. Figure 5-23 shows the capacitance (A) and 
resistance (B) of PAEC cultured either on collagen type I+III or on the PBCEC-derived 
matrices. 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
Figure 5-23. Time course of the capacitance measured at 40kHz for PAEC (A) and 
resistance measured at 400 Hz for PAEC (B). 
PAEC were seeded onto ECIS arrays coated with endogenously-derived PBCEC-ECM (—  —) 
compared to the reference collagen type I+III coating (—+—).  
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The time course of the capacitance measured for PAEC shows that attachment and spreading 
of macrovascular endothelial cells is slightly delayed on the PBCEC-derived ECM compared 
to collagen type I+III substrate. Readings of the capacitance after approximately 40 h indicate 
that even in fully established cell layers the state of cell-matrix adhesion is different. This 
difference in cell adhesion can be qualified in terms of the parameter α, that is determined 
from the impedance data by equivalent circuit modelling. It indicates a slight increase for the 
cells cultured on the collagen type I+III coating compared to the cells cultured on PBCEC-
derived substrate. The value of α for PAEC cultured on the collagen type I+III substrate is 
around 3.3 Ω1/2.cm (± 0.3 Ω1/2.cm), whereas on the PBCEC-derived substrate - 2.8 Ω1/2.cm 
(± 0.1 Ω1/2.cm). This fact is a hint that PAEC attach more tightly to the collagen type I+III 
substrate giving rise to the higher α-parameter than in the case of PBCEC-derived ECM. This 
phenomenon was also observed in electron microscopic studies (figure 5-24 C) revealing that 
PAEC cultured on PBCEC-derived ECM do not form such tight cell-substrate contacts, 
moreover they create foothills to form the cell-cell contacts and attach only in zones, in which 
self-secreted ECM molecules were deposited, but not on the available PBCEC-derived ECM 
(section 5.3.3). 
There is evidence that the macrovascular endothelial cells secrete predominantly type I and III 
of collagen (Wight, 1996). As it is known that the basement membrane of the microvascular 
endothelial cells consists mostly of collagen type IV, which is down-regulated in 
macrovessels, it was not surprising that the PAEC attached and spread on collagen type I+III 
coating faster than on PBCEC-derived ECM. As it is seen in figure 5-23 the values of 
electrical resistance measured at 400 Hz are rather low for PAEC and beyond those values 
obtained with microvascular endothelial cells (PBCEC).  
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5.3.3 Endogenously-derived ECM alters the morphology of cell-cell and cell-
substrate contacts of PBCEC and PAEC 
 
The results of electron microscopic investigations revealed that both cell-cell and cell-matrix 
contacts of endothelial cells are altered when PBCEC or PAEC are cultured on matrices 
endogenously produced by other cell types.  
Figure 5-24 A demonstrates that PAEC attach very tightly to the collagen type I+III coating 
and develop very close cell-cell contacts with well defined marginal folds. The development 
of cell-cell and cell-substrate contacts by PBCEC is depicted in figure 5-24 B also indicating 
very tightly connected cells with well-formed marginal folds. However, figure 5-24 C shows 
that aorta endothelial cells cultured on PBCEC-derived matrices form foothills that make 
contact with each others in a cell-cell contact zone. This type of cell-cell contacts differs from 
the cell morphology of PAEC cultured on the reference flasks coated with collagen type I and 
III (figure 5-24 A). The capillary endothelial cells show also morphologically different cell-
cell contacts by culturing these cells on astrocytes- (figure 5-24 D) as well as on pericytes-
derived ECM (figure 5-24 E) compared to the cells cultured under the control conditions 
(figure 5-24 B). PBCEC develop an overlapping zone of tight junction contacts with a very 
thick fibrous sheet of the extracellular matrix compounds marked by arrowheads in the image 
during the cultivation on the pericytes-derived ECM (figure 5-24 E). The astrocytes-derived 
ECM apparently stimulates the microvascular endothelial cells to synthesize more dense, 
globular type of matrix components with a lot of foothills and changes in cell shape. These 
results suggest that the brain as well as aorta endothelial cells are able to adjust their 
phenotype according to the available matrix. The efficiency of such matrices on the BBB-
formation properties of PBCEC was shown before in ECIS experiments (section 5.2.2).  
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Figure 5-24. Micrographs of TEM-images of PAEC and PBCEC cultured on different 
ECM substrates.  
The cell-cell and cell-substrate contacts of cultured cells indicated by arrows and arrowheads 
respectively. The cells were cultured in serum-free medium supplemented with hydrocortisone 
(550 nM). A: PAEC, cultured on collagen type I+III; B: PBCEC, cultured on collagen type I+III; C: 
PAEC on PBCEC-derived ECM; D: PBCEC on astrocytes-derived ECM; E: PBCEC on pericytes-
derived ECM. There are morphological differences between cell-cell and cell-matrix contacts in 
microvascular compared to macrovascular endothelial cells dependent on the available substrate.  
 
Conclusion 7 
The results of ECIS-readings for microvascular endothelium were compared with that 
measured for aorta endothelial cells (PAEC). These cells are representing the macrovascular 
endothelium without BBB properties detected by resistance values (1300 ±100) measured at 
400 Hz. The immunostaining against occludin, claudin–5 and ZO–1 verified the presence of 
tight junction proteins in PAEC. The transmission electron microscopic studies revealed that 
both cell-cell and cell-substrate contacts are altered in PBCEC as well as in PAEC due to the 
different endogenously-derived culture matrices.  
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5.3.4 Alteration in cell shape of PBCEC mediated by different endogenous 
matrices  
 
The origin of the ECM plays a great role in the establishment of a particular cell phenotype. 
The PBCEC cultured on pericytes, as well as on astrocytes-derived ECM showed a change in 
cell morphology compared to cells cultured on the reference flasks covered with collagen type 
I + III (figure 5-25). 
  Occludin               Claudin – 5    ZO – 1  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-25. Effect of endogenously-derived ECM on the PBCEC-morphology. 
The PBCEC were cultured in serum-free medium supplemented with HC. A, B, C: PBCEC cultured on 
collagen type I+III; D, E, F: PBCEC cultured on pericytes-derived ECM; G, H, I: PBCEC cultured on 
astrocytes-derived ECM. A, D and G: occludin staining; B, E and H: claudin – 5 staining; C, F and I: 
ZO – 1 staining. 
 
 
 
  
  
 
 
A. B. 
D. E. 
H. 
25 µm 
 
collagen type I+III 
pericytes-derived ECM 
astrocytes-derived ECM 
G. I. 
F. 
C. 
98 5 The functional impact of endogenously-derived ECM for BBB phenotype 
The immunofluoresence staining against TJ-proteins has been used to check if different glia-
derived matrices could change the PBCEC morphology. Particular ECM components in their 
up-regulated states in definite cells are able to give a signal to alter the differentiation program 
in other cells. It is known that pericytes, by their position and shape, are outlined by laminin-
positive ECM material (Jiang et al., 1994). Laminin was shown to be over-expressed in 
pericytes and established as a marker for vascular differentiation in vivo (Risau, 1991). 
Among laminin, other components of a newly synthesized endogenous ECM from glia-
derived substrate could direct the growth of PBCEC with changes in their cell morphology 
along the contours of formerly attached cells. 
 
5.3.5 Expression of the main tight junction proteins in PBCEC compared to 
PAEC on protein level  
 
Based on the results of transmission electron microscopy and immunofluorescence it was 
important to examine the expression of TJ-proteins in micro- and macrovascular endothelial 
cells grown on different endogenously-derived ECM.  
Figure 5-26 A and C depict the expression level of occludin (A), claudin-5 (B) and ZO-1 (C) 
in brain- compared to aorta endothelial cells cultured on different ECM-coatings as visualized 
by western blotting technique. Protein loading is indicated by vimentine which was used as a 
reference protein. The blots were stripped afterwards and the gel loading was controlled 
additionally by staining the whole protein by Protogold Detection Kit™ (Amersham). 
Figure 5-26 shows that the expression level of occludin and ZO-1, but not claudin-5 is 
increased upon culturing of PBCEC on glia-derived ECM (lanes 4 and 5) compared to cells 
grown on collagen type I+III coating (lane 1). It was expected that aorta endothelial cells 
cultured on PBCEC-derived ECM (lane 3) express a higher level of tight junction proteins 
compared to the cells grown on collagen type I+III (lane 2). Surprisingly, instead of up-
regulation, there is a complete down-regulation of occludin and ZO-1 in PAEC cultured on 
the PBCEC – derived ECM (figure 5-26 A and B, lane 3). Although immunofluorescence 
analysis has shown that PAEC express claudin-5 (figure 5-22), the expression of this protein 
could not be detected by western blot neither in PAEC cultured on collagen type I+III, nor on 
PBCEC-derived ECM. This shows that the expression level of this protein is at least very low 
in the macrovascular endothelial cells and thus, lies under the level of the detection by this 
method.  
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Figure 5-26. Change in expression of occludin (A), ZO–1 (B) and claudin–5 (C) in 
PBCEC and PAEC after culturing of these cells on different ECM coatings. 
The whole protein extract of the cells was used for the analysis. 1: PBCEC on collagen type I +III; 2: 
PAEC on collagen type I+III; 3: PAEC cultured on PBCEC-derived ECM; 4: PBCEC cultured on 
pericytes-derived ECM; 5: PBCEC cultured on astocytes-derived ECM.  
 
It has been shown previously that the formation of cell-cell contacts in endothelial cells 
depends on the available ECM. Transmission electron microscopy revealed that aorta 
endothelial cells cultured on PBCEC-derived matrices formed foothills to associate with each 
others in a cell-cell contact zone (figures 5-24 A and C). Presumably, the main tight junction 
proteins are only located in this zone. During the commonly used protein isolation technique 
the whole cell extract was centrifuged and the pellet was used in further experiments. Thus, it 
was reasonable to assume that the small particles of the cell-cell contacts remained in the 
supernatants. To improve the protein isolation method for PAEC cultured on PBCEC- derived 
ECM the whole protein from the cell culture flasks was collected and loaded into a gel. Thus, 
the small cell-cell contact zones formed within the cell monolayer were transferred into the 
gel and were now available to study the expression of the main tight junction proteins. The 
results depicted in figure 5-27 show that aorta endothelial cells grown on PBCEC-derived 
ECM (lane 3) do express both occludin as well as ZO-1 proteins in the same amount as in the 
cells cultured on the reference flasks (collagen type I+III coating).  
The expression of claudin - 5 was still not detected at all in aorta endothelial cells similar to 
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the data shown in figure 5-26. ZO-1 has a MW of 225 kDa and is found in two isoforms that 
differ by the presence or absence of an 80 amino acid region, named motif-alpha (Willott, 
1992). These two isoforms are indistinguishably localized to tight junctions. The existence 
and variable expression of other ZO-1 isoforms, which contribute to tight junction diversity is 
not excluded. Both ZO-1 α+ and α− isoforms (marked with arrowheads in figure 5-27 B) are 
detected in brain and aorta endothelial cells cultured on collagen type I+III (figures 5-26 and 
5-27 B, lanes 1 and 2). Presumably, additional isoforms of ZO-1 are appeared in PBCEC 
grown on astrocytes- and pericytes-derived ECM (figures 5-26 and 5-27 B, lanes 4 and 5). 
The level of occludin and ZO-1, but not claudin-5 is elevated in microvascular endothelial 
cells cultured on a glia-derived ECM. This leads to the conclusion that the extracellular matrix 
components derived from glial cells are able to elevate the expression level of cell-cell contact 
constituents in microvascular endothelial cells. 
Occludin      ZO – 1    Claudin – 
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Figure 5-27. Change in expression of occludin (A), ZO–1 (B) and claudin–5 (C) 
expression in PBCEC and PAEC cultured on different ECM. 
The whole protein extract of the cells was collected and loaded directly into the gel without 
centrifugation step. 1: PBCEC on collagen type I+III; 2: PAEC on collagen type I+III; 3: PAEC cultured 
on PBCEC-derived ECM; 4: PBCEC cultured on pericytes-derived ECM; 5: PBCEC cultured on 
astrocytes-derived ECM.  
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5.3.6 Expression of the main tight junction proteins in PBCEC compared to 
PAEC on RNA level 
 
In order to understand the peculiarities of cell-cell interactions with respect to the ECM 
coating, the expression of tight junction proteins was also studied on the RNA level. 
The RNA level of the main TJ proteins was analyzed upon culturing PBCEC and PAEC on 
different ECM coatings by means of quantitative real-time PCR (QRT-PCR).  
Due to the fact that different cell types were compared in QRT-PCR the cycle number to 
reach a pre-defined amplification was used as a quantitative measure for the expression level 
(see section 8.3.7.2). A higher cycle value represents a lower expression level of the 
corresponding mRNA. Values detected above cycle 30 are not significantly higher than the 
background of the reaction.  
The alteration of the expression level of tight junction proteins depends on the matrix 
deposited on the substrate is shown in figure 5-28.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-28. Results of QRT-PCR.  
mRNA expression level of tight junction proteins in PBCEC compared to PAEC on different 
extracellular matrix coatings. The values give the cycle where the templates reach a point in which the 
signal is first recorded as statistically significant above background (Gibson, 1996). The significant 
changes in relation to the reference (PBCEC, collagen type I+III) are marked with *. (n=3)  
 
 
 Claudin 5 ZO-1 Occludin 
PBCEC, collagen type I+III 17.7 ± 0.0 20.2 ± 0.1 16.7 ± 0.2 
PBCEC, pericytes-ECM  17.2 ± 0.2 18.7* ± 0.4 15.9* ± 0.1 
PBCEC, astrocytes-ECM 17.3 ± 0.0 18.1* ± 0.0 15.9* ± 0.2 
PAEC, collagen type I+III 26.4 ± 1.1 22.3 ± 1.0 17.6 ± 0.4 
PAEC, PBCEC-ECM  26.5 ± 0.0 21.5* ± 0.1 16.8* ± 0.0 
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There is an increase of mRNA level of ZO-1 and occludin, but not claudin-5 in PAEC grown 
on PBCEC-derived ECM compared to PAEC cultured on collagen type I+III. There is no 
difference in the expression of tight junction proteins on RNA level in PBCEC cultured on 
pericytes- compared to astrocytes-derived ECM substrate. However, the level of ZO-1 and 
occludin, but not claudin-5 is elevated in these cells compared to PBCEC cultured on collagen 
type I+III coating. These results are in agreement with western blot studies, indicating the 
same tendency of tight junction proteins expression level in brain and aorta endothelial cells 
upon culturing these cells on different matrices deposited on the substrate.  
 
Conclusion 8 
The morphology of PBCEC and their phenotypic properties were shown to be altered by the 
ECM components derived from glial cells. 
Both western blot analysis and quantitative real-time PCR revealed that the expression level 
of occludin and ZO-1, but not claudin-5 is higher in PBCEC cultured on pericytes- and 
astrocytes-derived ECM compared to the collagen type I+III coatings.  
Western blot analysis verified the expression of TJ proteins in PAEC with an exception of 
claudin-5. Application of two different protocols to isolate tight junction proteins from PAEC 
supports electron microscopic findings that the cells are connected in contact zones along 
foothills. QRT-PCR analysis revealed that the expression level of occludin and ZO-1, but not 
claudin-5 is increased in PAEC upon culturing these cells on PBCEC-derived ECM compared 
to collagen type I+III coating. 
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6.1 The production of matrix metalloproteinases and their inhibitors by glial 
cells in vitro  
The basement membrane (BM) functions as a part of the BBB by providing not only a filter 
modulating the transfer of molecules from the blood into the brain and vice versa across the 
endothelial cell layer (Lukes et al., 1999), but also as an important feature for BBB formation 
phenotype. Astrocytic foot processes and pericytes abut onto the BM, and thus provide a 
connection between the microvascular endothelium and the neuroglia. In the CNS, the 
components of the basement membrane have been shown to be degraded by matrix 
metalloproteinases (MMPs), leading to disruption of the BBB (Lukes, et al. 1999). The 
present study shows the involvement of MMPs on the regulatory mechanisms of BBB 
function.  
From previous studies it is known that MMP-2 is present in serum and may be responsible for 
the barrier-weakening effect of serum. Addition of MMP-2 to brain endothelial cells 
decreased the TEER and thus, lowered the barrier function of these cells in a dose-dependent 
manner (Lohmann, 2003). Microvascular endothelial cells were shown to secrete MMP-9 into 
the culture medium. Additionally, the secretion of MMP-9 was found to be reduced after 
addition of hydrocortisone. The basolateral secretion of MMP-9 into the ECM underneath 
PBCEC was also already demonstrated by immunocytochemical studies (Lohmann, 2003).  
In order to understand the mechanism of BBB regulation through the ECM components of 
BM and their degrading enzymes produced by glial cells, the expression pattern of the main 
MMPs and their inhibitors was examined in astrocytes and pericytes.  
In this work the PBCEC were shown to be stimulated through new glia-derived matrix to 
remodel the already available ECM with posterior changes in a cell differentiation process in 
vitro (sections 5.3.2 and 5.3.3). The complex of proteolytically active MMP molecules and 
integrins on the surface of PBCEC promote the degradation of ECM components in vitro. 
This reveals the inherent capacity of capillary endothelial cells to modulate their basement 
membrane in response to MMP secretion. The up-regulated expression level of collagen type 
IV and fibronectin, but not laminin in PBCEC cultured on astrocytes-derived ECM was 
shown in section 5.1.5.2. The reason for this increased expression of ECM proteins in PBCEC 
under the influence of endogenous matrices derived from astrocytes and pericytes is discussed 
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in this chapter. The secretion of both ECM and MMPs plays an important role in diverse 
physiological and pathophysiological processes. It is known that ECM synthesis by astrocytes 
is upregulated when endothelial cells proliferate during neurovascularization 
(Liesi et al., 1984). The astrocytes secrete components of the basement membrane to promote 
survival of injured neurons. Most studies of astrocytoma invasion showed that laminin, 
fibronectin, tenascin and collagen type IV promote migration of these cells (Chintala et al., 
1996; Giese et al., 1995). Injuries might also stimulate astrocytes to secrete matrix 
macromolecules (Liesi et al., 1984). It is known that the release of MMP-2 and MMP-9 from 
astrocytes could be stimulated by laminin, but not fibronectin secretion (Turpeenniemi-
Hujanen et al., 1986). The migration and invasion of astroglial tumors happens due to MMP 
activity. Oh et al. have also shown that MMP-9 facilitates the outgrowth process by glial cells 
in vivo and in culture (Oh et al., 1999).  
 
6.1.1 Localization of MMP-9 secreted by pericyte and astrocytes cultures in vitro 
 
It has previously been shown that PBCEC secrete MMP-9, TIMP-1 and TIMP-2 apically into 
the medium and additionally the basolaterally secreted proteins bind to the basement 
membrane as demonstrated by immunocytochemistry (Lohmann, 2003). Interestingly, the 
immunocytochemical characterization of MMP-9 expression in pericytes as well as in 
astrocytes revealed that MMP-9 secreted by these cells is not bound to the ECM produced by 
these glial cells. The results of immunostaining against MMP-9 in pericytes and their ECM 
are depicted in figure 6-1 B and D, and in astrocytes in figure 6-2 B and D. Both cell types 
were cultured until confluence in serum-containing and replaced in serum-free medium with 
hydrocortisone on DIV 4. After 2 days more the cells were either directly fixed for 
immunocytochemical analysis or lysed hypotonically with 20 mM ammonia solution to 
denudate ECM (figures 6-1 and 6-2).  
Apodaca et al. showed the production of metalloproteinases by human fetal astrocytes in 
culture (Apodaca et al., 1990). Gottschall et al. characterized the secretion of MMP-2 and 
MMP-9 by cultured rat astrocytes and postulated that the expression of these molecules was 
regulated by cytokines (Gottschall et al., 1995). Additionally, the migration capability of 
oligodendritic cells (OLs) in the CNS could be stimulated by astrocytes due to their specific 
degree of ECM expression, their cell surface receptors and proteinases activity (Oh and Yong, 
1996). Oh et al. also found that MMP-9 is necessary for the OLs to pursue the extension 
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process along an astrocytic ECM (Oh et al., 1999). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-1. Secretion of MMP-9 by pericytes into the culture medium and into their 
ECM. 
Immunocytochemistry against MMP-9 in pericytes (B) as well as in their ECM (D) after hypotonic lysis 
of the cells was performed in pericytes cultured in serum-free medium, + HC (550 nM). A, C – phase-
contrast of the cells. 
 
During brain development, astrocytes appear before oligodendrocytes, and many astroglial 
growth factors and ECM components can modulate the development of OLs in vitro. There is 
evidence that MMPs are secreted and localized by glial cells to the pericellular area where 
they are required. They are not diffusely distributed on the cell surfaces to effect widespread 
destruction. That is why, the astrocytes are supposed to secrete MMP-9 only into the brain 
side (and not to the basement membrane) what is essential for the OLs outgrowth. The 
secreted MMP-9 is bound either to the cell surface integrin receptors (Brooks et al., 1996), or 
to membrane localized forms of MMPs (Murphy and Knauper, 1997). Interaction with the cell 
surface hyaluronan receptor CD44 could be another mechanism to localize MMP activity to 
the cell surface what is essential for the promotion of the cell invasion process (Yu and 
Stamenkovic, 1999). The plausible role for the cell surface MMPs may be the release of 
growth factors that are anchored on the ECM.  
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Figure 6-2. Secretion of MMP-9 by astrocytes into the culture medium and into their 
ECM. 
Immunocytochemistry against MMP-9 in astrocytes (B) as well as in their ECM after hypotonic lysis of 
the cells (D) was perfomed in astrocytes cultured in serum-free medium, + HC (550 nM). A, C – 
phase-contrast of the cells. 
 
6.1.2 Secretion of MMP-2 and MMP-9 by pericyte and astrocyte cultures into 
the supernatant 
 
Under physiological conditions, MMP-9 activity is controlled in the brain and other tissues. 
Major regulation pathways include transcriptional control, zymogen activation and dynamic 
inhibition by tissue inhibitors of metalloproteinases (Fini, 1998). The signalling pathways that 
regulate MMP-9 activity in the brain cells remain to be fully elucidated. In vitro models may 
not always fully correspond to the in vivo situation. How the zymogens are processed in vivo 
where multiple activators and proteases are present may be quite different from what can be 
seen in simplified in vitro system. This study was focused only on the MMP-9 and MMP-2 
secretion to examine if these molecules are expressed by the brain cells involved in our in 
vitro model. Many types of MMPs are involved in brain regulation and it is known that for 
example, astrocytes can produce a wide spectrum of these proteases (Muir et al., 2002).  
The secretion of matrix metalloproteinases by pericyte and astrocyte cultures was firstly 
examined by zymographic studies (figure 6-3).  
Figure 6-3 indicates that pericytes as well as astrocytes are able to express both MMP-9 and 
MMP-2 molecules in serum-supplemented medium, but only MMP-2 in serum-free medium. 
25 µm 
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Both pericytes and astrocytes produce active and latent forms of MMP-9 in serum-containing 
medium, whereas MMP-9 was not detected at all in the cells grown in serum-free medium.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-3. Secretion of MMP-2 and MMP-9 by pericytes (P) and astrocytes (A) in 
serum-supplemented and serum-free medium (SFM). 
 
The MMP-2 expression level is much higher in the supernatants collected from pericytes both 
in serum-supplemented and in serum-free culture medium compared to astrocyte-conditioned 
medium. An additional band of gelatinolytic activity, possibly exhibiting a new MMP 
molecule, was detected above the MMP-2 in pericytes (figure 6-3). This form of MMPs was 
not found before in other cells, but is present in pericyte cultures in both serum-free and 
serum-supplemented medium. The origin of this band is still to be investigated. 
 
6.1.3 The expression of MMP-2 and MMP-9 by pericyte and astrocyte cultures 
on RNA level  
 
The expression pattern of both MMP-2 and MMP-9 was quantified by means of QRT-PCR in 
pericyte (figure 6-4) and astrocyte (figure 6-5) cultures. As it was mentioned before in 
sections 5.1.5.2 and 5.3.6 that the higher values of cycles represent the lower expression level 
of mRNA. The values detected later than cycle 30 are not significant above the background of 
the reaction. The total amount of reverse transcribed RNA was adjusted to 1µg/ml in each cell 
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sample. The QRT-PCR analysis shows that the culture conditions (serum-supplemented or 
serum-free medium) do not influence the mRNA expression level of MMP-9 and MMP-2 in 
both pericyte and astrocyte cultures.  
Additionally, as it is shown in figure 6-4, the signal of MMP-9 secretion was not significantly 
higher than the background of the reaction for pericytes grown in both serum-supplemented as 
well as in serum-free medium. While the results of zymography (figure 6-3) indicated MMP-9 
expression in serum-containing and no MMP-9 in serum-free medium, the regulation seems to 
occur on the translation or secretory levels. However, the expression profile of secreted MMP 
molecules into the medium can differ from that in the cytosolic fraction (Nguyen, 1998). The 
MMP-2 mRNA expression level in pericytes is rather high and remains unchanged in serum-
containing compared to serum-free medium. This fits the zymographic studies (figure 6-3) 
indicating another regulatory mechanism for MMP-2 in comparison to MMP-9 in pericytes. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 6-4. Comparison of MMP-9 and MMP-2 expression level in pericytes.  
The cells were cultured either in serum-free (with 550 nM of HC) or serum-supplemented medium. 
(n=3) 
 
The expression level of MMP-9 mRNA in astrocytes was not significant above the 
background of the reaction. MMP-2 was shown to be also down-regulated in both astrocytes 
cultured in serum-supplemented and serum-free medium. However, it is higher expressed in 
astrocytes of serum-supplemented compared to serum-free medium (figure 6-5).  
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Figure 6-5. Comparison of MMP-9 and MMP-2 expression level in astrocytes.  
The cells were cultured either in serum-free or serum-supplemented medium. (n=3) 
 
According to the cycle values of QRT-PCR analysis for pericyte and astrocyte cultures, the 
expression of MMP-2 is much higher in pericytes compared to astrocytes. The same results 
were derived from zymographic analysis (figure 6-3). Generally, an elevated MMP-2 
expression level is always followed by down-regulation of TIMP-2 and up-regulation of ECM 
components in vitro (Sternlicht et al., 2000). An elevated expression level of three major 
ECM components and the pattern and way of TIMPs expression will be demonstrated in 
pericytes consistent with the work of Sternlicht et al. in two next sections of this thesis 
(figures 6-8 and 6-9). 
 
6.1.4 Localization of TIMP-1 and TIMP-2 secreted by pericyte and astrocyte 
cultures  
 
This chapter aims to show the expression and targeting of tissue inhibitors of 
metalloproteinases by pericyte and astrocyte cultures. Figures 6-6 and 6-7 depict the results of 
indirect immunostaining. There is a difference in the secretion pathway of TIMP-1 and 
TIMP-2 by glial cells with respect to the destination that the proteins are targeted either 
basolaterally, into the ECM or remain in the cytoplasm of the cells.  
As shown in figure 6-6 B and D TIMP-1 is targeted to basolateral side of the cells. 
Interestingly, TIMP-2 secreted by pericytes (figure 6-6 F) is not bound to the extracellular 
 MMP-9 MMP-2 β-actin 
astrocytes, SFM 40.0 ± 0.8 29.2 ± 0.5 18.3 ± 0.3 
astrocytes, serum 33.0 ± 0.3 26.5 ± 0.6 18.5 ± 0.2 
astrocytes
0
5
10
15
20
25
30
35
40
45
MMP-9 MMP-2 b-actin
Cy
cl
e SFM
Serum
110 6 MMPs regulate barrier properties in vitro by ECM degradation 
matrix (figure 6-6 H). It is probably either secreted by pericytes apically and thus, removed 
together with cell bodies after their hypotonic lysis, or basolaterally, but in soluble form. Both 
enzymes are synthesized by pericytes and remain in the cell cytoplasm after washing of the 
cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-6. The secretion of TIMP-1 and TIMP-2 by pericytes. 
Immunocytochemistry against TIMP-1 (B, D) and TIMP-2 (F, H) in pericytes (B, F), as well as in their 
ECM (D, H) after hypotonic lysis of the cell bodies. The cells were cultured in serum-free medium, 
+ HC (550 nM). A, C, E and G – phase contrast of the cells. 
 
Figure 6-7 D shows that TIMP-1 secreted by astrocytes does not remain bound to the ECM 
after hypotonic lysis of the cells. However, TIMP-2 is secreted by astrocytes both apically, 
into the cell surface and basolaterally, into their ECM.  
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Figure 6-7. The secretion of TIMP-1 and TIMP-2 by astrocytes. 
Immunocytochemistry against TIMP-1 (B, D) and TIMP-2 (F, H) in astrocytes (B, F) as well as in their 
ECM (D, H) after hypotonic lysis of the cell bodies. The cells were cultured in serum-free medium, 
+ HC (550 nM). A, C, E and G – phase contrast of the cells.  
 
It is well known that the composition of the ECM is able to stimulate the expression of 
particular MMPs and their inhibitors depending on the cell type. The different levels of ECM 
expression by astrocytes and pericytes could be an explanation for different ways of TIMP-1 
and TIMP-2 secretion and targeting of these molecules with their deposition on the 
endogenous matrices after the hypotonic lysis of the cells. 
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6.1.5 Secretion of TIMPs by pericyte and astrocyte cultures on RNA level  
 
The expression of TIMP-1, TIMP-2 and TIMP-3 mRNA in pericytes and astrocytes measured 
by QRT-PCR is presented in figure 6-8. The total amount of cDNA was adjusted to 1µg/ml in 
each sample. The lower cycle value represents a high expression of target genes. According to 
the results pericytes have an up-regulated level of TIMP-1 and TIMP-3 compared to 
astrocytes. However, the astocytes express higher quantitities of TIMP-2 mRNA. TIMP-2 is 
the major inhibitor in astrocytes, whereas TIMP-1 shows highest expression in pericytes.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6-8. The mRNA expression level of TIMP-1, TIMP-2 and TIMP-3 in pericytes 
compared to astrocytes.  
All cell types were cultured in serum-free medium with HC (550 nM). (n=3) 
 
In order to check how the ECM components are regulated in pericyte and astrocyte cultures in 
relation to the MMP-TIMP balance, QRT-PCR analysis of collagen type IV, fibronectin, and 
laminin was performed for these cells. Figure 6-9 shows the expression of these ECM 
molecules in both pericytes and astrocytes cultured in serum-free medium with HC. Thus, it 
was demonstrated that pericytes have a higher mRNA expression level of major ECM 
proteins (collagen type IV, laminin and fibronectin) compared to astrocytes culture.  
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Figure 6-9.  ECM synthesis by pericyte and astrocyte cultures on RNA level 
The secretion of all investigated ECM molecules is up-regulated by pericytes compared to astrocytes. 
(n=3) 
 
Individual TIMPs differ with respect to their ability to inhibit various MMPs (reviewed in 
(Woessner, 2000). It is also known that increased expression of MMP-9 is associated and 
accompanied by an increased expression of TIMP-1 (Lukes et al., 1999). Likewise, TIMP-3 
appears to be a more potent inhibitor of MMP-9 than other TIMPs. It has been already 
discussed in 2.6.4 that MMP-2 is activated at the cell surface through a unique multistep 
pathway involving MT-MMPs and TIMP-2 (Strongin et al., 1995). Low levels of TIMP-2 
promote the activation of pro-MMP-2, whereas higher levels inhibit its activation by 
saturating free MT-MMPs that are needed to remove the MMP-2 prodomain (Strongin et al., 
1995). When TIMP-2 protein levels are reduced, MMP-2 activation is enhanced in the 
presence of the MMP-2 substrate, collagen type IV (Maquoi et al., 2000). Therefore, local 
accumulation of collagen type IV may trigger its own degradation by somehow lowering local 
TIMP-2 concentrations to levels that favour MMP-2 activation.  
As it has been shown in section 5.1.4, collagen type IV protein is up-regulated in both, sub-
cellular and whole cell lysates of PBCEC cultured on pericytes-derived matrix (figure 5-5 A, 
lane 4 and figure 5-6). This is in good agreement with an increased expression pattern of 
MMP-2 in pericytes revealed by zymographic studies (figure 6-3) and QRT-PCR (figure 6-4), 
and decreased expression level of TIMP-2 mRNA shown by means of QRT-PCR (figure 6-8) 
compared to astrocytes.  
The PBCEC cultured on astrocytes-derived ECM show a lower level of collagen type IV 
synthesis in sub-cellular matrix of PBCEC as detected in western blot (figure 5-5 A, lane 5) as 
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well as a low MMP-2 secretion as indicated by zymographic studies (figure 6-3). On the other 
hand QRT-PCR showed the highest expression level of TIMP-2 (figure 6-8) in astrocytes 
compared to pericytes. This means that the secretion of MMPs and their inhibitors by pericyte 
and astocyte cultures may contribute to the modulation of ECM expression by PBCEC in 
vitro. These results helped to explain an elevated expression of MMP-2 and down-regulation 
of TIMP-2 in response to accumulation of ECM components in pericytes compared to 
astrocytes.  
 
Conclusion 9  
The pericyte and astrocyte cultures were shown to be able to secrete matrix 
metalloproteinases and their inhibitors in vitro. The secretory profile of these molecules was 
checked by zymography, immunocytochemistry and QRT-PCR analysis. The results of 
zymographic gels showed that both pericytes and astrocytes express MMP-9 only in serum-
containing medium, whereas MMP-2 is present in both serum-free and serum-supplemented 
medium. The QRT-PCR analysis verified these results showing an expression of mRNA 
message of MMP-9 not significantly higher than the background of the reaction in serum-free 
medium for both cell cultures. The expression of MMP-2 mRNA was found under both 
culture conditions and at the same regulation level. Based on the QRT-PCR the pericytes 
express higher amounts of MMP-2 and TIMP-1, which remains bound to the ECM compared 
to astrocytes. However, astrocytes show a higher level of TIMP-2, the secretion of which 
differs from the pericytes not only in the amount but also with respect to the targeting to the 
basolateral side of the cells as revealed by immunocytochemistry. 
 
6.2 Aorta endothelial cells exhibit a different profile of MMP-2 and MMP-9 
secretion.  
 
The secretion of MMPs by microvascular endothelial cells is an essential first step in the 
formation of new blood vessels (angiogenesis). This enables degradation of the basement 
membrane and allows the endothelial cells to migrate through the connective tissue stroma. 
Since angiogenesis occurs in the microvasculature and not in the large blood vessels, it was 
interesting to investigate whether MMP secretion differs between microvascular (brain) and 
macrovascular (aorta) endothelial cells. 
As it was mentioned in section 2.4 there are morphological and physiological differences 
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between endothelial cells derived from different tissues. Some variations in protease synthesis 
between different human endothelial cells have already been observed in the literature 
(Cornelius, 1995; Hanemaaijer, 1993; Gerritsen, 1993). 
In this work it was shown that major ECM components disappeared from PBCEC-derived 
ECM when PAEC are seeded on these matrices (section 5.1.5.2). Since it is known that 
PBCEC secrete MMP-9 which remains bound to the ECM substrate it is supposed that bound 
MMPs can degrade the newly synthesized ECM from PAEC after subculturing these cells on 
the PBCEC-derived ECM. This fact could explain the disappearing of collagen type IV and 
fibronectin in the sub-cellular fraction during the western blot analysis and the upregulation of 
these molecules in the QRT-PCR results (sections 5.1.4 and 5.1.5). That is why, the 
expression level of MMP-2 and MMP-9 as well as their inhibitors (TIMP-1-3) in PAEC and 
in PBCEC cultured on reference flasks (collagen type I+III coated) were compared with 
PAEC grown on PBCEC-derived ECM by QRT-PCR analysis.  
Figure 6-10 represents the expression of MMP-2 and MMP-9 in PAEC cultured on collagen 
type I+III as well as on PBCEC-derived ECM under different culture conditions – serum-
supplemented and serum-free medium.  
 
 
 
 
 
 
 
 
 
 
 
Figure 6-10.  MMP-2 and MMP-9 secretion by PAEC in serum-supplemented and 
serum-free medium (+HC, 550 nM).  
PAEC were cultured on different ECM substrates – collagen type I+III (2, 4) and on PBCEC-derived 
ECM (3, 5). M - C-1 marker (section 8.2.8). 
 
In contrast to MMP-2, MMP-9 is present only in serum-supplemented, but not in serum-free 
medium. The presence of gelatinolytic bands of MMP-2 in serum-free conditioned medium 
could be explained by the remaining serum-induced activity of pro-MMP-2. The absence of 
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MMP-9 confirms the findings by others that endothelial cells do not constitutively secrete this 
enzyme (Cornelius, 1995; Hanemaaijar, 1993). Although second gelatinolytic band above 
MMP-2 was detected in PAEC sample under serum-free culture condition, no active form of 
MMP-2 (with lower molecular weight) was observed (figure 6-10). This band above the 
gelatinolytic MMP-2 detected in PAEC was never found in PBCEC. However, as it is seen in 
figure 6-10 the expression of MMP-2 in PAEC is much higher of that found in PBCEC in 
serum-free medium (figure 6-17).  
Since no difference in MMP-2 and MMP-9 expression level between PAEC cultured on 
collagen type I+III and PAEC grown on PBCEC-derived ECM was detected by zymography, 
QRT-PCR was performed to analyze MMP-TIMP balance in these cells on the RNA level. 
The results of QRT-PCR analysis of the mRNA of MMP-2, MMP-9 and TIMP-1, TIMP-2, 
TIMP-3 are presented in figure 6-11. For this purpose, both cell types PAEC and PBCEC 
were cultured under serum-free culture conditions with HC supplementation.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-11. The expression of MMP-9 and MMP-2 and their inhibitors - TIMP-1, 
TIMP-2 and TIMP-3 in PAEC compared to PBCEC. 
PBCEC were cultured on collagen type I+III and compared to PAEC cultured on PBCEC-derived ECM 
and PAEC grown on reference coating (collagen type I+III). The significant changes in relation to the 
reference (PBCEC, collagen type I+III) are marked with asterisks. (n=3) 
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These experiments showed that PAEC produce higher levels of TIMP-1 and TIMP-2, but less 
TIMP-3. The mRNA level of MMP-2 is higher in PAEC compared to PBCEC, while MMP-9 
expression profile is the same in both cell types (figure 6-11). This is in agreement with 
zymographic studies, showing visible down-regulation of MMP-9 in serum-free medium in 
both PBCEC (figure 6-17) and PAEC (figure 6-10). One of the possible reasons for an up-
regulation of MMP-2 in both serum-containing and serum-free supernatants of PAEC 
(figure 6-10) could be an increased expression level of TIMP-2 in PAEC shown in figure 6-
11. As it was already mentioned the work of Strongin et al. revealed that higher levels of 
TIMP-2 inhibit activation of MMP-2 by saturating free MT-MMPs that are needed to remove 
the MMP-2 prodomain (Strongin, 1995). Collagen type IV was shown to induce the activation 
of pro-MMP-2, in spite of balance between MMP-2 activation and the concentration of 
secreted TIMP-2 (Maquoi et al., 2000). This is also consistent with the observed increase of 
TIMP-2 secretion in PAEC compared to PBCEC (figure 6-11). Thus, the up-regulation level 
of collagen type IV mRNA detected by QRT-PCR in PAEC cultured on the PBCEC-derived 
ECM compared to the PAEC grown on collagen type I+III (figure 5-14) could stimulate the 
activation of pro-MMP-2 leading to a higher degree of ECM degradation than in case of cells 
grown on reference substrate, collagen type I+III.  
The turnover of the ECM mediated by matrix-degrading proteases is a complex and highly 
regulated process. It is commonly known that the activity of MMP-9 is regulated in particular 
by TIMP-1. The higher molecular weight forms of MMP-9 in PAEC supernatants detected in 
zymographic gel (figure 6-10) corresponds to complexes of pro-MMP-9 with TIMP-1 
(Nguyen, 1998), which are present in higher concentration in supernatants of PAEC cultured 
on collagen type I+III than on PBCEC-derived substrate. The formation of MMP-9-TIMP 
complexes induces the inhibition of active MMPs by TIMPs (Goldberg et al., 1992). A higher 
degree of ECM degradation by active MMPs is supposed to occur in case of released free 
forms of TIMPs. The up-regulation of TIMP-1 in PAEC on collagen type I+III may indicate a 
lower number of free MMP-9 and, thus reduced degradation of the ECM compared to PAEC 
grown on PBCEC-derived ECM with down-regulated level of TIMP-1. 
Thus, free forms of TIMPs indicate the presence of active proteases which could be bound to 
the culture ECM substrate. Furthermore, MMP-2 molecules are known to be up-regulated in 
response to a high degree of collagen type IV synthesis. All these factors could give an 
explanation for the disappearance of all main ECM proteins in sub-cellular matrix of PAEC 
grown on PBCEC-derived substrate (section 5.1.4). 
118 6 MMPs regulate barrier properties in vitro by ECM degradation 
Conclusion 10 
A comparison of the secretion profile of MMPs and TIMPs between macrovascular and 
microvascular endothelium was performed. A differentiated expression profile of both MMP-
2 and MMP-9 molecules has been shown in PAEC. Since the disappearance of collagen type 
IV and fibronectin was observed in sub-cellular matrix of PAEC cultured on PBCEC-derived 
substrate the expression of MMPs and their inhibitors was studied in comparison to PAEC 
grown on collagen type I+III. Free forms of TIMP-1 (no complex formation with MMP-9), as 
well as up-regulated level of MMP-2 and deposition of collagen type IV synthesis in PAEC 
cultured on PBCEC-derived ECM might lead to a higher degree of their ECM degradation.  
 
 
6.3 MMP-9 secretion by PBCEC is modulated by the presence of pericytes  
6.3.1 Purity optimization of PBCEC primary culture  
 
Due to the fact that brain capillaries in vivo are tightly embedded in diverse glial cells like 
astrocytes and pericytes, the isolation procedure of PBCEC is not completely endothelial cell-
specific but leads to co-cultivation with the above mentioned glial cells. To get pure PBCEC 
cultures these cells were selected by addition of puromycin in a concentration of 2 µg/ml 
(Weidenfeller, 2003).  
Figure 6-12 displays a fluorescence staining with rhodamine-labelled phalloidin against F-
actin filaments and an immunostaining against α-sm-actin for visualisation of pericytes 
(Skalli et al., 1989). Figure 6-12 A and C indicate a contamination of PBCEC by pericytes 
cultured without puromycin. No pericytes remained detectable in PBCEC cultured in 
puromycin-containing medium as depicted in figure 5-17 B and D. 
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Figure 6-12. Immunofluorescence staining of PBCEC in vitro:  
A+B: Rhodamin-labelled staining with phalloidin against F-actin filaments. C+D: Immunofluorescence 
staining against α-smooth-muscle cell actin (FITC-labeled). A, C: puromycin-free medium; B, D: 
puromycin-supplemented medium.  
 
Furthermore, the fraction of capillary endothelial cells in the whole cell population was 
determined using an indirect immunolabelling against platelet-endothelial cell adhesion 
molecule 1 (PECAM-1) and subsequent FACS analysis. PECAM-1 or CD 31 is a specific 
marker for endothelial cells (Mamdouh et al., 2003). It is an adhesion molecule that is 
localized preferentially at the borders between adjacent endothelial cells. The expression of 
this endothelial cell marker was studied in two populations of cells cultured in puromycin-
supplemented and puromycin-free medium (figure 6-13).  
As it is seen in figure 6-13 the fluorescence signal in the population of endothelial cells 
cultured in puromycin-supplemented medium (green) is stronger than in puromycin-free 
(yellow) cells indicated by the shift of the fluorescence histogram. Thus, puromycin treatment 
allows to improve the purity of PBCEC cultures.  
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Figure 6-13. The expression of PECAM-1 in PBCEC. 
The cells were cultured either in puromycin-free (yellow line) or in puromycin-supplemented (green 
line) medium analysed by FACS.  
 
Puromycin is an aminoacylnucleoside antibiotic produced by Streptomyces alboniger, and 
was described as a P-gp substrate (Bourgeois et al., 1993; McClean et al., 1993). When 
present in the cytoplasm puromycin induces apoptosis (Demeuse, 2004). Since PBCEC 
express P-gp and other multi-drug resistance (mdr) proteins, these cells are protected from 
puromycin-induced apoptosis. Thus, these puromycin properties allow to select specifically 
the endothelial cells in culture, while other cells, which do not express mdr die (Fernandez et 
al., 2001; Linnell et al., 2001; Sanwal et al., 2001); Drancoise Roux & Maria Deli, personal 
comment). This method of endothelial cell selection was already successfully applied to 
primary cell culture of murine brain capillary endothelial cells (MBCEC) (Weidenfeller C., 
2003).  
 
Conclusion 11 
Puromycin-treatment was necessary to obtain a pure primary culture of PBCEC free of 
contaminating glial cells like pericytes. FACS analysis after immunolabelling the endothelial 
specific PECAM-1, but also immunofluorescence studies directed against the pericytes 
marker α-sm-actin revealed that puromycin-supplemented medium allows to establish a pure 
endothelial cell culture. 
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6.3.2 Zymographic studies of MMP-9 secretion by PBCEC after puromycin 
treatment  
 
The secretion of matrix metalloproteinases in PBCEC in vitro was already analysed by 
zymographic studies (Lohmann, 2003). Whether the presence of pericytes in the primary 
culture of PBCEC alters the secretion of MMP-9 and MMP-2 by PBCEC through their direct 
contacts to the endothelial cells was investigated in this work. Since puromycin has been 
shown to selectively kill pericytes (figures 6-12 and 6-13), the presence of these cells could be 
switched on and off just by supplementing the culture medium with puromycin.  
Figure 6-14 shows the secretion of MMP-9 in conditioned medium of PBCEC in the presence 
(+Pur) and absence (-Pur) of puromycin. PBCEC without direct contact to pericytes secrete 
less MMP-9 than the cells directly “co-cultured” with pericytes. Furthermore, there is a higher 
expression level of MMP-9 dimer in PBCEC grown with pericytes (-Pur) compared to the 
pure culture (+Pur). In contrast, no difference in MMP-2 secretion was detected by 
zymographic analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-14. PBCEC show a higher MMP-9 secretion in co-culture with pericytes 
(-Pur) compared to a pure endothelial cell culture (+Pur). 
The conditioned medium of PBCEC was examined after DIV 3, DIV 4 and DIV 7 upon culturing these 
cells in serum-supplemented and serum-free medium (+HC), respectively.  
 
Moreover, MMP-9 is secreted by PBCEC into the culture serum-supplemented medium not 
only in its latent, but also in an active form (figure 6-14). Whereas only latent form of MMP-9 
is present in serum-free conditioned medium of PBCEC. The glucocorticoids are able to 
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reverse many cytokine-simulated events, including MMP-9 production in serum-free medium 
(Lohmann, 2003; Werb, 1989). Therefore, the expression of MMP-9 detected in supernatants 
of PBCEC cultured under the serum-free conditions with HC (550 nM) is rather low. As it is 
seen in figure 6-14 MMP-9 expression by PBCEC in conditioned SFM was also reduced in 
pericytes-free cultures compared to the cells cultured in pericytes presence. Since it is known 
that MMP-2 is present in serum (Lohmann, 2003), the gelatinolytic bands of this enzyme 
depicted in figure 6-14 could be explained by the remaining activity of serum-induced pro-
MMP-2.  
The pericytes are known to express the matrix metalloproteinases and their inhibitors in vitro 
suggesting a significance of these molecules for angiogenesis and tissue remodelling (Arihiro 
et al., 2001). The literature evidence suggests that MMP-9 expression may be associated with 
early rapid pericyte proliferation during the fist stages of angiogenesis. Later, during vessel 
growth, expression is taken over by endothelial cells themselves (Forsyth, 1999). This could 
be an explanation for the higher amount of MMP-9 secreted by PBCEC in pericytes presence 
as shown in figure 6-14. Whether the pericytes induce MMP-9 production by endothelial 
cells, or secrete MMP-9 themselves so that the sum of MMP-9 from both PBCEC and 
pericytes is detected in puromycin-free medium was investigated in further experiments. 
The zymographic studies are in good agreement with western blots showing an elevated 
expression level of MMP-9 in conditioned medium of PBCEC cultured with pericytes (-Pur) 
compared to PBCEC free of pericytes (+Pur) (figure 6-15). The elevation of the dimer of 
MMP-9 by immunodetection in western blot experiment is also induced in PBCEC cultured 
in pericytes presence compared to the cells free of pericytes similar to the zymographic 
studies (figure 6-15). 
 
 
 
 
 
 
 
Figure 6-15. Western blot analysis of MMP-9 secretion in PBCEC cultured in pericytes 
free (+Pur) and pericytes present cultures (-Pur).  
The supernatants of PBCEC were examined on 4 DIV upon culturing these cells in serum-
supplemented medium.  
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The higher molecular weight forms of MMP-9 (figure 6-15) may correspond to dimer of this 
enzyme, which are able to form complexes with TIMP-1 (Forsyth, 1999). MMP-9 secreted by 
PBCEC were shown to be bound to TIMP-1 forming MMP-9–TIMP-1 complexes 
(Lohmann, 2003). 
Furthermore, the expression of both MMP-9 and MMP-2 by PBCEC cultured with pericytes 
(-Pur) and free of pericytes (+Pur) was quantified by quantitative real-time PCR. The results 
showed that there is no difference on the mRNA expression level when using puromycin-free 
or puromycin- supplemented culture medium (figure 6-16). The expression level of TIMP-1 
detected by QRT-PCR in PBCEC is significantly higher than the mRNA level of MMP-9 and 
MMP-2, respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-16. Results of QRT-PCR. PBCEC were cultured in presence of pericytes 
(-Pur) and free of pericytes (+Pur).  
There is no significant difference in RNA-level of MMP-2, MMP-9 and TIMP-1 expression in PBCEC 
treated with puromycin-supplemented and puromycin-free medium. The values give the cycle values 
in relation to β-actin. (n=3) 
 
There is evidence that the expression pattern of both TIMPs and MMPs differ in QRT-PCR 
from that detected by means of zymography. By immunogold labeling it was already shown 
that MMPs as well as TIMPs are localized in membrane-bound secretory vesicles of human 
microvascular endothelial cells (Nguyen et al., 1998). These vesicles are encapsulated by a 
clearly defined vesicular membrane. They are also more abundant in extensions of the cells 
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and, in some instances, the immunogold labeling shows MMP-9 being secreted from the tips 
of these extensions (Nguyen et al., 1998). Using double immunogold labeling it was found 
that TIMP-1 is spread more diffusely throughout the cytoplasm. Although TIMP-1 is 
occasionally present in small vesicles, it was never found in the MMP-9-containing vesicles. 
Thus, these results showed that at least TIMP-1 and MMP-9 are separately compartmentalized 
within the cell and releazed from their vesicles further in culture. Only the secreted MMPs 
into the conditioned medium could be analyzed by zymographic gels generating the 
difference between the western blot and QRT-PCR studies with the latter addressing the 
activity of the cytosolic fraction.  
 
Conclusion 12 
A direct co-culture of pericytes with PBCEC revealed the stimulation of MMP-9 secretion by 
PBCEC using puromycin-free and puromycin-supplemented medium. Whether the pericytes 
induce MMP-9 production by endothelial cells, or secrete MMP-9 themselves, creating a sum 
of MMP-9 from PBCEC and pericytes remains to be investigated. Based on the literature data 
the expression profile of MMPs and TIMPs on mRNA level could be different from that 
detected in the culture supernatants. QRT-PCR analysis exhibited no difference in MMP-2, 
MMP-9 and TIMP-1 mRNA expression in PBCEC cultured under both conditions, in a direct 
co-culture of PBCEC with pericytes and in pure endothelial cells. 
 
6.4 Secretion of MMP-2 and MMP-9 by PBCEC is regulated by glial cells in 
co-culture conditions  
 
Although it was already shown that endothelial cells themselves are a source of MMP-9, it 
needs to be emphasized that the physiologic and/or pathologic interactions of endothelial cells 
with perivascular supporting cells (pericytes and astrocytes) play a major role in regulating 
enzyme expression, probably by releasing growth factors and cytokines or by direct cell-cell 
contacts (Behzadian et al., 2001; Laterra and Goldstein, 1991; Laterra et al., 1990; Sato et al., 
1993). A co-culture of BCEC with glial cells has been previuosly shown to be able to regulate 
the blood-brain barrier function in vitro. However, endothelial cells co-cultured with either 
Müller cells or astrocytes were also shown to be able to express MMP-9 (Behzadian, 2001).  
During brain development, endothelial cells in conjunction with astrocytes contribute to the 
components of the ECM (Wagner et al., 1997). At least partial inhibition of MMP-2 and 
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MMP-9, which are capable of degrading the major compounds of the basement membrane, 
with TIMP-2 and TIMP-1, respectively, was shown to decrease the angiogenesis process in 
vitro (Schnaper and Kleinman, 1993). Therefore, the influence of pericytes and astrocytes on 
PBCEC secretion of MMPs and TIMPs was additionally studied in this work. For these 
purposes, not only the direct co-culture of PBCEC with pericytes using puromycin-free and 
puromycin-supplemented medium, but also a filter model (with an indirect co-culture) was 
used to combine both cell cultures in one system.  
 
6.4.1 Zymographic analysis of PBCEC conditioned medium after co-culture 
with pericytes and astrocytes  
The impact of astrocytes and pericytes on the MMP-2 and MMP-9 secretion by PBCEC was 
firstly examined by means of zymography. Thus, the pericytes or astrocytes were cultured for 
4 DIV in 12 well plates until they reached confluence. Afterwards, PBCEC grown on 
transwell filters (Costar) were inserted into the upper side of the plates with confluent glial 
cells. This setup enables diffusive exchange of soluble factors between both cell types via the 
medium. The expression of MMP-9 and MMP-2 by PBCEC co-cultured with pericytes and 
astrocytes compared to pure culture of capillary endothelial cells is presented in figure 6-17. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-17. The MMP-2 and MMP-9 secretion in PBCEC supernatants.  
The cells were co-cultured in a filter system with astrocytes (2) and pericytes (3) and compared to a 
pure PBCEC culture (+Pur) (4) and a direct co-culture of PBCEC with pericytes (-Pur) (1) in serum-
supplemented and serum-free medium, +HC. PBCEC grown in a co-culture system with glial cells 
(lanes 2 and 3) were treated before with puromycin to avoid the impact of pericytes presence. 5: C1-
marker (section 8.2.8). 
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The zymographic samples show high amount of MMP-2 in serum-supplemented medium in 
all cultures. In case of a pericyte co-culture (figure 6-17, lane 2) there is a gelatinolytic band 
above the MMP-2, the origin of which is not yet clear (6.1.2). The presence of MMP-2 in 
serum-supplemented medium is not surprising as pro-MMP-2 was shown by zymographic 
analysis to be present in serum, which is a potential mediator of the barrier-weakening effect 
of serum on PBCEC in vitro (Lohmann, 2003). The remaining gelatinolytic bands of MMP-2 
in serum-free conditioned medium could be explained either by rests of serum-induced 
production of pro-MMP-2, or in case of co-culture with glial cells, by the influence of the 
glia-secreted soluble factors on the production of pro-MMP-2 in SFM.  
In comparison to serum-free samples, where only latent forms of MMP-9 were detected, there 
is an expression of both forms of MMP-9, latent and active in serum-supplemented medium 
of PBCEC co-cultured with pericytes and astrocytes. There was no MMP-9 detectable in 
serum-free conditioned medium (+HC) of all cell samples, except of PBCEC directly co-
cultured with pericytes (-Pur) (figure 6-17). It would have been interesting to study the 
expression pattern in PBCEC on RNA level under the influence of co-culture with pericytes 
and astrocytes. Because of the experimental difficulties to isolate the RNA from filter-grown 
cell layers, these experiments were not performed. Instead of this, western blot analysis and 
activity measurements of MMPs were perfomed to support the first zymographic studies for 
pericyte and astrocyte co-cultures with PBCEC. 
 
6.4.2 MMP-9 is detected in a complex with TIMP-1 in brain endothelial and glial 
cells  
 
The expression of MMP-9 and a complex of MMP-9–TIMP-1 in PBCEC co-cultured with 
pericytes and astrocytes is presented in figure 6-18. The supernatants were collected either 
from astrocytes and pericytes, or from the apical side of a filter system of PBCEC co-cultured 
with these glial cells. After immunodetection of MMP-9 in culture supernatants, the 
membrane was stripped and a new antibody against TIMP-1 was applied. Figure 6-18 shows 
that in both astrocyte co-culture with PBCEC (lane 4) and astrocytes alone (lane 2) there is 
only the MMP-9-TIMP-1 complex detectable. TIMP-1 is not present in an unbound, free form 
in both culture systems. However, pericytes (lane 1) alone and pericyte indirect co-culture 
with PBCEC (lane 3) express both an MMP-9-TIMP-1 complex and free TIMP-1 (figure 
6-18). 
6 MMPs regulate barrier properties in vitro by ECM degradation  127 
 
 
 
 
 
 
 
 
Figure 6-18. Western blotting analysis of conditioned medium collected from apical 
side of filter-grown PBCEC co-cultured with pericytes (3) and astrocytes (4), as well as 
pericytes (1) and astrocytes (2) alone.  
Pericytes express both MMP-9-TIMP-1 complex and free TIMP-1 (1) whereas astrocytes show the 
absence of free TIMP-1 (2). The indirect co-culture of PBCEC with pericytes revealed that TIMP-1 is 
present in both its free and complexed forms (3). There is no free TIMP-1 and only a complex of 
MMP-9-TIMP-1 in a co-culture of PBCEC with astrocytes (4).  
 
As it was mentioned before, MMPs are secreted as proenzymes and can be activated by 
autocatalytic cleavage. In the case of MMP-9, activation involves two consecutive steps 
generating 82- to 83 kDa and then 68 kDa molecules. The 68 kDa molecule is very unstable. 
The 82- to 83 kDa molecule, however, may bind TIMP-1 to form a complex of slightly more 
than 92 kDa, which is inactive, but stable and may resist further cleavaging process. 
Behzadian et al. added purified (TIMP-free) latent form of MMP-9 to bovine retinal 
endothelial cells (BREC) and found that MMP-9 increased BREC permeability. This means 
that the enzyme was activated during incubation with endothelial cells (Yu, 1999).  
It is well known that MMP-9 is unique among the MMPs in the way that it is able to strongly 
interact with TIMP-1 in its latent form via the C-terminal domain (Goldberg et al., 1992). 
Murphy et al. have proposed that MMP-9–TIMP-1 complexes are formed during intracellular 
protein folding (Murphy and Willenbrock, 1995). It is generally believed that these complexes 
are then secreted by the cells (Shapiro, 1995). Minh Nguyen et al. discovered that MMP-9 
secreted into the conditioned medium of endothelial cells is bound to TIMP-1. However, in 
the cytosolic fraction MMP-9 can exist in its free form (Nguyen, 1998). Thus, the formation 
of the MMP-9–TIMP-1 complex occurs after (or while) these molecules are secreted from 
microvascular endothelial cells. Further evidence for this was found using immunogold 
electron microscopy, which revealed that MMP-9 was separately compartmentalized from 
TIMP-1 within secretory vesicles of endothelial cells.  
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6.4.3 Fluoremetric measurements of active MMPs in PBCEC supernatants after 
co-culture with pericytes and astrocytes  
 
Until now the MMPs were detected only using zymographic gels or by means of QRT-PCR 
and immunocytochemistry. All these methods do not allow to detect the MMPs activity in the 
culture model. The gelatinolytic bands in the zymographic gels are produced by active MMPs, 
but these MMPs were artificially activated including the formerly latent molecules 
(Woessner, 1995). Therefore, the intensity of the MMP bands does not represent a real 
quantity of MMP-activity in the culture medium, but only the general MMP concentration.  
In order to investigate an impact of indirect glial cell co-culture on PBCEC and their influence 
on MMP-activity, a fluorometric assay was applied to directly measure the MMP-activity in 
the culture supernatants. The method is based on the specific cleavage of a fluorogenic 
substrate by active MMPs. The activity of the MMPs was quantified from the rate of 
fluorescence increase with time indicative for the amount of cleavage product liberated per 
unit time (8.2.9).  
The results of the fluorogenic measurements are presented in figure 6-19.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-19.  Fluorometric measurement of MMP-activity in conditioned supernatants  
of PBCEC and glial cell.  
The assay was performed using culture supernatants of PBCEC, pericytes and astrocytes in HC-
supplemented serum-free medium (SFM). SFM was measured as a control. The fluorescence 
increase (slope) with time indicate the amount of cleaved product from the fluorogenic MMP-substrate. 
MMP-activity correlates with slope of negative control (SFM) (n=3). 
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In this case, the pericytes or astrocytes were cultured in the basolateral and PBCEC in the 
apical compartments of the filter inserts. In order to avoid the impact of pericytes presence on 
the indirect filter-cultured PBCEC were treated with puromycin. Thus, pure cultures of 
PBCEC alone and in an indirect co-culture with pericytes and astrocytes were applied for 
detecting of MMP-activity. The culture supernatants were collected from the apical side of the 
filter inserts of PBCEC. Additionally, pericytes and astrocytes cultured alone were also 
analyzed for the presence of active MMPs (figure 6-19).  
There is no increased MMP-activity measured in supernatants of pericytes and astrocytes 
cultured alone. However, there is an obvious increase of MMP-activity in the PBCEC co-
cultured in a filter system with pericytes (slope: 4.2) as well as in PBCEC directly co-cultured 
with pericytes (-Pur) (slope 2.1). There are the same values of slopes (1.1) in the raw data of 
pure cell monolayer of PBCEC (+Pur) supernatant and PBCEC indirectly co-cultured with 
astocytes. Thus, it was shown that pericytes are able to induce the PBCEC to secrete active 
MMPs under direct (with physical contact between two types of the cells) and indirect (in a 
filter system) co-culture conditions in vitro.  
 
6.4.4 The transcellular electrical resistance (TEER) of PBCEC in co-cultures 
with glial cells  
 
Impedance measurements, as described in section 8.1.7, provide a sensitive tool to determine 
the TEER across cell monolayers. BBB function is impaired in a variety of pathological 
conditions in vivo as well as dependent on culture conditions in vitro. Both withdrawal of 
serum and addition of hydrocortisone to the culture medium results in improved barrier 
function (Hoheisel et al., 1998b). The endothelial cells forming the BBB were shown to be in 
strong communication with neighbouring glial cells in vivo, among which the perivascular 
end feet of astrocytes and pericytes are of particular importance (Abbott, 2002; Davson and 
Oldendorf, 1967; Isobe et al., 1996; Janzer and Raff, 1987; Wolburg et al., 1994). The impact 
of a direct presence of pericytes in a primary culture of PBCEC (-Pur), as well as an indirect 
co-culture of PBCEC with pericytes and astrocytes without physical contact between two cell 
types on the development of TEER is shown in figure 6-20.  
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Figure 6-20. TEER of PBCEC monolayers with (-Pur) or without (+Pur) direct contact to 
pericytes as well as in indirect co-culture with pericytes and astrocytes.  
TEER was measured across primary PBCEC-monolayers subcultured in serum-supplemented 
medium after DIV 3 and serum-free medium was applied on DIV 5. The measurement was perfomed 
after 2 more days under serum-free culture conditions with hydrocortisone supplementation (550 nM). 
(n=5) 
 
Both PBCEC cultured with direct contacts to pericytes (-Pur) and an indirect co-culture of 
PBCEC with pericytes showed an average values of 800  ± 150 Ω .cm2, whereas a pure 
culture of PBCEC (+Pur) reached 1800 ± 250 Ω .cm2. This shows that a pure endothelial cell 
culture without pericytes (+Pur) leads to more than 2-fold higher electrical resistance 
compared to PBCEC co-cultured with pericytes. This could be explained by the elevated 
MMPs activity shown in figure 6-19 in a supernatant of filter-grown PBCEC in pericytes co-
culture compared to the conditioned medium of pure PBCEC (+Pur) culture. The TEER 
measured for PBCEC supernatants in indirect filter astrocytes co-culture showed higher 
values than for the PBCEC grown in pericytes co-culture, but lower than for the pure PBCEC 
monolayer (+Pur). It should be mentioned that according to further measurements (from 
DIV 7 to 10) PBCEC indirectly co-cultured with astrocytes had more stable TEER values 
than cells without an astrocytes co-culture, the TEER of which drastically dropped after 
DIV 8.  
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Conclusion 13 
An impact of glial cells on MMPs secretion by PBCEC has been shown in indirect co-cultures 
of pericytes and astrocytes with PBCEC. The remaining gelatinolytic bands of MMP-2 in 
serum-free medium could be explained by the influence of the glia-secreted soluble factors, 
which induced the production of pro-MMP-2 in PBCEC co-cultured with glial cells, or 
remaining serum-induced activity of MMP-2. The immunodetection of MMP-9 and TIMP-1 
in supernatants of brain endothelial and glial cells revealed a free form of TIMP-1 only in 
pericytes grown alone and in PBCEC co-cultured in filter system with pericytes, but not with 
astrocytes. Fluorimetric analysis revealed that an indirect co-culture of endothelial cells with 
pericytes increased MMP activity at the BBB in vitro. Moreover, the TEER values of pure 
PBCEC monolayers in indirect filter co-culture with pericytes were lower compared to the 
pure PBCEC (+Pur) culture verifying the measurements of MMPs activity.  
 
6.5 Functional role of MMP-9 for the adhesion and spreading of PBCEC  
 
The secretion of MMP-9 by PBCEC is markedly reduced after addition of hydrocortisone 
(HC), which at the same time improves barrier function (Lohmann, 2003). Basolateral 
secretion of MMP-9 by PBCEC was demonstrated by immunocytochemical studies, which 
revealed that MMP-9 is bound to the extracellular matrix of PBCEC (Lohmann, 2003). Thus, 
the endogenous ECM derived from first generation of PBCEC grown in HC-free medium 
could be different from that ECM derived from the cells cultured in HC-supplemented 
medium. The influence of modified endogenously produced ECM by secreted MMPs on the 
the adhesion and spreading of the brain endothelial cells as well as their barrier formation 
properties was investigated by ECIS. For this purpose, the PBCEC were firstly cultured in 
serum-free medium with or without HC supplementation. The time course of the capacitance 
and resistance of PBCEC measured by ECIS is shown in figure 6-21. The cells were 
completely confluent in less than 10 h and adhered in the same manner under both culture 
conditions, with and without HC. As it has been mentioned before, HC improves the barrier 
properties and thus, increases the transendothelial electrical resistance (figure 6-21 B).  
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Figure 6-21.  Time course of capacitance (A) measured at 40 kHz and resitance (B) 
measured at 400 Hz for PBCEC monolayers. 
The cells were directly cultured on the gold-ECIS electrodes in serum-free medium with (—  —) and 
without (—x—) hydrocortisone, 550 nM (n=2). 
 
After 30 h of ECIS-measurement the cell bodies were lysed with the ECM remaining attached 
to the electrode surface. Thus, two different types of ECM have been generated on the 
electrode surface – the PBCEC-derived +HC-ECM and –HC-ECM. A second generation of 
PBCEC was then seeded on the endogenously derived ECM from PBCEC of both + and – 
HC-conditions. The time course of capacitance and resistance of second cell generation 
cultured in SFM without HC measured by ECIS is depicted in figure 6-22. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6-22. Time course of capacitance (A) measured at 40 kHz and resistance (B) 
measured at 400 Hz for the second generation of PBCEC. 
The cells were cultured in serum-free medium without HC on the ECM-derived from the first cell 
generation cultured with (—•—) and without (—+—) hydrocortisone (n=2).  
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In case of the endogenous ECM-derived from the PBCEC cultured without HC 
supplementation there is a delay in the time course of cell spreading compared to the cells 
seeded on the ECM-derived from the cells cultured in medium supplied with HC.  
Thus, the MMP molecules secreted before by PBCEC and bound to the ECM of these cells 
cultured in HC-free medium modified the substrate in such a way that the cells could not 
attach and spread as fast as on the ECM generated by PBCEC cultured in HC-supplied 
medium. HC was proven to suppress the secretion of MMPs by PBCEC significantly although 
not completely. The remained on the endogenously-derived ECM metalloproteinases alter the 
cell-substrate but not cell-cell contacts formation of PBCEC.  
 
Conclusion 14 
PBCECs have higher electrical resistances upon culturing these cells in HC-supplemented 
serum-free medium indicating the improved BBB properties measured by ECIS. MMP-9 
remains bound to the ECM substrate secreted by PBCEC as indicated by immunofluorescence 
(Lohmann, 2003). Endogenous ECM-derived from PBCEC cultured in HC-free medium was 
compared with ECM generated from PBCEC grown in HC-supplemented medium. The 
second generation of PBCEC dispalyed a delayed onset on HC-free endogenous ECM 
indicating a modified susbstrate through the MMP-9 secretion by the first generation of 
PBCEC.  
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7 General discussion and perspectives  
7.1 Functional significance of purified and endogenously-derived ECM for 
BBB formation in vitro 
 
The blood-brain barrier is formed by endothelial cells that are joined together by tight 
junctions. The brain endothelium and pericytes are surrounded by a basement membrane 
(BM) and glial foot processes. This BM is known to contain the main extracellular matrix 
proteins including laminin, fibronectin and collagen type IV. An impact of these proteins on 
BBB formation and regulation in vitro has been shown by culturing brain endothelial cells on 
glia-derived ECM with respect to changes in cell-cell and cell-substrate contacts. 
Comprehensive analysis of ECM secretion and their functional significance on BBB 
development and formation has been performed using a well established porcine cell culture 
model of the blood-brain barrier in vitro. This model is based on primary cultured porcine 
brain capillary endothelial cells (PBCEC) that are incubated in serum-free conditions with 
supplementation of hydrocortisone (550 nM). In order to identify any significant signaling 
that may affect the barrier properties through the ECM components, those PBCECs were 
compared with non-brain endothelial cells (aorta). 
Due to the fact that ECM proteins are present in serum-supplemented culture medium, the 
experimental conditions for PBCEC culturing have to be well defined and the use of serum-
free medium was imperative. However, withdrawal of serum from the culture medium led to 
an alteration of PBCEC adhesion and spreading on the ECM coatings. Small amounts of 
trypsin that had been introduced into the seeding serum-free medium during cell harvesting 
was proven to be able to delay the attachment of the cells on the ECM coatings. Serum 
addition into the cell suspensions stopped the remaining activity of trypsin as measured by 
ECIS. Since trypsin inhibitor was shown to have the same with serum effects on the adhesion 
and spreading of the cells seeding medium of PBCEC was treated with trypsin inhibitor. This 
improved the very critical subculture conditions for PBCEC and allowed to work directly with 
serum-free medium.  
It is known that every component of the extracellular matrix has different modulatory 
functions on cell behaviour. The attachment and spreading of PBCEC on purified ECM 
proteins and the impact of these matrices on the generation of barrier-forming cell–cell 
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contacts were studied by the ECIS-technique. Fibronectin was found to be the best inductor of 
the adhesion process and an accelerator of tight junction formation. The delayed spreading of 
PBCEC on a laminin coating was accompanied by the lowest TEER values (fig. 4-6). Since 
the TEER is a measure for junctional tightness, the significance of special matrix components 
on BBB formation could be derived from ECIS readings. Figure 7-1 shows a ranking for 
purified ECM proteins studied here with respect to their ability to promote PBCEC spreading 
and tight junction formation. 
 
 
 
Figure 7-1. Comparison of importance of purified extracellular matrix proteins for 
BBB formation of PBCEC in vitro  
 
Furthermore, decreasing concentrations of collagen type IV coating gradually delayed the 
spreading of cells on the electrode surfaces. Corresponding TEER values were reduced 
reflecting the dependence of cell-cell contact formation on the surface concentration of the 
ECM proteins (fig. 4-7).  
In all cell types, the adhesion of the cells to the extracellular matrix and the attachment of the 
actin cytoskeleton to the cell membrane are mediated via transmembrane proteins that act as 
receptors for the ECM. These integrins are composed of α and β subunits (Hynes, 1987). 
Based on integrin sequence data, the β subunits are very similar, while α chains are more 
variable. The ECM-binding diversity is generated by the association of different α subunits 
with β subunits. The well-characterised fibronectin receptor is  α5β1. This type of integrin 
was shown to be expressed on the PBCEC surface as detected by flow cytometry analysis 
after immunolabelling (section 4.4, fig. 4-8 and 4-9). Hocking et al. have shown that binding 
of the amino-terminal type I repeats of fibronectin to the  α5β1 integrin supports cell adhesion 
(Hocking, 1998). This ligand specifity of the  α5β1 integrin is regulated by the cytoskeleton, 
which modulates actin assembly and focal contact formation. The focal adhesions are 
dynamic structures that serve to structurally link the extracellular matrix with the cytoskeleton 
during the adhesion of the cells, and enable the transduction of signals from ECM molecules 
to the cell interior. Knowledge about the available integrin subunits in PBCEC will allow to 
study the adhesion properties of these cells on one particular ECM coating as well as on the 
endogenously produced ECM in detail, for instance by blocking cell surface receptors by 
highly specific disintegrins, or antibodies against integrins. When such disintegrins (including 
fibronectin > collagen type IV > collagen type I+III > laminin 
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soluble peptides that contain the RGDS sequence) or specific antibodies are added to the 
culture medium, they compete with extracellular matrix proteins for the integrin binding sites 
and may thereby inhibit normal attachment of the cells or even detach already established cell 
layers. Therefore, the modulation of cell-cell and cell-substrate contacts of PBCEC after 
disintegrin-treatment could be followed by ECIS readings.  
Another mechanism by which cell behaviour may be modulated is via soluble factors secreted 
by cells of different or the same type, whose activity may again be modulated by the 
composition and organization of the surrounding matrix. In experiments addressing the 
impact of endogenously produced ECM on endothelial cell function, this matrix was derived 
from glial cells such as pericytes and astrocytes for experiments with PBCEC, and from 
microvascular endothelium for PAEC. In general, the ECM was prepared by cell lysis with an 
ammonia solution for western blot analysis, electron microcopy, immunofluorescence and 
quantitative real-time PCR analysis. This method provided high quantities of remaining ECM 
after cell lysis. Lysis buffer containing both 1% desoxycholate and 1% nonidet P-40, or only 
1% nonidet P-40 was applied for the ECM preparation on ECIS-electrodes for further 
adhesion studies. This procedure was found to be optimal for ECIS experiments as neither 
membrane, nor integrins remain on the electrode surfaces (fig. 5-15 and 5-16).  
As it was already discussed in section 2.2.1 the astrocytes in the vicinity of endothelial 
capillaries may participate in the formation of BBB. Functional impact of extracellular matrix 
derived from cultured astrocytes for the BBB properties has been shown in this work. The 
astrocytes-derived surface coating led to the highest TEER value of PBCEC in vitro measured 
by ECIS. PBCEC cultured on ECM derived from pericytes also showed an increased 
resistance in comparison to the other substrates. However, culturing PBCEC on PAEC-
derived matrix led to a delayed attachment and spreading and the lowest TEER values 
respectively. This indicates that certain ECM components are missing in PAEC-derived ECM, 
which are significant for BBB formation in vitro. An overview of the quality of endogenously 
produced ECM for the promotion of BBB properties, most notably tight junction formation is 
shown in figure 7-2.  
 
 
 
Figure 7-2. Comparison of importance of endogenously derived extracellular matrix 
for BBB formation of PBCEC in vitro  
 
astrocytes-ECM > pericytes-ECM > PBCEC-ECM > PAEC-ECM 
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There is evidence that integrin expression on the cell surfaces is highly regulated by the 
available ECM. Therefore, it will be interesting to study the altered integrin expression on the 
PBCEC surface cultured on pericytes- and astrocytes-derived ECM by FACS analysis in the 
future.  
7.2 ECM and tight junction proteins expression in PBCEC differs from that 
found in PAEC on protein and RNA levels  
 
In order to prove the importance of the main components of basement membrane for BBB 
formation collagen type IV, fibronectin and laminin were shown to be expressed by micro- 
(brain) and macrovascular (aorta) endothelial cells, as well as by glial cell types–pericytes and 
astrocytes (fig. 5-1 - 5-4).  
The alteration of ECM proteins expression level was further studied in PBCEC cultured on 
collagen type I+III compared to PBCEC grown on endogenously glia-derived ECM by 
western blot and QRT-PCR analysis. The results of their expression were compared with 
PAEC grown on collagen type I+III and PBCEC-derived ECM.  
Since it is known that the expression of extracellular matrix proteins is directly related to 
astrocyte migration processes (Jiang, 1994), this study could be the first indication among 
others that glial cells are able to change the expression pattern of ECM in differentiating 
endothelial cells to initiate vasculogenesis in vivo. The synthesis of collagen type IV, 
fibronectin and laminin is increased in PBCEC cultured on pericytes as well as on astrocytes-
derived ECM compared to the collagen type I+III coating (fig. 5-14). Moreover, the 
expression pattern of collagen type IV and fibronectin was found to be different in the whole 
cell lysate compared to the sub-cellular ECM isolated after cell lysis (fig.5-5 – 5-7). However, 
the expression of collagen type IV is higher in PBCEC than in PAEC and fibronectin is higher 
in PAEC than in PBCEC in both fractions whole cell lysate and sub-cellular ECM of the cells. 
QRT-PCR analysis of ECM proteins expressed in PAEC cultured on PBCEC-ECM indicated 
higher expression level of collagen type IV, fibronectin and laminin compared to PAEC 
cultured on the collagen type I+III (fig. 5-14). In contrast, western blot studies indicated the 
disappearance of collagen type IV and fibronectin in PAEC grown on PBCEC-derived ECM 
in the whole cells lysate and sub-cellular ECM of the cells (fig. 5-5 – 5-7).  
Furthermore, BBB-relevant proteins were studied by QRT-PCR and western blot analysis and 
revealed that the expression of tight junction proteins is elevated in PBCEC cultured on glia-
derived ECM. The expression of occludin and ZO-1, but not claudin-5 is higher in PBCEC 
7 General discussion and perspectives  139 
cultured on both pericytes- and astrocytes-derived ECM compared to a collagen type I+III 
coatings (fig.5-26 - 5-28). Table 7-2 depicts the comparison of tight junction as well as ECM 
proteins in PBCEC as well as in PAEC cultured on different matrices.  
Table 7-1. Summarized results of tight junction and ECM protein expression in 
PBCEC compared to PAEC on RNA and protein levels  
 
 
 
Method Localization Protein Expression level 
Collagen IV 
PBCEC > PAEC 
PAEC < PAEC, PBCEC-ECM 
PBCEC, colI+III < PBCEC, astrocytes-ECM  
PBCEC, colI+III < PBCEC, pericytes-ECM 
Fibronectin 
PBCEC < PAEC 
PAEC = PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
ECM 
Laminin γ 1 
PBCEC > PAEC 
PAEC < PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III = PBCEC, pericytes-ECM 
ZO-1 
PBCEC > PAEC 
PAEC < PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
Occludin 
PBCEC > PAEC 
PAEC < PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
QRT-
PCR 
tight junctions 
Claudin - 5 
PBCEC > PAEC 
PAEC = PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
Collagen IV 
PBCEC > PAEC 
PAEC > PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
PBCEC, pericytes > PBCEC, astrocytes-ECM ECM 
Fibronectin 
PBCEC < PAEC 
PAEC > PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
PBCEC, pericytes < PBCEC, astrocytes-ECM 
ZO-1 
PBCEC > PAEC 
PAEC > PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
Occludin 
PBCEC > PAEC 
PAEC > PAEC, PBCEC-ECM 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
Western 
Blot 
tight junctions 
Claudin - 5 
PBCEC > PAEC 
PBCEC, col I+III < PBCEC, astrocytes-ECM 
PBCEC, colI+III < PBCEC, pericytes-ECM 
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7.3 Modulation of cell-cell and cell-substrate contacts in PBCEC and PAEC 
cultured on endogenously-derived ECM  
 
ECIS measurements of BBB induction in microvascular endothelial cells were compared with 
ECIS-readings for macrovascular endothelial cells (aorta). This cell model represents 
macrovascular endothelium without BBB properties as indicated by TEER values (1300 ± 
150 Ω) measured at 400 Hz. These values are much lower than those detected for PBCEC 
(25000 ± 1500 Ω) (fig. 5-23). The determination of α-value as an indicator of cell-substrate 
contacts formation demonstrated that PAEC attached more tightly to the collagen type I+III 
than to PBCEC-derived ECM. A strikingly different nature of these cell-substrate contacts 
formed by PAEC either cultured on collagen type I+III or on PBCEC-derived ECM was also 
observed by transmission electron microscopy (TEM) (fig. 5-24 A and C). The method of 
isolation for proteins which compose the tight junctions proved that PAEC cultured on the 
PBCEC-derived ECM are able to form foothills, in which cell-cell contact zones are located 
(fig. 5-27). Western blot analysis also verified the expression of tight junction proteins in 
PAEC with an exception of claudin-5. 
Moreover, PBCEC were also further cultured on glia-derived ECM and compared 
morphologically with the cells grown on the collagen type I+III by TEM studies (fig. 5-24). 
The micrographs revealed that both cell-cell and cell-substrate contacts are altered in PBCEC 
as well as in PAEC due to the different endogenously-derived matrices on the culture 
substrate. The morphology of PBCEC and their phenotypic properties were shown to be 
changed by the ECM components derived from glial cell populations as detected by 
immunocytochemistry (fig. 5-25). These results suggest that the brain as well as aorta 
endothelial cells are able to adjust their morphological phenotype according to the available 
matrix coating.  
Since the character of cell-cell and cell-substrate formation properties of PAEC cultured on 
glia-derived ECM were not investigated in this thesis, it will be interesting to study the 
dynamic changes in the formation of these type of contacts in the future.  
An overview of alterations in cell-cell and cell-substrate contacts in PBCEC and PAEC 
cultured on different ECM coatings discovered in this work is given in table 7-1. 
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Table 7-2. Morphology of cell-cell and cell-substrate contacts in PBCEC and PAEC 
cultured on different ECM coatings 
 
 
 
 
 
ECM 
Coating  
Contact 
type Cell Type  
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cell-cell 
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7.4 The role of ECM degrading matrix metalloproteinases at the BBB  
 
The high differentiated PBCEC in addition to monitoring the synthesis and integrity of the 
ECM components ensures that appropriate expression level of matrix degrading proteinases is 
synthesized in order to degrade the surrounding ECM components. There is evidence that the 
functionally differentiated cells can adjust the expression of proteases according to the 
expression of inhibitors of matrix-degrading proteases. The profile of both matrix proteinases 
(MMPs) and their inhibitors (TIMPs) has been studied in PBCEC under glial induction and 
compared with expression pattern in macrovascular endothelial cells. 
Since glial cells are known to be modulators of blood-brain barrier function in vivo, the co-
cultures of pericyte and astrocyte with PBCEC were supposed to clarify the regulation 
mechanism of MMPs secretion by endothelial cells. In this context pericytes and astrocytes 
were also shown to be able to secrete the matrix metalloproteinases and their inhibitors in 
vitro. The secretory profile of these molecules was checked by zymography, QRT-PCR 
analysis and immunocytochemistry (fig. 6-1-6-8). The results of zymographic gels showed 
that both pericytes and astrocytes express MMP-9 only in serum-containing medium, whereas 
MMP-2 was found in both serum-free and serum-supplemented medium. The QRT-PCR 
analysis verified these results showing that mRNA message of MMP-9 in serum-free medium 
was not significantly higher than the background of the reaction. The MMP-2 mRNA was 
found under both culture conditions (serum-free and serum-supplemented medium) and at the 
same regulation level. It was previously discussed (section 6.1) that MMP-9 is necessary for 
the OLs to pursue the extension process along an astrocytic ECM (Oh, 1999). Therefore, 
astrocytes are supposed to secrete MMP-9 only into the brain side (and not to the basement 
membrane) what is essential for the OLs outgrowth. Based on the QRT-PCR the pericytes 
express higher amounts of MMP-2 and TIMP-1 compared to astrocytes (fig. 6-3 and 6-8). 
TIMP-1 was found to be secreted by pericytes apically into the cytoplasm of the cells and 
basolaterally into the ECM. The astrocytes were found to be able to secrete TIMP-1 only into 
the culture medium. However, the astrocytes have a higher level of TIMP-2. The 
immunofluorescence labelling revealed that astrocytes target this molecule to the extracellular 
matrix, whereas TIMP-2 secreted by pericytes was detected only in the cytoplasm of the cells. 
The character of such TIMP-1 and TIMP-2 targeting by pericytes and astrocytes seems to be 
cell dependent process. However, it is still not clear if these enzymes are secreted and targeted 
apically or basolaterally, and whether the secreted basolaterally molecules are soluble and 
thus, not immunodetectable after hypotonic cell lysis. The information about apical or 
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basolateral targeting of TIMP-1 and TIMP-2 by pericytes and astrocytes could be derived 
from experiment with cultured glial cells in a two-chamber system. The conditioned medium 
of these cells collected from apical and basolateral sides of the chamber should be examined 
by western blot with specific antibodies against TIMP-1 and TIMP-2 molecules. Different 
expression level and targeting of TIMP-2 in pericytes compared to astrocytes lead to the 
conclusion of different transduction pathways existing for these cells.  
As it was discussed in section 6.3.1 pericytes are always present in primary cultures of 
PBCEC as a contaminating cell type. To get pure PBCEC culture these cells were selected by 
addition of puromycin in a concentration of 2 µg/ml (Weidenfeller C., 2003). Puromycin is 
known to be an inducer of apoptosis and thus an additive to select different cell-lines with 
resistance against puromycin (de la Luna and Ortin, 1992; Suzuki, 2001). Although 
endothelial cells also secrete MMP-9 in mono-culture, the physiological interactions of 
endothelial cells with perivascular cells (pericytes, astrocytes) play a major role in regulating 
enzyme expression, probably via release of growth factors and cytokines or by direct cell-to-
cell contacts. Therefore, two different co-culture systems were used in this work to study the 
glia-derived effects on the BBB properties of PBCEC: a direct co-culture of PBCEC with 
pericytes accomplished by puromycin-free medium (-Pur) and an indirect co-culture of 
PBCEC grown apically and pericytes (or astrocytes) cultured basolaterally in two-chamber 
system. These cells were compared with pure endothelial cell culture obtained by puromycin-
supplemented medium (+Pur). A direct co-culture of pericytes with PBCEC (-Pur) revealed 
the stimulation of endothelial cells MMP-9 secretion by pericytes (fig. 6-14). This means that 
either the pericyte presence stimulated the secretion of MMP-9 by primary cultured PBCEC, 
or pericytes produced MMP-9 themselves. Although pericytes were previously shown to have 
no detectable levels of MMP-9 (fig. 6-2 and 6-4), probable MMP-9 induction in PBCEC by 
pericytes was studied in an indirect co-culture experiments of PBCEC grown apically and 
pericytes placed in the basolateral side of the wells.  
Fluorimetric measurements of MMP-activity revealed that both an indirect co-culture of 
PBCEC with pericytes and pericytes cultured upon physical cell contacts to endothelial cells 
increased MMP activity of PBCEC in vitro. Moreover, the TEER values of PBCEC 
monolayers in indirect filter co-culture with pericytes were lower compared to the pure 
PBCEC (+Pur) monolayers verifying the measurements of MMPs activity. Thus, pericytes 
were proved to be able to induce MMP-9 expression by PBCEC in vitro. 
The functional relationship of MMPs accomplishment to modification of endogenously 
produced ECM was studied by ECIS technique. The adhesion and spreading of the brain 
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endothelial cells and, thus cell-substrate contacts were shown to be altered upon culturing 
PBCEC on endogenously modified ECM. It is known that PBCEC are able to secrete MMP-9 
molecules basolaterally, which are attached to the ECM. The secretion of MMP-9 is markedly 
reduced after the addition of hydrocortisone (HC), which at the same time improves barrier 
function. MMP-9 among other types of MMPs is able to change proteolytically the ECM 
secreted by PBCEC and thus, influence the adhesion of these cells to such matrices. The 
isolation of endogenous PBCEC-derived ECM from two populations of the cells cultured in 
serum-free medium with and without HC clarified that MMP-9 secreted by PBCEC in 
HC-free medium could modify the culture substrate leading to the delayed attachment and 
spreading of PBCEC to such ECM (fig. 6-21 and 6-22).  
All these factors contribute to the involvement of MMPs in the regulation of ECM secretion at 
the BBB. The schematic representation of the proposed mechanisms for MMP action in the 
ECM degradation is depicted in fig. 7-3.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7-3. Schematic representation of the proposed involvement of MMP action in 
the ECM degradation at the BBB.  
 
The turnover of the ECM by matrix-degrading proteases is a highly complex and regulated 
process. As it is seen in fig. 7-3 the ECM degradation involves the integrins and MT-MMPs. 
The binding of the MMP-2 to TIMP-2 and to MT-MMP at the cell surface is needed for the 
activation of the MMP-2. The active MMP-2 enzyme remains within the spatial region where 
it is activated. Inactivation occurs when another TIMP-2 binds the MMP-2 molecules in the 
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extracellular space. Thus, it could not be excluded that pericytes in response to an 
upregulation of ECM components stimulate the secretion of MMP-2 and decrease the 
production of TIMP-2. Whereas the astrocytes having a lower degree of ECM expression 
induce the production of TIMP-2 decreasing the MMP-2 secretion profile. An indirect co-
culture of PBCEC with pericytes revealed that soluble factors released by the pericytes into 
the culture medium not only induce the production of MMP-9, but increase the MMPs activity 
in the supernatant. This leads to the decreased TEER values measured for PBCEC co-cultured 
with pericytes (fig. 6-20). An indirect co-culture of PBCEC with astrocytes leads to the 
increased TEER compared to PBCEC co-cultured with pericytes. MMP-2 was previously 
shown to mediate a barrier-weakening effect (Lohmann, 2003). An elevated MMP-2 secretion 
by pericytes could contribute to the decrease of transendothelial electrical resistance of 
PBCEC co-cultured with pericytes. This gives a direct proof of MMP-2 and MMP-9 being 
involved in the BBB regulation in vitro.  
As recently described the tight junctions are directly linked to the actin filaments of the 
cytoskeleton (fig. 7-3). The integrins mediate a connection of the cytoskeleton with the 
extracellular matrix. The expression of particular integrin subunits depends on the ECM 
composition and can be altered leading to a redistribution of stress fibers and thus, alterations 
in tight junctions composition. PBCEC were shown to express a receptor for fibronectin 
(α5β1) in high amounts and showed high values of TEER, when cultured on fibronectin-
coating. Additionally, astrocytes exhibit an elevated expression pattern of fibronectin 
compared to the other cells. By ECIS it was shown that PBCEC attached firmly and 
developed the highest TEER values on astrocytes-derived ECM. Astrocytes were shown to 
express the inhibitors of MMPs and a low expression level of MMP-2 and MMP-9 enzymes. 
Thus, it it reasonable to assume that MMPs released by the glial cells may activate growth 
factors bound to the ECM proteins, which then can act through the ECM, or their receptors 
(integrins) to modify the cytoskeletal architecture and genes involved in growth and 
differentiation. These all can lead to the morphological and functional changes of PBCEC 
phenotype cultured on endogenously-derived ECM from pericytes and astrocytes in vitro.  
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8.1 Cell culture 
 
All working procedures concerning the cell culture experiments including the handling and 
sterilisation of pipettes and buffers were applied as described by Freshney to minimize the 
risk of contaminations (Freshney, 2000). 
Cell culture work was exclusively performed in a laminar-flow hood with sterile equipment, 
solutions and media. For cell plating, culture flasks (75 cm2), petri dishes (10 cm2 or 28 cm2), 
8-well electrodes and 12-well plates were used. The cells were cultured at 37°C in a water 
saturated atmosphere with 5% (v/v) CO2. 
 
8.1.1 Isolation and culture of porcine brain capillary endothelial cells (PBCEC) 
 
Preparation.  The isolation of porcine brain capillary endothelial cells (PBCEC) from 
6 month old pigs was performed as described by (Tewes et al., 1996). 
The hemispheres of porcine brains were taken from freshly slaughtered pigs and collected in 
ice-cold 70% (v/v) ethanol. For transport, ethanol was replaced by ice-cold PBS containing 
the antibiotics penicillin (200 U/ml) and streptomycin (200 U/ml). The storage buffer was 
refreshed once again in the laminar-flow hood. After shortly flaming the hemispheres, the 
meninges and adhering larger vessels were carefully removed. Secretory brain areas were 
dissected, and the grey and white matter consisting of cerebral tissue was then mechanically 
homogenized using scalpels and a sterile cutter with rolling blades. The homogenate was 
supplemented with preparation medium (37°C) to a final volume of 100 ml per brain. After 
addition of 1.6% (w/v) dry powdered unspecific protease/dispase II the suspension was stirred 
at 37°C for 2 h. To isolate the released capillaries, 100 ml of the digested homogenate were 
mixed with 150 ml of an 18% (w/v) dextran solution (4°C, MW ~ 160 kDa) and centrifuged 
(4°C, 6800 x g, 10 min). Both supernatant phases were discarded and the pellet containing the 
capillaries was resuspended in 9 ml plating medium per brain. This suspension was then 
filtered through a nylon mesh (180 µm pore size) to remove larger blood vessels. In order to 
improve the separation of the capillaries, the filtered suspension was triturated up and down 
5 times in a 10 ml sized pipette with the pipette tip placed directly onto the bottom of a petri 
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dish. This mechanical disruption of capillary fragments to small pieces allows a shorter 
incubation time of the second digestion: A mix of collagenase/dispase II (0.1% (w/v)) was 
added to remove the mainly collagen containing basement membrane and to release the 
endothelial cells. This digestion was performed at 37°C for 30 min in a flask with a hanging 
magnetic stirrer to avoid any cell damage. State of digestion was controlled by inverse 
microscopy. The isolated endothelial cells were collected by centrifugation (20°C, 140 x g, 
10 min) and resuspended in 10 ml plating medium per percoll gradient. This discontinuous 
percoll gradient was prepared from 15 ml percoll solution of a density of    = 1.07 g/ml and 
20 ml percoll solution of    = 1.03 g/ml. 10 ml of the cell suspension were carefully placed 
onto the top of the percoll gradient and centrifuged in a swing-out bucket rotor (4°C, 
1300 x g, 10 min). The cell load of each gradient was adjusted to correspond to 1-2 brains. 
The red-stained, sharp interface containing the endothelial cells was aspirated from the lower 
middle of the gradient and diluted in plating medium. After a final centrifugation (20°C, 
140 x g, 10 min), the pellet was gently resuspended in plating medium and the cell yield of 
one brain was plated on a total of 6 x 75 cm2 collagen-G coated culture substrates. 
 
Culturing.  One day after preparation the cells were washed twice with PBS++ buffer to 
remove cell debris and non-adherent cell bodies and afterwards supplied with fresh culture 
medium afterwards.  
 
8.1.2 Subcultivation of the cells  
 
Passage of cells.  To reduce contamination with other cells from the brain parenchyma, 
the cells were subcultured two days after preparation. First, cells were washed twice with PBS 
and detached with trypsin solution (0.25 % w/v). The displacement of endothelial cells was 
followed by inverse microscopy and trypsin digestion was stopped by addition of serum as 
soon as the majority of endothelial cells had lifted off the culture surface. The cell suspension 
was centrifuged (20°C, 140 x g, 10 min), the cell pellet was resuspended in plating medium 
and plated on either collagen-G coated flasks, glass cover slips or alternatively on rat tail 
collagen coated microporous polycarbonate filter membranes (0.4 µm pore size, 1 cm2 growth 
area, TranswellTM No.3401, Costar®) with a density of 220,000 cells/cm2. 
Exchange of media.  Two days after passage the plating medium was replaced by 
hydrocortisone containing serum-free medium without further washing. The cells were 
148 8 Experimental 
cultured for two more days until they were used for immunocytochemistry, permeability- and 
TEER studies or RNA- and protein-isolation. 
 
preparation medium    Earle´s Medium 199 
0.7 mM L-glutamine 
1% (v/v) penicillin/streptomycin (10 mg/ml) 
1%   gentamycin (10 mg/ml) 
 
plating medium    preparation medium 
    10%  newborn calf serum (NCS) 
 
culture medium    plating medium without gentamycin 
 
serum-free medium (SFM)   DMEM/Ham´s F12-Medium 
0.7 mM  L-glutamine 
1% (v/v) penicillin/streptomycin (10 mg/ml) 
1% (v/v) gentamycin (10 mg/ml 
SFM + hydrocortisone                                   SFM 
    550 nM hydrocortisone (HC) 
 
dextran solution  200 ml  Earle´s buffer (10 x) containing phenol red 
    4.4 g  NaHCO3 
    360 g   dextran (~ 162 kDa/mol) 
    ad 2 l  ddH2O 
 
percoll solutions 
    = 1.03 g/cm3 400 ml  PBS 
    90 ml  percoll 
    10 ml  Earle´s Medium M199 (10 x) 
 
    = 1.07 g/cm3 200 ml  PBS 
    270 ml  percoll 
    30 ml  Earle´s Medium M199 (10 x) 
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Cell Counting. A Bürker hemocytometer was used to determine the number of cells. 
For each determination two different cell samples were counted in three areas consisting of 
4 times 4 squares each. The average cell number of one area was multiplied by 10,000 to give 
the cell density per ml. 
8.1.3 Isolation and culture of porcine aorta endothelial cells (PAEC) 
 
The isolation of aorta endothelial cells was implemented from the porcine aorta taken from 
the breast area of the pigs. The aorta slices were 10-12 cm long. After the extraction of aorta 
pieces both ends were closed with sterile clamps and put into the transport solution on ice. 
Firstly, all tissue rests were cut from the aorta and closed with new sterile clamps. Then the 
arteries were prepared free to the small clamps and washed with PBS 2-3 times. The whole 
content of aorta was washed several times with medium containing antibiotics and then filled 
with collagenase solution (65U/mg). The aorta walls were digested by the collagenase within 
20 minutes in an incubator at 37°C. The digested cells were collected and centrifuged for 
7 minutes at 1100 rpm. The pellet was resuspended in aorta medium and seeded into the cell 
culture flasks (25 cm2). One day after preparation the cells were supplied with new culture 
medium to remove cell debris and non-adherent cell bodies.  
 
Transport solution    PBS 
     2% Penicillin/Streptomycin  
     1% Fungicide (Partricine) (Sigma) 
Culture Medium for aorta cells  DMEM (Dulbecco´s Modified Eagle Medium) 
     1% Penicillin/Streptomycin 
     1% Fungicide (Partricine) 
     1,7 ml L-glutamin 
     10% FCS (fetal calf serum) 
Collagenase     Type CLS: S9H3091-A 277 U/mg (Biochrom KG) 
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8.1.4 Culturing of rat astrocytes and porcine pericytes  
 
This thesis comprises experiments with two further glial cell types: porcine brain pericytes 
and rat astrocytes (kindly provided by Sabine Hüwel).  
Porcine pericytes were cultured in plating medium as described in section 8.1.1. The rat 
astrocytes were cultured in DMEM (1 x) containing 10% (v/v) FCS, 2% (v/v) L-glutamine 
(200 mM), 1% (v/v) gentamycin (10 mg/ml) and 1% (v/v) penicillin/streptomycin 
(10 mg/ml). The cells were routinely grown in culture flasks or on the ECIS-array coated with 
collagen type I+III. For immunocytochemistry experiments the cells were cultured on 12-well 
plates with glass coverslips. After having reached 100% of confluency cells were passaged 
using a trypsin/EDTA (0.5%/0.2% (w/v)) solution and plated at 1:2 to 1:4 dilution depending 
on further use.  
 
8.1.5 Storage of cells 
 
For storage cells were trypsinised after reaching their confluence and pelleted as described 
before. The cell pellet was then resuspended in 1.8 ml NCS  (normal calf serum) containing 
10% (v/v) DMSO to prevent formation of ice crystals, transferred into a cryotube and 
immediately frozen at –20°C. After 30 min the cryotube was placed in a –70°C freezer 
overnight and finally stored in liquious nitrogen. 
For thawing cells were placed in a water bath (37°C), slowly diluted with medium and 
replated at high cell density. 
 
8.1.6 Hypotonic lysis of the cells  
 
Ammonium lysis.  For the preparation of ECM-derived substrate secreted by the cultured 
cells, the cells were cultivated until reaching confluence. The medium was removed and the 
cells were washed two times with PBS. For the cell lysis 4 ml of an aqueous solution of 
20 mM ammonia was add to culture flasks and incubated at room temperature for 10 min. To 
remove any remaining cell debris and ammonia solution the culture dishes were washed 
10 times with deionised water. During this process, the matrix proteins remain firmly attached 
to the culture dishes and can be used as a ECM-derived substrate for further experiments. 
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ECM-coated dishes were stored in culture medium supplemented with an antibiotic for at 
least one month at 4°C (Gospodarowicz, 1984; Mizuguchi et al., 1997). 
Lysis with desoxycholate and nonidet-P 40®. Alternatively, nonidet-P 40® and desoxy-
cholate (Fluka, Germany) mixture was used for the preparation of ECM substrates. The cells 
were incubated with deionised water to achieve an osmotic effect. Afterwards, a mixture of 
1% (w/v) desoxycholate and 1% (w/v) nonidet-P40® was add to the cells. The microscopic 
control showed that after the incubation with lysis buffer no cells remain on the surface of 
culture dishes. The presence of the main components of ECM was checked by the 
immunocytochemistry.  
8.1.7 Subcultivation of PBCEC on transpermeable filters  
 
The filters for TEER determination were coated with rat-tail collagen one day before cell 
passage and incubated over night at 37°C in a water saturated atmosphere. Afterwards the 
filters were dried in the laminar flow hood and stored at 4°C. The cells were cultivated on rat 
tail collagen coated petri dishes (8.1.1) and passaged after reaching 70 % confluence. For 
measuring the TEER the cells were seeded on the coated filters in a density of 
250,000 cells/cm2. The medium was replaced by chemically defined medium (serum-free 
medium (SFM) supplemented with hydrocortisone after the cells had reached confluence on 
the filters and the measurements were performed after one and two days in incubation 
medium. The filters containing the cultured cells were transferred into a chamber with a gold 
coated bottom. A platinum ring electrode was placed into the medium of the apical chamber 
(figure 8-1). A frequency generator (Solartron) applied alternating voltages (10-100 mV) in a 
frequency range from 1 to 105 Hz, measured the resulting current in a phase-sensitive fashion 
and calculated the impedance according to Ohm´s law. The recorded impedance spectra were 
analysed by equivalent circuit modelling as described by (Wegener et al., 2000a).  
 
 
 
 
 
 
8.1.8 Culture of PBCEC on the electric cell-substrate impedance sensing (ECIS) 
Figure 8-1.  In vitro model of BBB and experimental setup for TEER measurement.  
The apical chamber represents the lumen of the vessel while the basolateral chamber simulates the 
brain side. The platinum ring electrode was placed into the apical chamber using the gold coated surface 
of the basolateral chamber as counter electrode.  
 
filter compartment 
cell layer 
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electrodes 
 
The principle of the measurements.  Electric cell substrate sensing (ECIS) is an 
experimental method for investigating the electrical impedance as a function of the frequency 
of cell covered film electrodes. In contrast to the TEER measurement as described in section 
(8.1.7) cells are directly cultured on gold electrodes for this measurements (Figure 8-2 A).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Preparation of ECIS arrays. The ECIS device is based on alternative current (AC) 
impedance measurements using weak AC signals (Giaever and Keese, 1993; Lo et al., 1995; 
Mitra et al., 1991; Wegener et al., 2000b). An oscillator applies an AC signal of 70 mV 
amplitude to the two-electrode system using culture medium as the electrolyte. The data 
analysis has been described elsewhere (Wegener et al., 2000a): 
Protein coating. For electrical cell-substrate impedance sensing (ECIS) 8-well arrays 
with 10 electrodes each (Applied Biophysics, Figure 8-3) were used. Each well consists of 10 
active electrodes at the bottom of the dish (250 µm diameter each), electrically in parallel. 
Before cell culturing the arrays were cleaned for 5 min in an argon plasma cleaner (Harrick, 
New York) and the electrodes were immersed with an aqueous solution of L-cysteine 
 
A B 
 
 
Rb 
CPE 
CM 
Rbulk 
Figure 8-2. Setup for electric cell substrate sensing (ECIS).  
A: The cells are cultured directly on gold electrodes. The working electrode is 300-fold smaller than 
the counter electrode. Thus, the working electrode becomes a bottle neck for the current and the 
electrical impedance of the system is dominated by the cells grown on the this electrode.  
B: Equivalent circuit (approximation). This model allows the determination of the parameters  , Rb 
and CM.  
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(10 mM) to stabilise the interface impedance. Afterwards the electrodes were washed and 
coated with collagen-G, synthetic extracellular matrix proteins (laminin, fibronectin and 
collagen type IV obtained from Sigma (St. Louis, USA), or in vitro- derived ECM from glia 
or other (aorta or brain) endothelial cells and lysed as described in section 8.1.6. The non-
occupied binding sites on the electrode surfaces were quenched with a solution of 1% heat-
inactivated BSA in PBS for 1 hour (Form, 1986; Madri, 1988). Following this, the electrodes 
were washed 3 times with sterile PBS and the cells were trypsinised as described in section 
8.1.2. The trypsinisation process was terminated by the addition of soybean trypsin inhibitor 
(Sigma). Cell density was monitored after centrifugation by using a standard hemacytometer 
and 300,000 cells were seeded into each chamber. Directly after seeding the arrays were 
placed into the array holder, electrical contact was established and the measurement was 
started.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Analysis of the data. The analysis of the data allows conclusions about the resistance Rb 
between adjacent cells, which is a measure for the integrity and barrier function of the layer, 
the parameter    which describes contribution to the impedance from the cell substrate 
adhesion zone and the capacitance of the cell membrane (CM). Together, these parameters 
permit the characterization of the barrier and adhesion properties of the cells in one 
experimental setup. 
 
 
 
Figure 8-3.  ECIS electrode in 8-well format (8W10E, Applied BioPhysics, Troy, NY).  
Each array consists of 8 wells with 10 electrodes per well in parallel. 
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8.1.9 Transmission electron microscopy (TEM) 
 
While the resolution of light microscopy is restricted by the wavelength of visible light (400-
700 nm), TEM permits to observe cellular structures within the range of the wavelength of 
electrons. Electrons can reach wavelengths as low as 1 pm. Practically, the resolution in 
ultrathin sections of biological samples is around 1 nm.  
For transmission electron microscopy the cells were cultivated as described in section 8.1.2, 
8.1.3 and 8.1.4 onto collagen I+III mixture coated Petri flasks. Fixation and embedding were 
performed as follows: the cells were washed twice with PBS++ and fixed for a minimum of 
1 h in sodium cacodylate buffer (0.1 M sodium cacodylate, 2.5% glutaraldehyde, 2 mM 
CaCl2) at room temperature. Afterwards, the specimen were washed with ddH2O (30 min, 
shaker) and incubated for 45 min at room temperature in 0.5 % (w/v) OsO4 solution in sodium 
cacodylate buffer) followed by a second washing step for 30 min in ddH2O. Subsequently, the 
samples were dehydrated by incubation in 75% (v/v) ethanol, 2 x 100% ethanol and finally 
propylene oxide for 5 min each. After incubation in a mixture of propylene/epon (1:1) for 
30 min the specimen were incubated in pure epon for 15 min. Finally, the samples were 
embedded in a pure epon containing mold and dried for 24-48 h at 60°C. Ultrathin sections 
were examined and photographed using a Philips EM 201. 
PBS++    140 mM  NaCl 
    2.7 mM KCl 
    8.1 mM Na2HPO4 
    1.5 mM KH2PO4 
0.5 mM MgCl2 
0.9 mM CaCl2 
 
8.1.10 Fluorescence activated cell sorting (FACS)  
 
The fluorescence-activated cell sorting (FACS) is a powerful technique used in flow 
cytometry for the separation and identification of specific types of cells from heterogeneous 
populations. The cells in a suspension are labeled with a fluorescent dye in order to provide 
the sorting in a FACS machine. The dye is selected to covalently bind to the antibodies of the 
particular cells that are to be separated from the conglomeration. The final single-cell 
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suspension with marked cells is then mixed with a buffer solution known as the sheath fluid. 
Once labeled, the cells are forced to flow rapidly through the FACS instrument where they are 
excited by light from a focused laser beam. Each cell scatters some light and the labeled cells 
generate fluorescence signals from the dye. The charged single drops containing the cells of 
interest emerge from a nozzle and pass between two high voltage deflection plates and are 
thereby separated into a collection tube from the other unmarked cells. In the present study 
FACS was used in the determination of the integrins as a particular endothelial cell receptors. 
The PBCECs were isolated as described in section 8.1.1 and 8.1.2 and cultured until reaching 
confluence. Afterwards, the cells were washed twice with PBS and detached with trypsin 
solution (0.25 % w/v) (see section 8.1.2). The trypsinization of the cells was stopped by a 
trypsin inhibtor as described in section 8.1.8. After the centrifugation the cells were counted 
using a standard hemacytometer and the cell density was adjusted to 1-1.5 Mio cells per ml of 
PBS solution. The cells were incubated for 20 min at 4°C in PBS containing 1% BSA to block 
the unspecific binding sites of the proteins. The primary antibody was applied for 1h at 4°C in 
an appropriate dilution (see table 9-6). The cells were then washed three times with cold PBS 
and incubated for 1h with FITC- or TRITC-conjugated secondary antibody (see table 9-7) at 
4°C. After three washing steps in PBS, the cells were resuspended in 500µl of PBS and the 
cell fluorescence signals were determined immediately after staining using a FACS flow 
cytometer equipped with an argon laser (emission 488 nm, Beckman Coulter, Germany). The 
analysis was performed using Expo32ADC software. A primary gate based on physical 
parameters (forward and side light scatter, FSC and SSC, respectively) was set to exclude 
dead cells or debris. The background level was estimated by omitting the primary antibody. 
The cell type specifity and purity of the primary endothelial cell culture was determined with 
the help of PECAM-1 antibody by excluding the contaminating cells with an addition of 
puromycin into the cell culture.  
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Table 8-1. Primary antibodies used in FACS. 
Antibody dilution (in PBS, 0.5% (v/v) BSA) 
Mouse anti human VLA-2 (α2β1) integrin BHA 2.1 (Chemicon International) 1:100 (10 µg/ml) 
Mouse anti human VLA-5 (α5β1) integrin HA5 (Chemicon International) 1:100 (10 µg/ml) 
Mouse anti human (α1β1) integrin A61 (Münster Klinikum, Dr. J. Eble) 1:100 (10  µg/ml) 
Mouse anti rat CD31 (PECAM-1) (Chemicon International) 1:100 (10 µg/ml) 
Rabbit anti human integrin α3 (polyclonal antiserum) (Chemicon International) 1:100 (10 µg/ml) 
Rat anti human β1 integrin 9E67 (Münster Klinikum, Dr. J.Eble) 1:100 (10 µg/ml) + 1 M MnCl2 
Rat anti human α6 integrin GOH3 (Chemicon International) 1:100 (10 µg/ml) 
Mouse anti human α3 integrin A3IIF5 (Ak Bruckner, Dr. Eble) 1:100 (10 µg/ml) 
 
Table 8-2. Secondary antibodies used in FACS 
 
Antibody dilution (in PBS, 0.5% (v/v) BSA 
Anti-mouse Alexa 488 1:1000 (20 ng/ml) 
Anti-rat Alexa 488 1:1000 (20 ng/ml) 
Anti-rabbit Alexa 488 1:1000 (20 ng/ml) 
 
 
8.2 Protein biochemistry  
 
For protein isolation the cells were cultured as described in 8.1.2, 8.1.3 and 8.1.4. Cells were 
either passaged before protein isolation, or took after reaching a confluent cell monolayer 
without subculturing the cells. Protein were isolated after two days in chemically defined 
medium with hydrocortisone supplementation. 
 
8.2.1 Isolation of proteins from cultured cells  
 
Isolation of the whole protein amount. Cells were washed three times with PBS, covered 
with SPBS-solution, scratched with a rubber policeman and collected in a clean tube. All 
steps after the washing were performed on ice to avoid protease activity. After centrifugation 
(4°C, 400 x g, 10 min) the supernatants were discarded and the pellets were resuspended in 
100 µl SPBS buffer containing protease inhibitor. The cells were homogenised by pipetting 
up and down with a syringe, diluted with 100 µl SDS (2x) and denatured for 5 min at 95°C in 
order to destroy the nucleic acids present in the whole protein lysate. The protein solutions 
were stored at –20°C. 
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SPBS    50 mM NaPi (pH 7.4) 
150 mM NaCl 
0.32 M Sucrose 
1 mM  Na-EDTA 
Protease Inhibitor Cocktail® (Boehringer Mannheim) 
 
Isolation of the components of ECM. In order to characterize the ECM proteins 
secreted beneath the cells, they were washed twice with PBS and then incubated with 20 mM 
ammonia in deionised water (2 x 5 min) followed by washing with PBS (7-10 x). The matrix 
then was solubilised in scraping buffer and transferred into eppendorf tubes and lyophilized 
(Gospodarowicz, 1984; Wagner and Gardner, 2000). The lyophilized probes were 
resuspended in an appropriate amount of SPBS supplemented with protease inhibitor and used 
for further isolation procedure as described in section 8.2.1 above.  
 
 
Scraping buffer  10 mM Tris/HCl (pH 7.5) 
100 mM mercaptoethanol 
0.1%   SDS 
8.2.2 Determination of protein concentration  
 
In order to determine the protein concentration of the isolated solubilized proteins the method 
developed by Bradford was used (Bradford, 1976). It involves the addition of an acidic dye to 
the protein solution and uses measurements at 595 nm with a spectrophotometer. Comparison 
to a standard curve provides a relative measurement of protein concentration. Bio-Rad protein 
assay is a dye-binding assay in which a differential colour change of a dye occurs in response 
to various concentrations of protein. The absorbance maximum for Commassie Brilliant Blue 
G-250 dye shifts from 465 nm to 595 nm when binding to protein occurs. 
 
8.2.3 SDS-polyacrylamide gel electrophoresis  
Discontinuous polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 1970) was 
performed in order to separate complex mixtures of proteins according to their size. SDS-
containing sample buffer by heating up to 100°C denatures the proteins to give a so-called 
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random-coil conformation. SDS also masks the intrinsic protein charge and gives a negative 
charge to all proteins which is proportional to their molecular weight. When loaded to a gel 
matrix and placed into an electric field, the negatively charged proteins migrate towards the 
anode and are separated by a molecular sieving effect. Discontinuous gels contain a short 
stacking gel with a low percentage of acrylamide to concentrate the sample followed by a 
resolving gel with a higher percentage of acrylamide. The degree of protein separation 
depends on the concentration of polyacrylamide, and so the concentration of the separating 
gel must be chosen according to the expected molecular weight of the sample proteins 
(table 8-3). Before gel electrophoresis protein samples were denatured for 10 min at 100°C in 
Laemmli sample buffer. For a 6 cm x 8 cm gel, electrophoresis was performed with 1 x 
electrophoresis buffer at 20 mA per gel. Experimental conditions for SDS-PAGE are listed in 
Table 8-4. 
 
Table 8-3. Acrylamide concentration for separation of proteins  
 
 
 
Table 8-4. Compounds of SDS-gels.  
 
 
 
 
 
 
 
Laemmli sample buffer (3 x)  30% (v/v)  glycerol 
     15% (v/v)   -mercaptoethanol 
     6% (w/v) SDS 
     37.5% (v/v) 0.4% (w/v) SDS, 0.5 M Tris/HCl, pH 6.8 
     small amount of bromphenol blue 
 
Electrophoresis buffer  0.25 M Tris/HCl 
     0.1 M  glycin 
     10% (w/v) SDS 
 
Resolving gel (% acrylamide) 6 8 10 12 15 
Molecular weight range (kDa) 30-200 20-175 15-150 10-100 6-50 
 
Stacking gel 
4% 
Resolving gel 
8% 
ddH2O 1.85 ml 2.9 ml 
0.4% (w/v) SDS, 1.5 M Tris/HCl, pH 8.8 0.75 ml - 
0.4% (w/v) SDS, 0.5 M Tris/HCl, pH 8.8 - 1.5 ml 
Acrylamid / bisacrylamid (37.5 /1) 0.5 ml 1.6 ml 
TEMED 20 µl 20 µl 
APS (10% (w/v) 12 µl 12 µl 
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8.2.4 Coomassie Blue staining 
 
The location of proteins in a gel was determined by Coomassie Blue staining. This detection 
method depends on non-specific binding of the dye Coomassie Brilliant Blue R to proteins. 
The detection limit is 0.3 to 1 µg per protein band. Proteins separated in a polyacrylamide gel 
were stained using a solution containing 25% (v/v) isopropanol, 10% (v/v) acetic acid and 
0.05% (w/v) Coomassie Brilliant Blue for 30 min. For destaining, the gel was agitated in 
10% acedic acid until the blue protein bands were visible against the clear background. 
 
8.2.5 Protein blotting and immunodetection 
 
The proteins were detected by separating the protein samples by SDS-polyacrylamide-gel 
electrophoresis (section 8.2.3) and transferring them onto a nylon membrane (Hybond, 
Amersham Biotech) by semi-dry blotting. Thus, the proteins become immobilized and 
accessible for antibodies. The nylon membrane was pre-wetted with transfer buffer and the 
gel was placed onto the membrane. The gel and the membrane were positioned between the 
transfer buffer pre-wetted Whatman™ paper and an electrical field (0.5 mA/cm2) was applied 
for 20 hours. Subsequently, the membrane was washed 3 times with H2O and rests of the gel 
were removed. Phosphate buffer saline (PBS) with 0.05 % Tween-20 (PBST) (as a detergent), 
supplied with a 5% milk solution, was applied for 30 minutes to block non-specific binding 
sites. The primary antibody was applied in an appropriate dilution (see table 8-5) in 
0.5% milk (w/v) solution for 1h. The membrane was washed again three times in PBST and 
the secondary POD-labelled antibody was applied for 30 min in 0.5% milk solution 
(table 8-5). The detection of the signal was performed by applying Amersham Biosciences 
Innovative ECL Kit™ (Amersham) and exposition to Hyperfilms (Amersham Biotech). The 
protein loading was determined by Protogold Detection Kit™. For this reason the membrane 
was washed in H2O and incubated overnight in Protogold solution.  
Transfer buffer:   20 mM  Tris 
150 mM  Glycin 
0.1%(w/v)  SDS 
20% (v/v)  Methanol 
PBS-T buffer      PBS 
0.05% (v/v)   Tween-20 
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8.2.6 Stripping of nitrocellulose membranes  
 
The antibodies applied to the membrane in western blot experiments could be removed by 
incubation with stripping buffer. Afterwards, the membrane with immobilized protein probes 
could be used for further immunological analysis with further antibodies. Therefore, the 
membrane was washed 3 x 10 min with PBST buffer to remove all remaining ECL solution. 
The membrane was incubated in stripping buffer for 90-120 minutes and washed again 3 x 
10 min with PBS-T. The complete removal of the antibodies from the membrane has been 
checked by the ECL detection. Before the application of the first antibody the membrane was 
washed 10 minutes with PBST again and further used as already described in section 8.2.5. 
 
stripping buffer   200 mM Glycin 
     0.1% (w/v) SDS  
     1% (v/v) Tween 20 
     pH 2.2 
 
Table 8-5. Antibodies for western blotting 
Primary antibody dilution (in 0.5% milk (w/v); 0.05%TWEEN (v/v) in PBS) 
Rabbit anti-occludin (Zymed) 1: 1000 (0.25 mg/L) 
Rabbit anti-claudin 5 (Calbiochem) 1: 1000 (0.25 mg/L) 
Rabbit anti-ZO1 (Zymed Laboratories) 1:1000 (0.25 mg/L) 
Rabbit anti collagen type IV (Albiochem) 1:500 (0.5 mg/L) 
Mouse anti fibronectin (Dunn laboratories ) 1:500 (0.5 mg/L) 
Mouse anti-laminin (Dunn Laboratories) 1:500 (0.5 mg/L) 
Mouse anti-MMP-2 (Calbiochem) 1:500 (0.2 mg/L) 
Mouse anti-MMP-9 (Calbiochem) 1:500 (0.2 mg/L) 
Mouse anti-TIMP-1(Calbiochem) 1:500 (0.2 mg/L) 
Secondary antibody Dilution (in 0.5% milk (w/v); 0.05%TWEEN (v/v) in PBS) 
Goat anti-mouse (POD) (Sigma) 1:3000 (0.35µg/L) 
Goat anti-rabbit (POD) (Chemicon) 1:3000 (0.53 µg/L) 
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8.2.7 Immunocytochemistry 
 
For immunofluorescence studies, the cells were plated on either collagen-G coated coverslips 
placed into 12 well-plates or, alternatively, on rat tail collagen coated microporous 
polycarbonate filter membranes. In the latter case, all experimental steps (until the 
embedding) were performed on the filter-inserts placed in 12-well plates. The cells were 
washed twice with PBS before fixation was performed by adding 250 µl 4% (v/v) 
paraformaldehyde (PFA) followed by an incubation period of 10 min at room temperature 
(RT). Before incubation with the primary antibody, the fixed cells were washed 5 times with 
PBS and non-specific binding-sites were blocked for 20 min at room temperature in PBS 
supplemented with 3% (v/v) NGS and 0.1% (v/v) TRITON-X-100. Afterwards, the primary 
antibody diluted in PBS supplemented with 0.3% (v/v) NGS and 0.1% (v/v) TRITON-X-100, 
was added and the specimen were incubated for 1 h at room temperature. For the dilution of 
the primary antibodies see table table 8-6. Both antibodies were centrifuged at 15000 rpm for 
5 min to avoid antibody precipitations. After incubation, probes were washed with PBS and 
blocked with 10% (v/v) NGS (in PBS) before the secondary antibody (table 8-7) was applied 
in a 1:1000 dilution in PBS containing 3% NGS followed by a 30 min incubation at RT. After 
further washing (2x with PBS) cells were postfixed with 4% (v/v) PFA for 10 min at RT. The 
fixative was removed by washing 5 times with PBS and cover slips or filters were then shortly 
treated with ddH2O and dried on Kimwipes®. For embedding, one drop of Paramount 
(Polysciences) was placed onto an optical slide and the coverslip was then put face down onto 
the slide. Filters membranes were excised from the inserts, transferred to the optical slide and 
allowed to settle. The samples were stored at 4°C in darkness to prevent bleaching of the 
fluorophores. Normally, the detection was performed 48 h after embedding of the cells, either 
by epifluorescence or laser scanning microscopy. Otherwise samples were stored at 4°C. 
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Table 8-6. Primary antibodies used in immunofluorescence staining 
Antibody dilution (in PBS, 0.3% (v/v) NGS, 0.1% (v/v) TRITON-X-100) 
Rabbit anti-Occludin (Zymed Laboratories) 1:200 (1.25 µg/ml) 
Mouse anti-Occludin (Zymed Laboratories) 1:200 (2.50 µg/ml) 
Rabbit anti-Claudin 5 (Zymed Laboratories) 1:100 (2.5 µg/ml) 
Rabbit anti-ZO1 (Zymed Laboratories) 1:100 (2.5 µg/ml) 
Rat anti-ZO1 (Chemicon International) 1:100 (2.3 µg/ml) 
Rabbit anti-GFAP (Sigma) 1:80 (1.25 µg/ml) 
Mouse anti-   -sm-Actin (Zymed) 1:100 (81 µg/ml) 
Rabbit anti collagen type IV (Albiochem) 1:500 (0.5 mg/L) 
Mouse anti fibronectin (Dunn laboratories ) 1:500 (0.5 mg/L) 
Mouse anti-laminin (Dunn Laboratories) 1:500 (0.5 mg/L) 
Mouse anti-MMP-9 (Calbiochem) 1:500 (0,2 mg/L) 
Mouse anti-TIMP-1 (Calbiochem) 1:500 (0.2 mg/L) 
Table 8-7. Secondary antibodies used in immunofluorescence staining 
Antibody dilution (in PBS, 0.3% (v/v) NGS, 0.1% (v/v) TRITON-X-100) 
Anti-mouse FITC (Mobitec) 1:1000 (20 ng/ml) 
Anti-mouse TRITC (Mobitec) 1:1000 (20 ng/ml) 
Anti-rat TRITC (Mobitec) 1:1000 (20 ng/ml) 
Anti-rabbit FITC (Sigma) 1:1000 (20 ng/ml) 
Anti-rabbit TRITC (Sigma) 1:1000 (20 ng/ml) 
 
fixing solution  4% (w/v) paraformaldehyde (in ddH2O) 
 
blocking solution  10% (w/v) new-born goat serum 
    0.5% (v/v) Triton X-100 
    1% (w/v) bovine serum albumine 
 
antibody incubation solution 3% (w/v) new-born goat serum 
    0.5% (v/v) Triton X-100 
    0.1 % (w/v) NaN3 
    1% (w/v) bovine serum albumine 
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8.2.8 Zymographic analysis 
 
The secretion of MMP molecules was investigated by zymographic analysis in the cell culture 
supernatants (Woessner, 1995; Kleiner, 1994). 8 µl of undiluted medium supernatant were 
mixed with 8 µl of non-reducing sample buffer and applied to 10% SDS-PAGE (see section 
8.2.3). The gels were prepared with a final concentration of 0.1% (w/v) gelatine. MMP-
Control-1 (Sigma-Aldrich, Taufkirchen, Germany) (0.1 µl) was used as a positive control. 
MMP-Control-1 is a concentrated medium supernatant of a serum-free culture of human skin 
fibroblasts. It contains MMP-1, -2, -3, and -9. In order to remove the remaining SDS and to 
re-establish the enzymatic activity of the probes after the electrophoresis, the gels were 
shaken 2 x for 30 minutes in 50 ml of renaturation buffer. Afterwards, the gels were washed 
4-5 x in deionised H2O followed by 5 min incubation in 25 ml of developing buffer. The 
activity of the enzymes was stimulated over night at 37°C by shaking the gels in 75 ml of 
developing buffer. The activity of the MMP molecules present in the probes led to the 
degradation of the gelatin according to the size of correspondent molecules in the gel. The 
digestion was stopped by application of fixation buffer for 30 min at room temperature. For 
the detection of the signals, the gels were incubated for 30 min in 0.25% (w/v) Coomassie 
Brilliant Blue solution. After 30 min of washing with color stripping buffer 1 and 2 
respectively, the gels were scanned and incubated for another 30 min in gel dry solution for 
storing the gels. 
 
Sample buffer for zymography (2x) 126 mM Tris/HCl (pH 6.8) 
     20% (v/v) Glycerin 
     4% (w/v) SDS 
     2 mM EDTA 
0.01% (w/v) Bromphenolblue 
Renaturation buffer   2.7% (w/v) Triton-X 100 
 
Developing buffer    50 mM Tris 
     200 mM NaCl   
     5 mM CaCl2  
     0.02% (v/v) Brij-35     
     pH 7.5 
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Staining buffer    0.25% (w/v) Coomassie Brilliant Blue 
     25% isopropanol (v/v) 
     10% acetic acid (v/v)  
 
Stripping buffer I   50% methanol (v/v) 
     10% acetic acid (v/v) 
 
Stripping buffer II   10% methanol (v/v) 
     10% acetic acid (v/v) 
 
8.2.9 Fluorimetric measurement of the activity of MMPs in the supernatant of 
the cell cultures 
 
Principle. The activity of MMP could be determined directly in the cell culture by the 
application of the fluorogenic MMP substrate MCA-PRO-LEU-GLY-LEU-DPA-ALA-ARG-
NH2 (Calbiochem, Bad Soden; Fluorophore: MCA = (7-Methoxyco-umarin-4-yl) acetyl; 
Quencher: DPA = N-3-(2.4-Dinitrophenyl)-L-2,3-diaminopropionyl). The method is based on 
a protocol of (Knight et al., 1992). The quencher DPA is separated from the fluorophore 
MCA by the enzymatic hydrolysis of the peptide bound between glycine and the following 
leucine catalysed by MMPs. The time course of the increase of the fluorescence intensity 
reflects the MMP activity in the sample. 
Application.  1 ml of stock solution of fluorogenic peptides in methanol (used as a substrate) 
was diluted in assay buffer to achieve the final concentration of 10 µM. 60 µl of the cell 
culture probes were mixed with the same volume of substrate to reach a final concentration of 
5 µM. The fluorescence intensity of the mixture was measured in a termostated cuvette at 
37°C (fluorescence spectrometer (LS 50 B, Perkin Elmer, Überlingen). The calibration was 
carried out with assay buffer. As a negative control culture medium was mixed with substrate 
solution as described before. The enzymatic hydrolysis of the DPA resulted in an increasing 
intensity of fluorescent degradation product (MCA-PRO-LEU-GLY-OH; λ ex=328 nm; 
λem =393 nm). The measured fluorescence intensities were taken for 15 min against the time 
and a linear fit was applied. The slope is a measure of the MMP activity in the samples. Due 
to the slight pale of the fluorophore MCA appearing during the measurements, the results 
were calibrated with the negative control. 
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Assay buffer    NaCl  200 mM 
     Tris  50 mM 
     CaCl2  5 mM 
     ZnSO4  20 µM 
     Brij-35 0.05% (v/v) 
       pH 7.4 
 
 
8.3 Molecular biology 
 
All devices, solutions, pipette tips and reaction tubes were sterilized by routine sterilization 
techniques. Only chemicals of molecular biology grade were used. When working with RNA 
material, solutions were treated additionally with 0.1 % (v/v) dimethylpyrocarbonate (DMPC) 
to inactivate RNases. Glassware was treated at 200°C for at least 4 h and gloves worn during 
all RNA preparations and handlings. 
8.3.1 Quantification of nucleic acids 
 
Photometric determination of nucleic acid concentrations. Concentrations of nucleic 
acids were measured with an UV-VIS recording spectrophotometer (UV-2401PC, Shimadzu) 
at a wavelength of 260 nm, which is most suitable for RNA/DNA quantification due to the 
absorbance of purine and pyrimidine bases. Using a 1 cm cuvette the optical density at 
260 nm (OD260) corresponds to 40 µg/ml of single stranded RNA and to 60 µg/ml of double 
stranded DNA.  
The purity of isolated nucleic acids was determined by measuring the optical density at 
280 nm where the aromatic amino acids of proteins show the highest degree of absorbance. 
The ratio OD260/OD280 is supposed to be between 1.8 and 2.1 for RNA dissolved in buffer 
with pH > 7 and about 1.8 for DNA. 
Determination of concentrations by ethidiumbromide staining. The quantity of 
DNA, especially when used for cloning, was estimated on ethidiumbromide stained agarose 
gels with the help of commercially available DNA ladders from Eurogentech. The 
SMART-ladder contains definite amounts of DNA in each visible band to which the intensity 
of analysed DNA sample was visually compared and thus, the amount of DNA of the sample 
could be estimated.  
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8.3.2 Agarose gel electrophoresis 
 
Nucleic acids can be separated according to their size in an agarose gel electrophoresis. The 
concentration of agarose was varied according to the expected size of the DNA fragments in 
order to obtain optimal separation results (table 8-8). To guarantee that the nucleic acids move 
in the electrical field to the anode the electrophoresis must be performed at almost neutral pH. 
Therefore, 1 x TAE-buffer for non-denaturing gels (DNA) and 1 x MEA-buffer for denaturing 
gels (RNA) were used. In case of DNA gels, variable amounts of agarose were directly 
dissolved in 1 x TAE-buffer by heating in a microwave oven, whilst for RNA gels 1% (w/v) 
agarose was first dissolved in DMPC treated water. Afterwards, 10 x MEA and a 
37% solution of formaldehyde were added to a final concentration of 1 x MEA and 6% (v/v) 
formaldehyde. Prior to electrophoresis the samples were diluted in DNA- or RNA-loading 
buffer. Furthermore, RNA samples were denatured for 10 min at 65°C and both formaldehyde 
and formamide present in the loading buffer inhibited further formation of RNA secondary 
structures. To determine the size of DNA fragments, DNA ladders (Life Technologies and 
Eurogentech) were used. Gel electrophoresis was performed at 100 V. Nucleic acid fragments 
were visualised by using UV-light (254 nm) and ethidiumbromide as a dye. In case of DNA 
separation, gels were stained after electrophoresis in ethidiumbromide containing solution 
(0.5 mg/ml in 1 x TAE-buffer, while for RNA-visualisation 1 µl of an ethidiumbromide 
solution (1 mg/ml) was directly added to the samples prior to loading.  
Table 8-8. Concentrations of agarose gels 
agarose concentration (% w/v) 0.3 0.6 0.8 1.0 1.2 1.5 2.0 
nucleic acid range (kb) 5-60 1-20 0.8-10 0.5-5 0.4-7 0.2-3 0.1-2 
 
50 x TAE   2 M  Tris 
    2 M   sodium acetate 
    0.5  EDTA 
      pH 7.4-7.8 
 
10 x MEA   0.01 M EDTA 
    0.2 M  MOPS 
    0.05 M sodium acetate 
      pH 7.0 
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10 x DNA-loading buffer 0.25 % (w/v) bromophenol blue 
    0.25 % (w/v) xylene cyanole 
    15 % (v/v) Ficoll 
 
1 x RNA- loading buffer  50 % (v/v) formamide de-ionised 
    10 % (v/v) 10 x MEA 
    16 % (v/v) 37 % formaldehyde 
    5 % (v/v) glycerol 
    0.25 % (w/v) bromophenol blue 
 
8.3.3 Isolation of DNA from agarose gels 
 
Gel extraction of DNA fragments was performed by using the QIAquick Gel Extraction Kit 
(Qiagen) according to the manufacturer´s instructions. The DNA fragments were excised 
from agarose gel, weighted and dissolved in 3 gel volumes of Buffer QG at 50°C for 10 min 
(1 mg ~ 1 µl). Afterwards, one gel volume of isopropanol was added and the DNA was 
purified by using a QIAquick spin column. DNA may adsorb to the silica membrane in the 
presence of a high concentration of chaotropic salts at pH<7.5, while contaminants pass 
through the column and are efficiently washed away. The pure DNA was then eluted by 30-
50 µl of 10 mM Tris/HCl (pH 8.5). Concentrations of purified DNA fragments were 
determined as described in section 8.3.1. 
 
8.3.4 Isolation of plasmid DNA 
 
For different applications such as PCR, restriction digest and sequencing, plasmid DNA was 
isolated from E. coli. The QIAprep Spin Miniprep (Qiagen) was used to isolate plasmid DNA 
from E. coli cultures grown overnight in LB-medium containing ampicillin. The isolation 
procedure is based on the principle of alkaline lysis of the cells, precipitation of genomic 
DNA, onto silica in the presence of high salt concentrations. The procedure was performed 
according to the manufacturer’s instructions given in the manual.  
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8.3.5 Isolation of RNA 
 
Total RNA from cultured cells was isolated using commercially available kits. For the 
isolation from porcine brain capillary endothelial cells, the High Pure RNA Isolation Kit® 
(Roche) was applied according to the instructions given in the manual.  
The cells were washed with PBS before lysis was carried out by incubating the sample with 
400 µl Triton® X-100 and guanidine hydrochloride containing lysis/binding buffer to 
inactivate RNases. Cells were detached with a rubber policeman and collected in a clean 
RNase-free tube. The cell suspension was applied to the filter tube where RNA binds to the 
surface of glass fibres in the presence of chaotropic salts. The binding process is specific for 
nucleic acids and optimised here for RNA. The rest of the contaminating DNA was digested 
by DNase I, applied directly onto the glass fibre and incubated for 15 min at room 
temperature. The bound RNA was then purified from salts, proteins and other cellular 
impurities by three washing steps and was finally eluted in 60 - 100 µl RNase-free water. The 
purity of the RNA was checked by OD260/OD280-ratio (see section 8.3.1). RNA was quantified 
by measuring the OD260 and stored at -70°C. 
 
8.3.6 cDNA synthesis 
 
cDNA was transcribed from 5 µg of total RNA using Superscript™ II RNase H+ Reverse 
Transcriptase (Life Technologies™). The reaction mix was supplemented with accompanied 
5 x First Strand Buffer and 0.1 M DTT as well as a primer mix. To synthezise cDNA for 
amplification of gene fragments, an oligo (dT)12-18 (500 µg/ml) and a random primer mix 
were applied for cloning and TaqMan Realtime PCR, respectively. 1 µl primer solution was 
added to the RNA sample to a final volume of 12 µl and incubated for 10 min at 25°C first in 
case of random primer and then for 20 min at 50°C. The first incubation was skipped when 
using oligo (dT) primer. Then the sample was denaturated at 65°C to dissolve secondary 
structures and immediately chilled on ice. 4 µl First Strand Buffer, 2 µl 0.1 M DTT and 1 µl 
dNTP mix (10 mM dATP, dCTP, dGTP, dTTP, respectively) were added and incubated at 
42°C for 2 min before 1 µl (100 units) of SuperScript II™ was added. cDNA synthesis was 
performed at 42 °C for 50 min and finished by inactivation of the enzyme  at 70°C for 15 min. 
The cDNA pool was either used directly for Real-Time PCR or stored at -20°C. 
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8.3.7 Polymerase chain reaction methods 
8.3.7.1 PCR 
The polymerase chain reaction (PCR) was applied to amplify DNA fragments using two 
specific primers complementary to the ends of the desired DNA fragment. As templates either 
plasmid DNA or cDNA pools were used. All primers and their annealing temperatures are 
listed in appendix E. PCR using plasmid-DNA was performed to generate enough material for 
perfoming northern blots. In these cases the thermostable Taq DNA polymerase™ (Life 
technologies) was used as follows: 5 µl in a reaction volume of 50 µl 10 x PCR buffer and 
1.5 µl 50 mM MgCl2 (both provided by the manufacturer), 2 µl dNTP mix (10 mM for each 
nucleotide), 0.5 µl of 5´- and 3´-primer (10 µM), 0.5 µl plasmid DNA (approx. 0.2 µg/µl), 
40.5 µl ddH2O, and finally, 0.5 µl of Taq DNA polymerase were gently mixed and incubated 
in the mastercycler gradient (Eppendorf). The PCR was performed according to the following 
program: 3 min initial denaturation at 95°C, 30 cycles of 30 sec denaturation at 95°C, 1 min 
annealing of the primers at specific temperatures (listed in appendix E) and 1.5 min 
elongation at 72°C. Afterwards the mixture was incubated for 5 min at 72°C for complete 
elongation of PCR fragments and finally stored at 4°C. PCR products were then analysed by 
agarose gel electrophoresis (section 8.3.3), purified from agarose gels (section 8.3.3), 
quantified (section 8.3.1) and used either for probing in northern blotting or cloning. 
 
8.3.7.2 Quantitative real-time polymerase chain reaction (QRT-PCR) 
 
TaqMan Real-time PCR was performed to determine the quantity of specific mRNA targets 
within isolated RNA (section 8.3.5). Comparable to northern blot analysis this method is used 
to quantify the mRNA expression of different RNA species of interest. This method is very 
sensitive and the required amount of RNA is lower than in northern blot analysis. Real time 
PCR is a two step RT-PCR system. In the first step the RNA is transcribed by reverse 
transcriptase to complementary DNA (cDNA) by applying random primer mix as described in 
paragraph (8.3.6). The following second step is based on the polymerase chain reaction 
technology combined with a fluorescence detection system. Special dyes intercalate into DNA 
during the amplification of the targets and allow a determination of differences in the quantity 
during the exponential phase of amplification. Due to the fact that the applied dye intercalates 
unspecifically into double stranded DNA, it is obliged to use primers with special standards. 
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A reliable quantitative comparison of two independent sequences (target and house keeping 
gene) demands a similar efficiency of amplification in the exponential phase of amplification. 
Primers were chosen regarding the following criteria: The GC-content was between 40-60% 
and the length of oligonucleotides corresponded to 15 to 25 base pairs. For all primers the 
melting temperature was 60°C. Primers were chosen using the software Primer Express 
(version 2.0; Applied Biosystems). 
 
8.3.7.2.1 TaqMan SYBR-Green PCR protocol 
 
20 µl of the RT-product obtained as described in section 8.3.6 were diluted 1:1 with DMPC-
ddH2O. 2.5 µl of this dilution were applied to the reaction mix containing 7.88 µl SYBR-
Green universal PCR Master Mix™ (PE Biosystems), 3 µl of 5´- and 3´-primer (5 µM each) 
and 9.77 µl DMPC-ddH2O (all primers are listed in appendix E). The SYBR-Green universal 
PCR Master Mix™ contains reaction buffer, dNTPs, MgCl2, AmpliTaq Gold DNA-
polymerase and two fluorescence dyes, the reporter dye SYBR-green which intercalates with 
DNA and a reference dye whose fluorescence properties are not influenced by amplification 
of DNA. The fluorescence of the reporter dye is normalized to the reference dye to avoid 
falsification of fluorescence fluctuation. The TaqMan-PCR was performed using a 
GeneAmp 5700 (PE Biosystems; software version 1.3) according to the following program: 
initial denaturation at 95°C for 10 min, 40 cycles of denaturation at 95°C for 15 sec followed 
by hybridisation and finally elongation at 60°C for 60 sec completed by a final elongation at 
60°C for 15 min. To check the specifity of the obtained DNA fragment the amplification 
protocol was followed by dissociation at 95°C for 15 sec and hybridization at 60°C for 20 sec. 
The final slow heating process from 60 to 90°C was detected by fluorescence signal and when 
a distinct signal was present the obtained amplification signals could be assumed as the 
specific estimated targets. 
8.3.7.2.2 Analysis of quantitative Real-Time PCR data 
 
To analyse real-time PCR data, a relative quantification of target genes was performed by 
determing the amount of specific targets in one cDNA-population compared to another cDNA 
population. cDNA populations were transcribed from RNA obtained from cells cultivated on 
the control flasks coated with collagen type I+III in comparison to cells cultured on the 
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endogenously derived ECM. All target genes were compared from RNA obtained from the 
cells cultured under serum-free conditions with hydrocortisone supplementation. Fluorescence 
values are recorded during every cycle with a CCD camera and represent the amount of 
product amplified up to that point in the amplification reaction by determination of the 
intensity of SYBR-green fluorescence. The fluorescence intensity of this dye increases by 
intercalation into the small groove of double-stranded DNA. The more templates present at 
the beginning of the reaction, the fewer number of cycles it takes to reach the point in which 
the signal is first recorded statistically significant above background (Gibson, 1996). This 
point is defined as the threshold cycle (Ct) and will always appear during the exponential 
phase of amplification (figure 8-4). Therefore, quantification is not affected by any reaction 
components becoming limited in the plateau phase. 
 
 
Figure 8-4.  Semilog diagram of the fluorescence signal intensity versus cycle.  
Ct is the number of the cycle where the fluorescence intensity is first recorded as significant above 
background in the exponential phase of amplification.   Ct gives the difference of fluorescence 
intensity corresponding to an internal reference gene (  -actin or GAPDH). 
 
To correct for the varying quality of applied nucleotides, the results of the target genes were 
compared with those of an internal reference gene. Moreover, the PCR buffer contains a 
fluorescence dye (ROX) which allows to normalise fluctuations of the fluorescence intensity 
of SYBR-green. 
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For preliminary analysis of the expression of target genes, the cycle values of specific targets 
were compared. The latter are correspondent to the normalized starting quantity of target 
genes. The higher values for cycle correspond to lower expression level of target genes (XN). 
The values were displayed independently from the control as the threshold cycle, since 
different types of the cells were compared within an experiment. The lower values for cycle 
represent the higher expression level of mRNA. The values detected later than cycle 30 are 
corresponding to the down-regulation of mRNA expression. Those signals are not 
significantly higher than the background of the reaction.  
 
8.3.8 Nucleic acid blotting and hybridization 
8.3.8.1 Northern blotting 
 
After having separated RNA molecules in a denaturing gel (section 8.3.2), RNA was 
transferred from the gel onto a positively charged nylon membrane (Hybond, Amersham 
Biotech) by capillary transfer. The RNA of interest was then identified by hybridisation with 
radioactive, 32P-labelled probes and visualisation using autoradiography as described in the 
following section (8.3.8.2). For the experimental setup a nylon membrane and Whatman™ 
filter papers were equilibrated in transfer buffer (20 x SSC) and the gel was soaked in RNase-
free water immediately after gel electrophoresis. Capillary transfer proceeded for 12-18 h. 
Afterwards, the membrane was neutralised in 2 x SSC and transferred RNA was fixed to the 
membrane by UV-crosslinking (350 nm) for 100 sec and subsequent incubation (2 h, 80°C). 
Membranes were stored between Whatman™ filter papers at room temperature until further 
use (Sambrook J., 1989).  
 
20 x SSC   3 M  NaCl 
    0.3 M  sodium citrate 
 
8.3.8.2 Preparation of   -32P-labelled DNA probes 
 
For probing northern blots radioactive labelled DNA samples were generated by using the 
MegaprimeTM DNA labelling system (Amersham Biotech) according to the supplied protocol. 
After denaturation of purified DNA the Klenow fragment of E. coli DNA polymerase 
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synthesises a second DNA strand and incorporates 32P-labelled dCTP starting at the random 
primer present in the reaction mix. This primer mix contains nonanucleotides, which 
statistically bind 80-100 nucleotides along the template. 
To 25 ng DNA and 5 µl random primer solution the appropriate volume of water was added 
to give a final volume of 50 µl in the final MegaprimeTM reaction. After 5 min of denaturation 
at 100°C, 10 µl labelling buffer, 5 µl dCTP32 (10 µCi/µl) and 2 µl enzyme were added and 
incubated for 15 min at 37°C. The reaction was stopped by applying 5 µl EDTA (0.2 M) to 
chelate the bivalent cations needed for the reaction. The radioactive probes were then purified 
from non-incorporated 32P-labelled dCTP by size exclusion using MicroSpinTM G-50 
Columns (Amersham Biotech) before the activity was measured by a scintillation counter 
(Beckmann). 
 
8.3.8.3 Hybridization 
 
To identify and visualize specific mRNA molecules the radiolabelled probes were hybridized 
to the nucleic acids bound onto the nylon membrane. Before hybridization the membranes 
were equilibrated with 10 mg/ml denatured herring sperm DNA-containing hybridisation 
solution at 42°C overnight to minimise unspecific binding of the probe to the membrane 
afterwards. For hybridization the radiolabelled probe was denatured at 100°C for 10 min, 
chilled on ice and finally added to the hybridization solution. Hybridization was performed 
overnight at 42°C in a rotation incubator. 
 
Hybridization solution 5 x  SSPE 
    50%  formamide (v/v) 
    5 x   Denhardt solution 
    1%   SDS(w/v) 
    10%  dextrane sulphate sodium salt (w/v) 
 
20 x SSPE   3 M   NaCl 
    0.2 M  NaH2PO4·H2O 
    0.02 M EDTA 
      pH 7.4 
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100 x Denhardt solution 2% (w/v) Ficoll 
    2% (w/v) polyvinylpyrrolidone 
    2% (w/v)  bovine serum albumin 
 
8.3.8.4 Washing 
 
Unspecifically bound radiolabelled probes were removed by separate washing. Membranes 
were washed twice with low stringent buffer (2 x SSPE) for 15 min at room temperature, then 
twice with medium stringent buffer (2 x SSPE, 2% (w/v) SDS) for 15 min at 65°C. After 
monitoring the radioactivity of the membrane, high stringent buffer (0.1 x SSPE) was applied 
at room temperature as long as no further background activity could be monitored. For 
visualisation by autoradiography, the membranes were exposed to Hyperfilms (Amersham 
Biotech) at -70°C for some hours up to some days depending on signal intensity. 
 
20 x SSPE   3 M   NaCl 
    0.2 M  NaH2PO4·H2O 
    0.02 M EDTA 
      pH 7.4 
 
8.3.8.5 Stripping 
 
In order to normalize the RNA quantity transferred to the membrane, blots needed to be 
stripped and probed with   -32P-labelled GAPDH afterwards. Therefore, initially applied 
radioactive probes were removed by heating the membrane in stripping solution for 10 min at 
100°C. 
Stripping solution  0.015 M NaCl 
0.1 x   SSC 
1%  SDS (w/v) 
 
20 x SSC   3 M   NaCl 
    0.3 M   dehydrate sodium citrate (C6H8O7Na3 . 2 H2O) 
      pH 7.0 
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8.3.9 Cloning and ligation 
 
The construction of vectors was performed by two different ways. Either DNA was generated 
by PCR, purified by agarose gel electrophoresis and isolation from the gel, digested at the 
primer sites and cloned into a vector of choice which was linearised using the same restriction 
endonucleases. In case of single cut reaction the vector was dephosphorylated with shrimp 
alkaline phosphatase (0.1 U/µl) (Roche) before the ligation (30 min, 37°C). Alternatively, 
DNA was generated by PCR and directly cloned into a pT-Adv Vector (Clontech) or PCR 2.1 
(Invitrogen) by TA-cloning. In both cases ligation mixes were transformed into E.coli 
competent cells to amplify plasmids. Subsequently, plasmids were isolated, analysed by 
restriction digestion and sequence analysis. All vectors are listed in appendix F .  
 
8.3.9.1 Restriction 
 
1 to 5 µg of DNA (either plasmids or PCR-fragments) were cut by 1 µl restriction 
endonucleases (10 U/µl, New England Biolabs, NEB) in the presence of 2 µl of the 
appropriate 10-fold concentrated reaction buffer in a final volume of 20 µl. The restriction 
mix was incubated for 90 min at 37°C. In case of plasmids the restriction reaction was 
controlled by gel electrophoresis and the linearised DNA or the insert were directly purified 
by the QIAquick Gel Extraction Kit (Qiagen) similar to the protocol given in section 8.3.3.  
8.3.9.2 Ligation 
 
Prior to ligation the concentration of purified and restricted DNA was estimated from agarose 
gel as described in section 8.3.1. The vector/insert-ratio was adjusted to 1:3 for best ligation 
efficiency. The ligation was carried out at 14°C overnight using 1 µl T4-DNA ligase (6 U/µl) 
(NEB), 2 µl 10 x ligation buffer (NEB), vector and insert DNA in the calculated ratio. ddH2O 
was applied to a final volume of 20 µl. The ligation mix was stored until transformation into 
E .coli cells. 
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8.3.9.3 TA-cloning 
 
TA-cloning was performed as described by Clontech´s user manual. During PCR 
thermostable Taq polymerase adds a single desoxyadenosine (A) to the 3´end and the pT-Adv 
Vector, with its 3´T-overhangs, enables to directly clone a product. Fresh PCR products and 
50 ng pT-Adv (or PCR 2.1) vectors were added to 1 µl ligation buffer and 1 µl T4-DNA 
ligase (4U/µl) in a final volume of 10 µl. The ligation reaction was incubated at 14°C either 
for 4 h or overnight and finally transformation into E.coli cells was performed.  
 
8.4 Microbiology 
 
All microbiological procedures were done in a laminar flow hood (Flow BSB 4a) with sterile 
devices and solutions according to security level 1 conditions. Liquid cultures were carefully 
shaken and LB-plates were kept in an incubator. Both, liquid cultures and plates were 
incubated at 37°C. 
 
8.4.1 Preparation of competent E. coli cells 
 
To produce competent E. coli cells the bacteria were streaked out for a single colony on LB-
plates. One colony was inoculated into 10 ml LB-medium and incubated in a shaker overnight 
at 37°C. The next day 100 ml LB-medium were inoculated with approximately 5 ml of 
overnight culture to give a final optical density of OD600 = 0.1 and the bacterial suspension 
was grown to OD600 = 0.7 – 1.0 at 37°C. 50 ml of the culture were centrifuged (5 min, 
4500 x g, 4°C), resuspended in 20 ml ice-cold 0.1 M MgCl2-solution, and incubated for 
10 min on ice. After a second centrifugation (5 min, 4500 x g, 4°C), the pellet was 
resuspended in 20 ml ice-cold 0.1 M CaCl2-solution and kept on ice for further 25 min. 
Finally, the suspension was again centrifuged (5 min, 4500 x g, 4°C), the pellet was 
resuspended in 2 ml ice-cold 0.1 M CaCl2-solution and 500 µl glycerol (100%) were added to 
immediately freeze cells in liquious nitrogen in 100 µl aliquots for storage. Competent cells 
were stored at -70°C. 
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LB-medium   1%  peptone (w/v) 
    0.5%  yeast extract (w/v) 
    1%   NaCl (w/v) 
 
LB-plates   LB-medium 
1.5%  agar (w/v) 
 
8.4.2 Transformation of E.coli cells 
 
For transformation one aliquot (100 µl) of competent E.coli cells was thawed on ice, either 
10 µl of ligation mix or 1 µl of isolated plasmid-DNA was added and the mixture was 
incubated on ice for 30 min. To allow the DNA to permeate the cell membrane, cells were 
heat shocked at 42°C for 2 min. After 5 min on ice, 300 µl LB-medium were added and the 
mixture was incubated at 37°C for 1 h. Cells were then plated onto LB plates containing the 
antibiotic ampicillin (50 µg/ml) and incubated at 37°C until single colonies were grown. In 
case of blue/white screenings 0.01% X-Gal (w/v) and 0.1 mM IPTG had been spread 
additionally on the LB-plates before. 
 
8.4.3 Cultures of E. coli cells 
 
In order to isolate plasmid-DNA or to make glycerol stocks one single colony of choice was 
picked and inoculated in 3 ml LB-medium containing ampicillin (50µg/ml) overnight at 37°C 
until the culture was saturated. 
 
8.4.4 Storage of E. coli cells 
 
For long time conservation 700 µl of a saturated bacterial suspension was mixed with 300 µl 
of glycerol (100%) and stored at -70°C. 
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Appendix A: Abbreviations 
APS     ammonium peroxodisulfate 
BM    basement membrane 
BBB     blood-brain barrier 
BCEC     brain capillary endothelial cells 
BCSFB   blood-cerebrospinal fluid barrier 
bFGF    basic fibroblast growth factor 
bp base    pair(s) 
BSA     bovine serum albumin 
 
cDNA     complementary deoxyribonucleic acid 
Cl-5     claudin - 5 
CNS     central nervous system 
CM    conditioned medium 
CIV    collagen type IV 
CSF     cerebrospinal fluid 
 
Da     Dalton 
dATP     deoxyadenosine triphosphate 
dCTP    deoxycytosine triphosphate 
dd     double distilled 
ddNTP    didesoxynucleoside triphosphate 
dGTP     deoxyguanosine triphosphate 
DiI      1,1`-Dioctadecyl-1-3,3,3`,3`-tetramethyl-indocarbo-cyaninperchlorate 
DIV     day(s) in vitro 
DLB    domain lysis buffer 
DMEM    Dulbecco’s Modified Eagle Medium 
DMF     dimethylformamide 
DMPC    dimethylpyrocarbonate 
DMSO    dimethylsulfoxide 
DNA     deoxyribonucleic acid 
dNTP     deoxynucleoside triphosphate 
ds     double-stranded 
DTT     dithiothreitol 
dTTP     desoxytyrosinetriphosphate 
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E. coli    Escherichia coli 
ECIS    electric cell substrate sensing 
ECM    extracellular matrix  
EDTA    ethylendiamine tetraacetic acid 
EGF    endothelial growth factor 
EHS    Engelbreth-Holm-Swarm 
EMMPRIN   extracellular matrix metalloproteinase inducer 
 
FACS    fluorescence activated cell sorting  
f.c.     final concentration 
FCS     fetal calf serum 
FN    fibronectin 
for    forward 
 
g     acceleration due to gravity (9.81 m/s2) 
GAPDH    glyceraldehyde-3-phosphate dehydrogenase 
GDNF    glial cell line derived neurol trophic factor  
GFP    glial fibrillary acidic protein 
GGT      -glutaryltranspeptidase 
 
h    hour(s) 
HC    hydrocortisone 
Hepes    2-[4-(2-hydroxyethyl)-1-piperazinyl]-ethanesulfonic acid 
HMW    high molecular weight marker  
kb     kilo base 
kDa     kilo Dalton 
 
LAM    laminin  
L     liter 
LB     Luria and Bertami 
LMW    low molecular weight marker 
 
M     molar (mol/l) 
MDCK    Madin-Darby Canine Kidney Cell  
min     minute(s) 
MMPs     matrix metalloproteinases  
MOPS    [N-morpholino]-propylsulfonic acid 
mRNA    messenger ribonucleic acid 
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MW     molecular weight 
 
NCBI     National Centre for Biotechnology Information 
NCS     newborn calf serum 
OD     optical density 
 
p.a.     pro analysis 
PAEC     porcine aorta endothelial cells 
PAGE     polyacrylamide gel electrophoresis 
PBCEC    porcine brain capillary endothelial cells 
PBS     phosphate buffered saline 
PCR     polymerase chain reaction 
PDS    plasma derived bovine serum 
PECAM-1   platelet endothelial cell adhesion molecule (CD-31) 
PDGF    platelet-derived growth factor 
 
QRT-PCR   quantitative real-time polymerase chain reaction 
 
       density 
RNA     ribonucleic acid 
Rev    revers 
rpm     rounds per minute 
rRNA     ribosomal ribonucleic acid 
RT     reverse transcription 
 
SDS     sodium dodecyl sulfate 
sec     seconds 
SSC     standard saline citrate 
SSH     subtractive suppression hybridisation 
 
TEMED   N,N,N’,N’-tetramethylethyldiamine 
TEER    transendothelial/epithelial electrical resistance 
TEM     transmission electron microscopy 
TIMPs    tissue inhibitors of matrix metalloproteinases 
TGF-β    transforming growth factor 
TNF-α    tumor necrosis factor  
Tris    tris-(hydroxymethyl)-aminomethane 
TA    Annealing temperature 
U     unit 
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UV     ultra violet 
 
V     voltage 
VE    vascular endothelial 
VEGF    vascular endothelail growth factor  
VIS     visible 
v/v     volume per volume 
vol     volume 
vWF    von-Willebrand-Factor 
 
W     watt 
w/v    weight per volume 
WWU    Westfälische Wilhelms-Universität 
 
ZO     zonula occludens 
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Appendix B: Materials and devices  
Cell culture devices 
 
Autoklav, Tuttnauer 3870 EL Systec, Wettenberg 
Incubators BB 6220 CU 
                       IR 1500 
                       IG 150 
Heraeus, Düsseldorf 
Flow, Meckenheim 
Jouan, Unterhachingen 
Hemacytometer (Bürker) Fischer, Frankfurt 
Inverse phase-contrast microscope Nikon, Düsseldorf 
Centrifuge J2-21 with Rotor JA-14 (cold) Beckman, München 
Other centrifuges in the lab Heraeus, Düsseldorf 
Steril flows BSB 6A und BSB 4A Gelaire, Meckenheim 
Sterilisator UT 6120 Heraeus, Düsseldorf 
Water bath GFL 1004 GFL, Burgwedel 
 
Cell culture solutions 
 
Collagen G (I+III type) Seromed, Berlin 
Collagenase/dispase (from Vibrio alginolyticus) Boehringer Mannheim 
Collagen type IV (100µg/ml) Sigma, Deisenhofen 
Dextran Sigma, Deisenhofen 
DMEM/Ham´s F-12  Sigma, Deisenhofen 
FCS (foetal calf serum) PAA, Linz (A) 
Fibronectin (100µg/ml) Sigma, Deisenhofen 
Gentamycin Sigma, Deisenhofen 
Hydrocortisone  Sigma, Steinheim 
Laminin (from EHS) BD Biosciences 
L-Glutamin (200mM) Seromed, Berlin 
M199 (1x and 10x) Seromed, Berlin 
NGS (new-born calf serum) PAA, Linz (A) 
Penicillin/Streptomycin (10mg/ml) Seromed, Berlin 
Percoll Sigma, Deisenhofen 
Protease/dispase (from Bacillus polymyxa) Sigma, Deisenhofen 
Rat tail collagen  WWU Muenster 
Trypsin (0.25%) w/v in PBS  Seromed, Berlin 
 
 
Protein biochemistry 
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Semi-dry blotting equipment  Sigma, Steinheim 
Developer for the films AGFA Curix 60 AGFA, Leverkusen 
SDS-Gelelektrophorese (Minigel 10 x 10 cm) Sigma, Steinheim  
Voltage device EPS 100 Amersham Biotech, Freiburg 
Elektrophoresis Power Supply PowerPac 2000 BioRad 
 
Biophysi s 
 
ECIS-Elektrode arrays Applied Biophysics, Troy, USA 
Frequence generator Solartron Instruments, GB 
Impedance analysator SI-1260 Solartron Instruments, GB 
 
Others 
 
Balance Sartorius,Göttingen 
Fluorescence microscope Diaphot TMD Nikon, Düsseldorf 
Fluorescence Spectrometer LS 50 B Perkin-Elmer, Überlingen 
Inverse-phase contrast microscope Leica, Wetzlar 
Confocal Laser Scanning Microscope (CLSM) Leica, Wetzlar 
Milli Q RO 10 Plus clean water device Millipore, Eschborn 
Milli Q plus 185 clean water device Millipore, Eschborn 
pH Meter Knick 761 Calimatic  Knick, Berlin 
pH-Elektrode InLab423
 
Mettler Toledo, Steinbach 
Table centrifuges 5804 und 5415 Eppendorf, Hamburg 
UV/Vis-Photometer UV-1601 PC Shimadzu, Gießen 
Vortexer IKA-VibraxVXR IKA Labortechnik, Staufen 
 
Materials 
 
Glas coverslips Roth, Karlsruhe 
Hyperfilm RPN 2115 K Amersham Biotech, Freiburg 
Kryo tubes Nunc, Wiesbaden 
Microcon YM-30, Nr. 42409 Millipore, Eschborn 
Mikrotiterplates Nunc, Wiesbaden 
Multiwell cell kulture plates Costar, Bodenheim 
Nitrocellulose-Membran Hybond ECL RPN 203 D Amersham, Freiburg 
Petri dishes Greiner, Frickenhausen 
Polycarbonate cell culture filter substrate Transwell No. 3401 Costar, Bodenheim 
Skalpel Bayha, Tuttlingen 
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Sterile filters Minisart 0,2 µm Sartorius, Göttingen 
Whatman-Paper No.1 und No.3 Whatman, Maidstore, UK 
Cell culture flasks Nunc, Wiesbaden 
Rubber policeman  Costar, Bodenheim 
Centrifuge tubes Greiner, Frickenhausen 
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Appendix C: WWW links  
www.ub.uni-bielefeld.de/netahtml/jaso1.html  Jason: ordering of literature 
www.uni-muenster.de/ULB/Welcome.html   Uni-Muenster: download of papers 
Medline: literature search 
www.embl-heidelberg.de/srs5/    Genbank, EMBL: sequence data bases 
www.ncbi.nlm.nih.gov/   NCBI: sequence alignment, basic blast 
search, PubMed 
www.pubmed.de/index.plip3    literature data bases 
www.sigmaaldrich.com    chemical search service 
www.expasy.ch/   Expert Protein Analysis System Molecular 
Biology Server 
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Appendix D: DiIC18(3) structure  
 
 
1,1'-Dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (C59H97ClN2O4) 
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Appendix E: Genotypes of Escherichia coli K12 strains  
TOP10F This strain can be used for general cloning and blue/white screening without IPTG. 
F- mcrA 
  (mrr-hsdRMS-mcrBC)  80lacZ  M15   lacX74recA1 deoR araD139 
  (ara-leu)7697 galU galK rpsL (StrR) endA1 nupG 
 
TOP10F’ This strain exresses the Lac repressor (lacIq gene). For blue/white screening 
IPTG has to be added to obtain expressing from the lac promoter. This strain 
contains the F episome and can be used for single-strand rescue of plasmid 
DNA containing an f1 origin. 
F’ [lacIq Tn10(TetR)] mcrA   (mrr-hsdRMS-mcrBC)  80lacZ  M15 
  lacX74recA1 deoR araD139   (ara-leu)7697 galU galK rpsL (StrR) endA1 
nupG 
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Appendix F: Sequences  
Primer sequences: PCR 
 
All primers for PCR were purchased from MWG Biotech and are listed in 5´-3-orientation. 
 
Collagen type IV  for  GCAGTGCACAGCCAGACCATCCAG 
    rev  CCAAGCCGTCCAACTTNAAGGCCGG 
 
Fibronectin   for   GCCAGGTTGGTGATGTCCTTCGGG 
    rev   GTCCCTTAGTCCAGATAGGTCCAA 
 
Laminin β1   for   GGGTGCCTTGGATAGCATTA 
    rev   TGGAGAGCTGTTCCACTTCA 
 
Laminin γ1   for   GCCCAGGATGTCAAAGATGT 
    rev   AACAAGCTGCCCGAGTACAT 
 
Laminin α4   for   TCTCAGCAATCTCCAGCTCA 
    rev   TCTACTGACACCACGCTTGG 
 
MMP-2   for   CACCTACACCAAGAACTTCC 
    Rev   AACACAGCCTTCTCCTCCTG 
 
MMP-9   for   GGAGACCTGAGAACCAATCTC 
    rev   TCCAATAGGTGATGTTGTCGT 
 
Primer sequences: QRT-PCR 
Primers for QRT-PCR were purchased from Proligo  
 
β-actin   for   TCCAGAGGCGCTCTTCCA 
    rev  CGCACTTCATGATCGAGTTGA 
 
Collagen type IV   for  CATCTCGCTCCGCTCTATGG 
rev  CGCGGGACCTGCAATTACTA 
Claudin – 5   for  CTCTGCTGGTTCGCCAACAT 
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rev  CCAGCTCGTACTTCTGCGACA 
 
Fibronectin    for  GCACGAGAGCTTAAAGCCAGA 
rev  TCGACCCCTACACGGTTTCC 
 
GAPDH   for   TCCACTACATGGTCTACATGT 
    rev  AGATGGTGATGGGATTTCCAT 
Laminin γ1   for  CAGAGAACTGGAGAAAGCAAAGGT 
rev  TGTTGTTTGGGTCCCCTGTAG 
 
MMP-2    for  GGCTTGTCACGTGGTGTCACT 
rev  ATCCGCGGCGAGATCTTCT 
 
MMP-9    for  GAAGCTTTAGAGCCGGTTCCA 
rev  GGCAGCTGGCAGAGGAATATC 
 
Occludin    for  GGAGGAAGACTGGATCAGGGAAT 
rev  GCCACTGTCAAAATTTCTCTTGTAGAG 
 
TIMP-1    for  CAAAACTGCAGGTGGTGATGTG 
    rev  CGCAGCCAGGAGTTTCTCAT 
 
TIMP-2    for  CAGGTACCAGATGGGCTGTGA 
    rev  ACTCGTCCGGAGAGGAGATGTAG 
 
TIMP-3    for  GTACCGAGGCTTCAC 
rev  GCTTCTGTGTGGATATAC 
 
ZO-1     for  AACGTGTCAACGCCACTATCA 
rev  CCTGCTTCTCCAAAAACTCTT 
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Appendix G: clone charts  
Vectors designed for probing and sequencing: 
 
porcine GAPDH in pT-Adv (provided by Tanja Eisenblätter) 
RT-PCR (total RNA from PBCEC, GAPDH-for and GAPDH-rev, TA 55°C); TA-cloning 
 
porcine collagen type IV in PCR 2.1 
RT-PCR (total RNA from PBCEC, collagen type IV-for and collagen type IV-rev, TA 60°C); TA-cloning 
 
porcine fibronectin in pT-Adv (provided by Tanja Eisenblätter) 
RT-PCR (total RNA from PBCEC, fibronectin-for and fibronectin-rev, TA 50°C); TA-cloning 
 
porcine laminin γ1 in PCR 2.1 
RT-PCR (total RNA from PBCEC, laminin γ1-for and laminin γ1-rev, TA 55°C); TA-cloning 
 
porcine laminin β1 in PCR 2.1 
RT-PCR (total RNA from PBCEC, laminin β1-for and laminin β1-rev, TA 50°C); TA-cloning. 
 
porcine laminin α14 in PCR 2.1 
RT-PCR (total RNA from PBCEC, laminin α4-for and laminin α4-rev, TA 56°C); TA-cloning. 
 
porcine MMP-2 in PCR 2.1 (provided by Patrick Zeni) 
RT-PCR (total RNA from PBCEC, MMP-2-for and MMP-2-rev, 53°C); TA-cloning. 
 
porcine MMP-9 in PCR 2.1 (provided by Patrick Zeni) 
RT-PCR (total RNA from PBCEC, MMP-9-for and MMP-9-rev, TA 49°C); TA-cloning. 
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pT-Adv-Vector (Clontech) 
 
pTAdv-Clontech
3906 bps
500
1000
1500
2000
2500
3000
3500
HindIII
Acc65I
KpnI
Ecl136II
SacI
BamHI
SpeI
AflII
EcoRV
NotI
AvaI
XhoI
NsiI
Ppu10I
XbaI
EcoO109I
ApaI
Bsp120I
DraIII
BstAPI
XcmI
BglII
BclI
MscI
Tth111I
BssHII
DsaI
NcoI
RsrII
XmnI
ScaI
TatI
BpmI
BsaI
AhdI
BspHI
BspLU11I
 
 
PCR 2.1-Vector (Invitrogen) 
 
PCR2.1
4047 bps
1000
2000
3000
4000
FseI
HindIII
Acc65I
KpnI
Ecl136II
SacI
BamHI
SpeI
AflII
EcoRV
NotI
AvaI
XhoI
XbaI
BglII
BclI
MscI
Tth111I
SacII
BssHII
NcoI
RsrII
EcoNI
ScaI
TatI
ApaI
Bsp120I
BpmI
BsaI
AhdI
BspHI
Eco47III
BspLU11I
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Appendix H: List of table and figure captions  
Table captions 
 
Table 2 1. Central nervous system disorders involving BBB dysfunction  25 
Table 2 2. Functions of the basement membrane (modified from Lindblom et al.) 32 
Table 2 3. The structures of collagen molecules     34 
Table 2 4. Classification of known Matrixmetalloproteinases (Cawston, 1996; Chandler et 
al., 1997; Yong et al., 1998)        41 
Table 7 1. Summarized results of tight junction and ECM protein expression in PBCEC 
compared to PAEC on RNA and protein levels     135 
Table 7 2. Morphology of cell-cell and cell-substrate contacts in PBCEC and PAEC 
cultured on different ECM coatings       137 
Table 8 1. Primary antibodies used in FACS      151 
Table 8 2. Secondary antibodies used in FACS     152 
Table 8 3. Acrylamide concentration for separation of proteins   154 
Table 8 4. Compounds of SDS-gels       154 
Table 8 5. Antibodies for western blotting      156 
Table 8 6. Primary antibodies used in immunofluorescence staining   158 
Table 8 7. Secondary antibodies used in immunofluorescence staining  158 
Table 8 8. Concentrations of agarose gels      162 
 
 
Figure captions 
 
Figure 2-1. Schematic view of the mammalian brain     7 
Figure 2-2. Micrograph of a brain capillary in a cross-section (A) and a three dimensional 
view with astrocytes (B) (Krstic, 1988)      9 
Figure 2-3. Transcellular and paracellular ways of the permeability through the endothelial 
cell monolayer        13 
Figure 2-4. Molecular structure of tight junctions      16 
Figure 2-5. Glial cells in the CNS        18 
Figure 2-6. Schematic draw showing some features of the perivascular astrocytic endfeet, 
which form „rosette“ like structures on the brain capillary surface   20 
Figure 2-7. Pericyte function        23 
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Figure 2-8. Schematic representation of the multiple pathways activated by hypoxia and 
ischemia that lead to brain edema, hemorrhage or cell death   27 
Figure 2-9. Schematic view of an arterial wall in cross-section    28 
Figure 2-10. Schematic representation of integrins     31 
Figure 2-11. Schematic view of the capillary separated from the other cells by a basement 
membrane (A) and the scanning electron microscopic image of the BM (B) 33 
Figure 2-12. Laminin is a trimer of α, β and
 
 γ-subunits

 
     36 
Figure 2-13. Domain structure of the MMPs      44 
Figure 2-14. Regulation of the MMPs       45 
Figure 2-15. Mechanism of pro-matrix metalloproteinase 2 (pro-MMP-2) activation. 47 
Figure 4-1. The changes in resistance (A) and capacitance (B) as a function of frequency 
and time during the attachment and spreading of brain capillary endothelial cells on 
ECIS electrodes         53 
Figure 4-2. Time course of cell spreading on a culture substrate and the concomitant 
increase of the adhesion area´s projection on the substrate   53 
Figure 4-3.  The time course of capacitance measured at 40 kHZ for PBCEC freshly 
subcultured on collagen type I+III in SFM      56 
Figure 4-4. The time course of capacitance measured at 40 kHz for PBCEC cultured on 
collagen type I+III mixture        57 
Figure 4-5. The time course of capacitance measured at 40 kHz for PBCEC cultured on 
collagen type I+III mixture        58 
Figure 4-6. (A): Time course of the capacitance measured at 40 kHz. (B): The resistance 
measured at 400 Hz for PBCEC cultured on different ECM coatings  60 
Figure 4-7. Collagen type IV accelerates the development of the transendothelial electrical 
resistance in PBCEC.         61 
Figure 4-8. The expression of the main integrin α subunits in PBCEC measured by FACS
          64 
Figure 4-9. The expression of the β1 integrin subunit in PBCEC measured by FACS 64 
Figure 5-1. Detection of extracellular matrix proteins by immunofluoresecence staining in 
PBCEC          67 
Figure 5-2. Detection of extracellular matrix proteins by immunofluorescence staining in 
PAEC           68 
Figure 5-3. Detection of extracellular matrix proteins by immunofluorescence staining in 
pericytes          69 
Figure 5-4. Detection of extracellular matrix proteins by immunofluorescence staining in 
astrocytes          69 
Figure 5-5. Collagen type IV (A) and fibronectin (B) expression in PBCEC and PAEC 
cultured on different ECM        71 
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Figure 5-6. Collagen type IV expression in PBCEC and PAEC cultured on different ECM
          72 
Figure 5-7. Fibronectin expression in PBCEC and PAEC cultured on different ECM 72 
Figure 5-8.  Detection of amplificated DNA message of sequenced sus scrofa collagen 
type IV (α1-chain) in PBCEC (1) and PAEC (2) with RT-PCR   74 
Figure 5-9. The comparison of sequence data of sus scrofa collagen type IV (α1-chain)-
fragment (283 bp) with mRNA of homo sapiens collagen type IV (α1-chain) 74 
Figure 5-10. The comparison of sequence data of laminin β1-fragment (442 bp) with mRNA 
of sus scrofa laminin β1-chain       75 
Figure 5-11. The comparison of sequence data of laminin γ1-fragment (497 bp) with mRNA 
of homo sapiens laminin γ1-chain (formerly LAMB2)    76 
Figure 5-12. The comparison of sequence data of laminin α4-fragment (499 bp) with mRNA 
of homo sapiens laminin α4-chain (LAMA4)      77 
Figure 5-13. The comparison of sequence data of fibronectin-fragment (780 bp) with mRNA 
of Bos taurus fibronectin precursor       78 
Figure 5-14. Results of QRT-PCR        79 
Figure 5-15. Different types of cell lysis for ECM denudation    82 
Figure 5-16. A phase-contast micrographs (A) and immunostaining of α1β1-integrin (B) in 
PBCEC after cell lysis with 20 mM of ammonia solution    83 
Figure 5-17. Immunostaining against collagen type IV (A) and α1β1-integrin (B) in PBCEC 
after the treatment of cell monolayers with a lysis buffer    83 
Figure 5-18. Phase-contrast images of rat astrocytes (A), porcine pericytes (B), PBCEC (C) 
and PAEC (D)          85 
Figure 5-19. Time course of the capacitance measured at 40 kHz (A) and the resistance 
measured at 400 Hz for PBCEC cultured on endogenously-derived ECM (B) 86 
Figure 5-20. The influence of different components of the basement membrane on the 
transendothelial electrical resistance (cell-cell contacts) of PBCEC  87 
Figure 5-21. Phase-contrast photomicrographs of porcine aorta (A) and brain (B) 
endothelial cells         89 
Figure 5-22. Immunofluorescence labelling of tight junction proteins in PAEC  89 
Figure 5-23. Time course of the capacitance measured at 40 kHz for PAEC (A) and 
resistance measured at 400 Hz for PAEC (B)     90 
Figure 5-24. Micrographs of TEM-images of PAEC and PBCEC cultured on different ECM 
substrates          93 
Figure 5-25. Effect of endogenously-derived ECM on the PBCEC-morphology  94 
Figure 5-26. Change in expression of occludin (A), ZO–1 (B) and claudin–5 (C) in PBCEC 
and PAEC after culturing of these cells on different ECM coatings   96 
Figure 5-27. Change in expression of occludin (A), ZO–1 (B) and claudin–5 (C) expression 
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in PBCEC and PAEC cultured on different ECM     97 
Figure 5-28. Results of QRT-PCR        98 
Figure 6-1. Secretion of MMP-9 by pericytes into the culture medium and into their ECM
          102 
Figure 6-2. Secretion of MMP-9 by astrocytes into the culture medium and into their ECM
          103 
Figure 6-3. Secretion of MMP-2 and MMP-9 by pericytes (P) and astrocytes (A) in serum-
supplemented and serum-free medium (SFM)     104 
Figure 6-4. Comparison of MMP-9 and MMP-2 expression level in pericytes  105 
Figure 6-5. Comparison of MMP-9 and MMP-2 expression level in astrocytes  106 
Figure 6-6. The secretion of TIMP-1 and TIMP-2 by pericytes    107 
Figure 6-7. The secretion of TIMP-1 and TIMP-2 by astrocytes    108 
Figure 6-8. The mRNA expression level of TIMP-1, TIMP-2 and TIMP-3 in pericytes 
compared to astrocytes        109 
Figure 6-9.  ECM synthesis by pericyte and astrocyte cultures on RNA level  110 
Figure 6-10.  MMP-2 and MMP-9 secretion by PAEC in serum-supplemented and serum-
free medium (+HC, 550 nM)        112 
Figure 6-11. The expression of MMP-9 and MMP-2 and their inhibitors - TIMP-1, TIMP-2 
and TIMP-3 in PAEC compared to PBCEC      113 
Figure 6-12. Immunofluorescence staining of PBCEC in vitro:    116 
Figure 6-13. The expression of PECAM-1 in PBCEC     117 
Figure 6-14. PBCEC show a higher MMP-9 secretion in co-culture with pericytes (-Pur) 
compared to a pure endothelial cell culture (+Pur)     118 
Figure 6-15. Western blot analysis of MMP-9 secretion in PBCEC cultured in pericytes free 
(+Pur) and pericytes present cultures ( Pur)      119 
Figure 6-16. Results of QRT-PCR. PBCEC were cultured in presence of pericytes (-Pur) 
and free of pericytes (+Pur)        120 
Figure 6-17. The MMP-2 and MMP-9 secretion in PBCEC supernatants  122 
Figure 6-18. Western blotting analysis of conditioned medium collected from apical side of 
filter-grown PBCEC co-cultured with pericytes (3) and astrocytes (4), as well as 
pericytes (1) and astrocytes (2) alone      124 
Figure 6-19.  Fluorometric measurement of MMP-activity in conditioned supernatants 125 
Figure 6-20. TEER of PBCEC monolayers with (-Pur) or without (+Pur) direct contact to 
pericytes as well as in indirect co-culture with pericytes and astrocytes  127 
Figure 6-21.  Time course of capacitance (A) measured at 40 kHz and resitance (B) 
measured at 400 Hz for PBCEC monolayers     129 
Figure 6-22. Time course of capacitance (A) measured at 40 kHz and resistance (B) 
measured at 400 Hz for the second generation of PBCEC    129 
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Figure 7-1. Comparison of importance of purified extracellular matrix proteins for BBB 
formation of PBCEC in vitro        132 
Figure 7-2. Comparison of importance of endogenously derived extracellular matrix for 
BBB formation of PBCEC in vitro       133 
Figure 7-3.  Schematic representation of the proposed involvement of MMP action in the 
ECM degradation at the BBB        140 
Figure 8-4.  Semilog diagram of the fluorescence signal intensity versus cycle 167 
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